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Mechanical ventilation (MV) is used to support or fully control patient breathing to treat
respiratory failure. Patients with respiratory failure, specifically acute respiratory dis-
tress syndrome (ARDS) and acute lung injury (ALI), require MV to fully control their
breathing and provide adequate positive end-expiratory pressure (PEEP) to prevent
alveolar lung collapse. ARDS patient have high mortality rates up to 60%, with signif-
icantly increased daily medical cost. Current practice in using MV to treat respiratory
failure is a mixture of clinician intuition and generalised one size fits all approaches,
which can lead to poor MV therapy care and ventilator-induced lung injury (VILI), in-
creasing time on MV and cost, while reducing patient outcomes.
Currently, there are growing trends towards individualising care in medicine. In venti-
lation care, model-based methods are applied to identify patient physiology and respi-
ratory mechanics to assist and guide ventilation therapy. Model-based methods can be
utilised to provide greater insight to patient condition and allow more optimal patient-
specific care. Optimal, personalised care would increase the quality of MV therapy and
decrease the duration of MV. It would also reduce VILI and, as a result, decrease mor-
tality and morbidity along with their associated costs.
Spontaneous breathing (SB) effort is when patients try to breath on top of the supported
iii
MV breathe. SB patients are generally transitioned into assisted spontaneous breath-
ing (ASB) ventilation modes, which synchronises with patient breathing and supports
breaths based on their demand, resulting in reduced overall work of breathing and in-
creased pulmonary gas exchange. However, SB breaths hinder the accuracy of identi-
fied patient-specific elastance. SB efforts can be highly variable and are not measurable
without invasive tests, but would be clinically useful to know. In this thesis, SB is quan-
tified utilising dynamic lung elastance Edrs. The time-varying elastance is the sum of
alveoli elastance, chest wall elastance and patient elastance generated by the patient de-
mand, and can be utilised to identify SB effort. The Edrs trajectory is used by itself and
again with proven basis function models to quantify patient demand and SB effort. The
SB effort is identified and validated using measured electrical activity of the diaphragm
(Eadi).
Preterm neonates are prone to respiratory failure syndrome (RDS) due to their prema-
turity, which sees reductions in alveoli growth and surfactant production. Thus, they
require MV therapy to assist breathing due to their lack of respiratory development.
Neonatal MV is common in the neonatal intensive care unit (NICU) and aims to min-
imise duration of MV as prolonged ventilation can lead to bronchopulmonary dysplasia
or VILI.
Infants are known to exhibit different pulmonary mechanics compared to adults, and
are also not widely studied. In this thesis, a first in-depth study on neonatal elastance
is presented. The well-validated single compartment model of pulmonary mechanics
is used to identify patient-specific elastance in this cohort, which consists of 535,428
breaths over N=10 patients. The model fit was good and was further validated by com-
paring with known physiological differences, such as weight, and use of surfactant.
Anecdotally, male infants are harder to ventilate than female infants. The sex differ-
iv
ences between male and female infants stems from their fetal growth stage where, fe-
male infants are typically more developed than males by 1.5-2 weeks. This thesis quan-
tifies sex differences in neonatal elatances and breath-to-breath variability of each co-
hort, a first of its kind result in MV for any cohort. Male infants shown higher specific
elastance than female infants and thus have lower variability. The results indicate the
potential for potentially entirely different approaches to MV care for male and female
pre-term infants.
This thesis presents analyses of lung physiology, pulmonary mechanics, and quantifica-
tion of SB efforts. These outcomes advances the state of the art in modelling and MV,
particularly with first of its kind, in-depth analyses and results in NICU MV. The physi-
ology and respiratory mechanics was successfully quantified in this cohort and further
validated in sub-cohort analyses. These results presented would provide good basis for
further clinical use of model-based methods in both adult and infant cohorts.
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Mechanical ventilation (MV) is required for patients with respiratory failure (Sundare-
san and Chase, 2012; Girard and Bernard, 2007; Major et al., 2018; Slutsky, 1999; Rose,
2010; Fan et al., 2018; Flaatten, 2013; Borges et al., 2006; Bos et al., 2018) and in particu-
lar, patients with a more severe form of respiratory failure, Acute Lung Injury (ALI) and
Acute Respiratory Distress Syndrome (ARDS). MV is an irreplaceable life support during
the course of treatment and recovery (Sundaresan and Chase, 2012; Girard and Bernard,
2007; Major et al., 2018; Slutsky, 1999; Rose, 2010; Fan et al., 2018; Flaatten, 2013; Villar
et al., 2013; Borges et al., 2006; Bos et al., 2018). Positive end-expiratory pressure (PEEP)
and tidal volume are the key ventilator parameters when treating ARDS and other forms
of respiratory failure (Villar et al., 2006; Girard and Bernard, 2007; Brower et al., 2000;
Amato et al., 1998; Meade et al., 2008; Mercat et al., 2008a; Oba et al., 2009; Briel et al.,
2010; Bos et al., 2018; Hickling et al., 1990). Equally, the use of low tidal volume settings
results in lower mortality rates (Villar et al., 2006; Brower et al., 2000; Bos et al., 2018;
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Amato et al., 1998; Hodgson et al., 2011; Hickling et al., 1990). It has also been proposed
that setting PEEP to where the lung had minimum elastance would be clinically bene-
ficial (Suarez-Sipmann et al., 2007; Carvalho et al., 2013a, 2007; Sundaresan et al., 2009;
Chiew et al., 2012) as, at this point, the lung has the largest volume for the least pres-
sure input, which minimises risk of overstretching the lung tissue and creating further
damage.
The current practice in treating respiratory failure is based on either clinician intuition
or a generalised, “one size fits all” approaches (Fan et al., 2017; Amerling et al., 2008; Fer-
nandez et al., 2015). Poor treatment increases the risk of ventilator-induced lung injury
(VILI) through poor choices in settings that either overdistend the lung or provide too
little support to maintain lung recruitment (Brochard et al., 2017; Fan et al., 2008; Pannu
and Mehta, 2004; Parker et al., 1993; Gattinoni et al., 2003; Dreyfuss and Saumon, 1998;
Slutsky and Ranieri, 2013a). The main outcomes of sub-optimal MV care are increased
risk of morbidity and mortality, especially in patients with ARDS. ARDS patients already
have mortality rates up to 60% and significantly increased medical cost per day (Dasta
et al., 2005; Phua et al., 2009). Therefore, any methods to improve care and shorten
the length of mechanical ventilation (LoMV) would significantly impact outcomes and
economic cost.
In addition, there are growing trends towards individualising care in medicine. How-
ever, in ventilation care, there has not been a significant study based employing person-
alised or patient-specific care (Chase et al., 2018). Tools such as ventilators, computers,
and other technology can measure, identify and perform care more precisely and effi-
ciently and yet the fundamental modes of treatment have not significantly changed in
the last 30 years.
Premature infants are one cohort which is highly susceptible to respiratory distress syn-
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drome (RDS), due to their prematurity at birth and thus have under-developed lungs
(Brown and DiBlasi, 2011; Liggins et al., 1972; Carroll and Agarwal, 2010; Jobe and Ikegami,
1998; Kotecha, 2000; Polin et al., 2014). Premature infants lack surfactant production in
their lungs to prevent lung collapse (atelectasis) and maintain alveoli recruitment (Jobe
and Ikegami, 1998; Brown and DiBlasi, 2011; Thomas, 1971; Goerke, 1998; Wood and
Jobe, 1993). Therefore, MV is vital tool used to treat RDS or othFer respiratory failure.
According to O’Donnell et al. (2004), 3-5% of newborn infants worldwide require resus-
citation at birth each year. This statistic makes it one of most frequently performed
aspects of care in the neonatal intensive care unit (NICU). There are various guidelines
(Sweet et al., 2010; Niermeyer et al., 2000; Kattwinkel et al., 1999) on how these pro-
cedures should be performed, but while they agree adequate ventilation is the key to
successful resuscitation, there is little agreement on the implementation of MV.
Utilising a model-based method can achieve greater understanding of the patient condi-
tion and allow better clinical judgement (Chase et al., 2011, 2018). Simple models allow
low computational requirement and can thus easily be applied clinical environment and
utilised in real-time to support clinicians by providing greater insight on patient-specific
underlying condition. Such tools would lead to much more personalised, patient-specific
care to reduce both length of mechanical ventilation and VILI, and as result, mortality,
cost and time.
1.2 Lungs
The major role of the lungs is to process gas exchange between oxygen, O2, and car-
bon dioxide, CO2. Gas exchange occurs between the lung alveolar air and blood of pul-
monary capillaries (Neumann and Von Ungern-Sternberg, 2014; West, 1975). The flow
of air into and out of the alveoli is ventilation (V) and the flow of blood to capillaries is
perfusion (Q). During inspiration, fresh oxygen is delivered to alveoli and during expi-
ration carbon dioxide is emitted. Clinically, it is common to measure the ratio of ventila-
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tion and perfusion to determine patient’s gas exchange, where a low V/Q ratio can lead
to hypoxemia (low oxygen level in the blood).
Although the major function of the lungs are to deliver gas exchange, lungs are con-
trolled by diaphragm. Diaphragm is a muscle that is located under the base of chest and
separates between chest and abdomen. During inspiration, the diaphragm contracts
and flattens creating a vacuum effect and pulls the air into the lungs through trachea
bifurcating into bronchus which branches into bronchioles and finally, into alveoli sacs.
The diaphragm relaxes during expiration and thus air is pushed out of the lungs. The
basic physiology of lung can be seen Figure 1.1
Gas exchange in the alveoli occurs primarily through diffusion. Oxygen travels from
the alveoli to capillary blood through alveolar surfactant,the alveolar epithelium, the
basement membrane, and the capillary endothelium (Goerke, 1998; Neumann and Von
Ungern-Sternberg, 2014; West, 1975). Alveolar surfactant or pulmonary surfactant is a
lipoprotein and lowers the surface tension the lungs and thus, prevents atelectasis (Go-
erke, 1998; Neumann and Von Ungern-Sternberg, 2014; West, 1975).
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Figure 1.1: Lung physiology structure. Image from FIRSTAID for free!. Url: https://www.firstaidforfree.com/
how-do-we-breath-a-guide-to-the-respiratory-system/
1.3 Mechanical Ventilation
Mechanical ventilation (MV) is used to treat respiratory failure. A ventilator either fully
controls or partially supports patient breathing with the goal of enduring efficient gas
exchange. This approach reduces the work of breathing done by the patient and allows
time for recovery. For patients with respiratory diseases like ARDS, it also prevents lung
collapse, also known as atelectasis (Pelosi et al., 2001; Halter et al., 2003). There has
been a great deal of research on setting optimal MV parameters, from which there is
consensus on the use of low tidal volumes as it has been shown to reduce mortality
and increase ventilator free days (VFD) (Brower et al., 2000; Girard and Bernard, 2007).
However, on other MV settings and parameters, there have only been conflicting results
(Amato et al., 1998; Villar et al., 2006; Meade et al., 2008; Briel et al., 2010), as reviewed
by Major et al (Major et al., 2018)
PEEP is known to reduce hypoxemia and intrapulmonary shunting in ARDS patients
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and the clinical practice of titrating PEEP ameliorates these effects (Mercat et al., 2008a).
PEEP-induced alveolar recruitment helps to avoid airway collapse and reopening, pro-
tects lung surfactant and improves ventilation homogeneity within the lung (Mercat
et al., 2008a). Although alveolar recruitment and oxygenation are often related, oxy-
genation is complex and affected by many factors and therefore should not be used as
a surrogate for recruitment (Mercat et al., 2008a).
Throughout the duration of MV therapy, patient condition will start to improve and
lower level of sedations will be used. Thus, patient will attempt to breathe by them-
selves on top of supported MV breathe. This natural breathing performed by the pa-
tient is called spontaneous breathing effort (SB). SB introduces both patient-ventilator
asynchrony and can lead to poor ventilation outcomes (Epstein, 2011; Chiew et al., 2018;
Freebairn and Hickling, 2005; Hickling et al., 1990; Major et al., 2018). Therefore SB pa-
tient would undergo assisted spontaneous breathing modes (ASB), which are designed
to support patients natural breathing. These modes are typically used as intermediate
steps before weaning the patients of MV.
ASB modes aim to reduce work of breathing done by the patient by synchronising with
patient breathing patterns while providing adequate pressure and oxygen. The amount
of pressure and oxygen are typically determined by patient-specific demand triggers.
ASB modes have been known to increase pulmonary gas exchange, systemic blood flow,
and oxygen supply to the tissue (Burchardi, 2004; Putensen et al., 2005; Spahija et al.,
2010; Brander and Slutsky, 2006; Freebairn and Hickling, 2005; MacIntyre, 1986).
Improved patient condition during ASB will lead to weaning the patient off MV and
from endotracheal tube (ETT) (Boles et al., 2007). This process is important and efficient
weaning process is desired as it reduces length of mechanical ventilation (LoMV). Re-
ducing LoMV through both efficient MV strategy and weaning will lead to lower chance
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of VILI, reduce significant costs associated with MV, and most importantly improved
patient care.
Mechanical Ventilation for preterm neonates is one of most commonly practiced forms
of MV care around the world (Sweet et al., 2013, 2010; Brown and DiBlasi, 2011). Treating
respiratory failures of preterm neonates require invasive MV. The risks of invasive MV
on infants is they are susceptible to inflammation and lung injury caused by the ventila-
tor. One cause of this injury is the lack of understanding of the physiological differences
between adult lungs and preterm neonate lungs.
Patient ventilator asynchrony or dyssynchrony can occur when MV is mis-matched with
patient breathing efforts. Asynchrony is common in the ICU occurring up to 25% venti-
lated patients (Mellott et al., 2014). Asynchrony may occur due to low sedation level or
poor ventilator settings, or ineffective triggering. In neonates, it may also occur when
infant is crying or coughing. Asynchrony in adults is known to be associated with signifi-
cant patient discomfort, poor gas exchange, VILI, prolonged ventilation and higher mor-
tality (Thille et al., 2006; Chao et al., 1997; Epstein, 2011; Mellott et al., 2014). However,
asynchrony in unstudied in neonates, but it is reasonable to assume a similar overall
negative impact.
1.4 MV in Adults
1.4.1 ARDS/ALI
The Berlin definition of ARDS is defined as a ratio of partial arterial oxygen pressure
and fractional inspired oxygen (PaO2/FiO2) less than 300mmHg (Flaatten, 2013; Ranieri
et al., 2012). The causes for ARDS are non-cardiogenic pulmonary edema, decreased
pulmonary compliance, and ventilation perfusion mismatch (Dunkel, 2006; Raghaven-
dran and Napolitano, 2011). The core treatment for ARDS is MV (Sundaresan and Chase,
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2012; Mertens et al., 2009; Brower et al., 2000, 2001; Brochard et al., 1998). MV is an ir-
replaceable form of life support during the course of treatment and recovery (Brower
et al., 2001). To treat ARDS/ALI, high doses of oxygen and PEEP are used to maximise
the recruitment of collapsed alveolar (Hodgson et al., 2011; Oczenski et al., 2004; Riva
et al., 2009). MV assists breathing by either completely or partially taking over the pa-
tient’s breathing effort (Ducharme-Crevier et al., 2015; Oliva et al., 2012). In doing so, it
provides the support required to allow the patient’s lung to recover.
Severe forms of respiratory failure, such as ARDS, occur due to inflammatory response
in the lung. This inflammation, due to disease or trauma, impairs patient breathing
efforts as alveoli collapse, which significantly reduces gas exchange. This loss of gas ex-
change is the main course of the resulting high, mortality and morbidity rates in ARDS.
The mortality rate from ALI or ARDS is approximately 40 to 50% (Bersten et al., 2002;
Sigurdsson et al., 2013). The variability in reported numbers is largely due to the vari-
ability in quality and care resulting from lack of a consensus approach to MV in these
patients and in general.
More specifically, Patients with ALI/ARDS develop pulmonary edema, resulting in clini-
cally stiff, non-compliant, and heterogeneous lungs with regards to healthy alveoli and
alveoli that are inflamed and filled with fluid, and others that are unscathed. For this
reason, excessive pressure or tidal volumes to increase recruitment of injured alveoli
can cause additional lung damage and may result in VILI (Villar et al., 2006; Lipes et al.,
2012). VILI is difficult to diagnose as it overlaps with, or is secondary to, the actual
disease being treated, but its presence leads to longer, more difficult recovery and/or
increased mortality. Hence, setting pressure, in particular, is a careful patient-specific
balance, which is often overlooked in protocolised “one size fits all” approaches (Major
et al., 2018; Chase et al., 2018).
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The use of low tidal volumes and a plateau pressure of less than 30cmH2O have been
reported to decrease mortality and morbidity amongst patient with ARDS (Brower et al.,
2000). According to The Acute Respiratory Distress Syndrome Network, a RCT was con-
ducted to compare the difference between treatment with lower tidal volume and tra-
ditional tidal volume. The traditional tidal volume was 12ml per kilogram of predicted
body weight and lower tidal volume was 6ml per kg of predicted body weight. The study
showed the mortality rate of patients treated with lower tidal volume was lower, and
also increased number of ventilator free days (Brower et al., 2000; Lipes et al., 2012). It
has also been found lower tidal volumes, or a lung protective ventilation strategy, re-
duces VILI (Neto et al., 2014). Equally, Amato et al. (2015) showed minimum driving
pressures per unit recruited volume improved outcomes. However, all these results
provide only basic guidance within which care is still highly variable and inefficient
(Carvalho et al., 2007; Sundaresan et al., 2009; Chiew et al., 2012).
There are many generalised approaches for guiding MV therapy. For example, the ARD-
SNet, EXPRESS, and ALVEOLI study protocols (Brower et al., 2000, 2004; Meade et al.,
2008; Mercat et al., 2008a; Briel et al., 2010). However, these approaches are built on
population studies and cannot capture the heterogeneity and patient-specificity of AL-
I/ARDS. Currently, there are no conclusive, generalisable approaches or methods for
PEEP selection Sundaresan and Chase (2012); Major et al. (2018).
PEEP is important parameter setting and it has been proposed to be set at minimal elas-
tance (Carvalho et al., 2007; Suarez-Sipmann et al., 2007; Lambermont et al., 2008; Chiew
et al., 2011; Pintado et al., 2013; Chiew et al., 2015a; Amato et al., 2015). The goal is to bal-
ance the risks of low PEEP, causing repeated collapse and recruitment (atelectrauma), or
high PEEP, causing overdistension, both of which lead to VILI. Minimum elastance pro-
vides, by definition, the maximum recruitment for minimum pressure, thus balancing
rewards and risk.
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Experimental animal trials have induced ARDS in pigs and reported had minimal respi-
ratory elastance at a specific PEEP was associated with higher oxygenation, maximum
recruitment, and higher functional residual capacity, without evidence of VILI (Car-
valho et al., 2007). Experimental human studies suggest setting PEEP to minimal respira-
tory elastance or maximum compliance, where elastance is the inverse of compliance,
may be beneficial (Suarez-Sipmann et al., 2007; Amato et al., 2015). Despite these find-
ings, the current standard of care does not utilise this data, as it is hard to accurately
estimate elastance in real-time. Instead, typical care reverts to clinical intuition or a
generalised approach lacking patient-specificity and thus unable to accurately address
the significant inter- and intra- patient variability these patients exhibit..
Model-based mechanical ventilation is desired as it provides more detailed patient-specific
data which can be used to reduce the length of mechanical ventilation (LoMV) (Major
et al., 2018; Major, 2015). Minimal elastance PEEP selection is one of a few new meth-
ods proposed for MV therapy for patients with ALI/ARDS (Suarez-Sipmann et al., 2007;
Amato et al., 2015) and is much more feasible using model-based methods (Chase et al.,
2018; Morton et al., 2018, 2019b,a). At the University of Canterbury and the Christchurch
Hospital intensive care unit (ICU), research has been performed to use a model-based
method to create model-based ventilation therapy (Chiew et al., 2011; Redmond et al.,
2014; Chiew et al., 2015a; Chase et al., 2018; Morton et al., 2019b,a). This model uses
model identified patient specific and breath-specific respiratory mechanics that provide
greater insight in treating ALI/ARDS than pressure and flow curves alone. Pilot stud-
ies have been conducted and have shown great potential (Chiew et al., 2011, 2015c). A
randomised control trial (RCT) is currently under way to show the effectiveness of this
model-based treatment over current clinical practice (Szlavecz et al., 2014; Kim et al.,
2020).
A Randomised Controlled Trial (RCT) is a medical experiment to show effectiveness of
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a treatment. It is often used in medical community as it is proof a new treatment is su-
perior over the current treatment approach (Hariton and Locascio, 2018; Altman, 1981;
Akobeng, 2005; Sibbald and Roland, 1998; Calvert et al., 2018). Generally RCTs are con-
ducted whereby a patient eligible for the trial is randomly selected into either a control
or intervention group. The randomisation itself removes any bias towards one treat-
ment over the other, as patients are selected and matched between cohorts based on
diagnosis and age. Depending on the trial, participants may be blinded (group alloca-
tion is concealed until end of study) to remove bias when conducting the experiment
(Karanicolas et al., 2010). In the medical field, a well blinded study is considered a gold
standard and is commonly used to test efficacy of new form of intervention.
1.4.2 Clinical Utilisation of Respiratory Elastance (CURE) Trial
The Clinical Utilisation of Respiratory Elastance (CURE) is ongoing RCT designed by re-
searchers at University of Canterbury and Christchurch Hospital ICU (Chiew et al., 2015c;
Kim et al., 2020). Given the diversity of lung condition in patients with respiratory fail-
ure, the inter-variability between patients can be significant along with time-varying
intra-patient variability. Hence, a patient specific and time specific or evolving treat-
ment approach is desired. For this reason, a model-based PEEP selection method has
been developed (Chiew et al., 2011, 2015a). This model-based and patient specific ap-
proach offers the ability to identify and directly manage intra- and inter- patient vari-
ability in response to care, and thus has the potential to guide MV therapy based on a
patient-specific condition and real time-response to care. This procedure has been clin-
ically validated in pilot trials at Christchurch Hospital ICU (Chiew et al., 2015c).
The CURE RCT is a single centre trial, conducted at the Christchurch Hospital ICU, New
Zealand. This trial aims to recruit 320 patients, 160 in intervention and 160 in control
group, where intervention will utilise model-based method with protocolised recruit-
ment manoeuvres and PEEP will be selected to minimal elastance afterwards (Kim et al.,
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2020; Chiew et al., 2015c; Major, 2015; Major et al., 2018). The control group will be cur-
rent standard practice. The aim of this RCT is to utilise model-based methods to reduce
LoMV (the length of MV), and improve patient care and outcomes.
1.5 MV in Preterm Neonates
1.5.1 Neonatal Lung and development
Prematurely born infants in the neonatal intensive care unit (NICU) have different lung
mechanics compared to both adults or children. They severely lack in total numbers of
alveoli and they also lack surfactant production (Neumann and Von Ungern-Sternberg,
2014; Brown and DiBlasi, 2011). The lack of alveoli and surfactant causes a reduction in
collagen and elastin and thus a reduced functional residual capacity (FRC) in the lung
(Neumann and Von Ungern-Sternberg, 2014; Brown and DiBlasi, 2011; Carroll and Agar-
wal, 2010). This reduction makes them more susceptible to VILI during MV therapy be-
cause the lung is actually much stiffer (Brown and DiBlasi, 2011; Carvalho et al., 2013b;
Kannangara et al., 2018). Stiffer (non-compliant) lungs can lead to both VILI or longer
duration of MV. For this reason, when invasive MV is used, strategies are now focused
to reduce the time of invasive MV (Brown and DiBlasi, 2011; Jobe, 2009).
Lung development is an ongoing process starting as early as 26 days of gestational age
(GA) as it grows during prenatal and postnatal phase. Lung development is highly vari-
able between individuals, but can be divided into 5 distinct stepwise phases (Hislop et al.,
1986; Colin et al., 2010; Copland and Post, 2004; Joshi and Kotecha, 2007; Carroll and
Agarwal, 2010):
1. Embryonic Phase (26 days to 6 weeks GA)
2. pseudoglandular (6-16 weeks GA)
3. canalicular (16-28 weeks GA)
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4. saccular (28-36 weeks GA)
5. alveolar (36 weeks GA to term)
Even after the alveolar growth phases, the lung continuously develops until childhood
(Colin et al., 2010). The bronchial branching is developed by 16 weeks of GA. During the
canalicular phase (16-28 weeks GA), the conducting airways and terminal bronchioles
are formed. The saccular phase is when clusters of sacs are formed on the terminal
bronchioles and alveoli are starting to form. During the alveolar phase, the alveoli ma-
tures and the two capillaries become single capillary, and lungs are able to carry out
functioning gas exchange (Colin et al., 2010; Joshi and Kotecha, 2007). It is around 32
weeks of GA, alveoli begin to develop, and during alveolar phases, the alveoli grow in
numbers and maturity. At term, infants have around 30% of the alveoli of an adult (Jobe,
2002).
As a result, the total lung volume significantly increases during the last trimester of
gestation (saccular to alveolar to term) (Langston et al., 1984). Langston et al. (1984),
states at 30 weeks of GA, the lung volume is only 34% of the lung volume at mature
birth and at 34 weeks, the lung volume is at 47%. This rapid increase in lung volume
occurs during the lung development as the air-space walls decrease in thickness and
other development (Langston et al., 1984).
There is a hypothesis that preterm delivery, regardless of any neonatal respiratory dis-
ease, may have adverse effects on the lung growth and development. These adverse
effects persist and worsen during the first 5 years of life (Stocks et al., 2007; Jobe, 2002;
Hjalmarson and Sandberg, 2002; Greenough, 2007; Gappa et al., 2003).
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1.5.2 Respiratory Distress Syndrome (RDS)
Respiratory distress syndrome (RDS) in infants is a condition of pulmonary insufficiency
commencing at or after birth. Without treatment, it can lead to hypoxia and respiratory
failure (Sweet et al., 2010; Lauterbach et al., 2001). The deficiency and immaturity of
alveolar surfactant along with structural immaturity of the lung causes RDS. The treat-
ment for RDS generally involves oxygen administration, positive pressure lung infla-
tion, and surfactant replacement therapy (Brown and DiBlasi, 2011; Keszler, 2009; Sweet
et al., 2010, 2013). The problem is these practices can vary depending on the gestation
period the infant (O’Donnell et al., 2004; Brown and DiBlasi, 2011).
Surfactant is a lipoprotein which lowers the surface tension of the lungs to prevent at-
electasis. Infants with RDS commonly undergo surfactant replacement therapies, as
they have shown to reduce mortality and decrease the incidence of pneumothorax (air
leak) (Griese, 1999; Polin et al., 2014; Sweet et al., 2013). Surfactant replacement thera-
pies have been shown to increase lung function and are thus a reliable method to reduce
length of mechanical ventilation (LoMV) (Yuksel et al., 1993; Wood and Jobe, 1993).
Preterm neonates have deficient surfactant. This lack of surfactant causes a reduction
in collagen and elastin and thus a reduced functional residual capacity (FRC) in the lung
(Brown and DiBlasi, 2011; Lista et al., 2017). This reduction makes them more suscepti-
ble to VILI in MV because the lung is much stiffer (Brown and DiBlasi, 2011; Carvalho
et al., 2013b). It is thus problematic for treating preterm neonates with invasive MV. For
this reason, when invasive MV is used, strategies are now focused on reducing the time
of invasive MV (Brown and DiBlasi, 2011).
Overall, invasive ventilation of the neonate is effective, but can also lead to serious
damage. Preterm neonates with respiratory failure require invasive ventilation, but
CHAPTER 1. INTRODUCTION 15
MV is known to be associated with VILI and bronchopulmonary dysplasia (BPD) (Car-
valho et al., 2013b; Jobe and Bancalari, 2001; Kair et al., 2012). BPD occurs when the
bronchi are damaged causing destruction of alveoli, and thus can be caused by either
over-oxygenation or VILI (Kair et al., 2012; Jobe and Bancalari, 2001).
PEEP is significant parameter in neonatal ventilation, just as in the adult case, as it is
the main determinant of FRC and thus available lung volume in intubated infants. The
use of adequate PEEP also conserves surfactant and increases lung volume, surface area
and compliance. Hence, as in adults, it is a critical parameter with little consensus on
how to find or maintain an optimal PEEP level.
The use of low tidal volume to reduce lung injury has been shown in adults (Brower
et al., 2000), but not in neonates. There is little clinical evidence using lower tidal vol-
ume reduces lung inflammation (Donn and Boon, 2009; Chow et al., 2002). According
to (Brown and DiBlasi, 2011), 5ml/kg of tidal volume for preterm neonates resulted in
improved outcomes in comparison to a 3ml/kg group. The 3ml/kg group had higher in-
flammatory response and a longer duration of MV. These unexpected results, compared
to adults, may be explained by a comparison of adequate and inadequate tidal volume,
rather than high and adequate tidal volume. Equally, they may indicate the neonatal
lung is not simply a small adult lung.
High Frequency Oscillatory Ventilation (HFOV) is a specific ventilation mode deliver-
ing relatively very small tidal volumes at rapid rates superimposed on a variable mean
airway pressure. There are studies suggesting that HFOV is more effective when venti-
lating preterm neonates (Gerstmann et al., 1996; Group, 1993; Yoder et al., 2000; Plavka
et al., 1999). However, some reviews and RCTs have shown conflicting results in this
area. One study by Courtney et al. (2002) concluded HFOV has small benefit in terms of
the pulmonary outcome for very low birth weight infants, whereas Cools et al. (2010);
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Van Reempts et al. (2003); Rettwitz-Volk et al. (1998); and Sweet et al. (2013) concluded
there is no benefit in using HFOV on the basis of gestational age, birth weight and initial
lung disease severity. Hence, as with the adult case, there is no consensus.
1.5.3 Sex Differences in boys and girls
Unlike adults, there is a wide range of literature comparing differences between male
and female preterm neonates (Carey et al., 2007; Torday et al., 1981; Miller and Futrakul,
1968; Stevenson et al., 2000; Peacock et al., 2012). Preterm infants are born with vary-
ing gestational age and size. However, in utero, male foetuses are less developed than
females at the same gestational age by 1.5 to 2 weeks (Torday et al., 1981). The newborn
male infants also have higher incidence of RDS, morbidity, and mortality than females
at the same birth weight (Torday et al., 1981; Miller and Futrakul, 1968; Stevenson et al.,
2000). For these reasons, male infants are more likely to receive invasive MV (Stevenson
et al., 2000). Anecdotally, it is known male infants are harder to ventilate, but no stud-
ies have yet quantified any differences in lung stiffness or mechanics to support this
observation.
Male infants are less developed than females at the same birth weight or gestational
age. Therefore, male infants lack surfactant production more than females (Torday and
Nielsen, 1987). Deulofeut et al. (2007) showed females responded better to treatment
and had lower length of stay. These anecdotes along with known differences in sex has
yet to be quantified. It can be hypothesised males will have higher elastance compared
to female infants based on the literature. However, no study has calculated any of the
fundamental pulmonary mechanics of infants in NICU.
1.6 Preface
Mechanical ventilation in respiratory failure and pathology of ARDS, ALI, and RDS is
discussed in this chapter. The importance of optimal MV parameters is discussed in
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terms of minimising, both VILI and improving efficient gas exchange. Thus, reducing
length of mechanical ventilation and improving overall MV therapy. This thesis covers
twofold main sets of outcomes and Figure 1.2 shows how these outcomes are related:
1. First NICU analysis and unique data sets - variability, size, range of elastance, and
on top of its sex differences, which in turn shows the model sensitive to important
differences.
2. Second, how to deal with spontaneous breathing, prevalent in NICU MV, based on
first analysis in a relatively unique adult cohort.
In adults, an approach is presented to quantify patient spontaneous breathing effort,
which remains an important and unquantified clinical parameter, and protocol for a
randomised control trial of model-based MV to be undertaken is presented. The quan-
tification of SB effort performed in this thesis allows separation of active patient demand
and passive patient-specific lung mechanics (elastance) without use of invasive or ad-
ditional sensors. This metric can be further developed and utilised in clinical setting to
give further information of on SB patients during ASB mode ventilation. It can also be
used to adjust ventilator parameters to further reduce patient-specific work of breath-
ing and speed up the weaning process, ultimately resulting in decreased LoMV.
The second part of this thesis aims to apply model-based methods to pre-term neonates.
While model-based methods have been somewhat widely studied in adult cases, there
has not been any in-depth study for pre-term neonates. Thus, this research presents a
first ever extensive study on model-based methods in this cohort beginning with iden-
tifying and verifying physiology and respiratory mechanics parameters for this cohort
for the first time. The single compartment model was utilised to identify patient-specific
elastance in neonates and was also used to show significant differences in sex. Basis
function modelling was also utilised in attempt to separate patient-specific SB effort
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Figure 1.2: Thesis overview flowchart
Chapter 2 introduces the foundation models used in this thesis. It covers three major
different models and presents the derivation of each of them and their physiological
and mechanical relevance.
Chapter 3 presents the two, adult and neonatal cohorts, and associated data sets used
in this thesis.
Chapter 4 develops an initial basis for quantifying patient-specific and breath-specific
spontaneous breathing effort in adults using a time-varying elastance model. This ap-
proach aims to identify spontaneous breathing effort from inspiratory effort and is ver-
ified with known electrical activity of the diaphragm. This work has previously been
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published in Kim et al. (2017).
Chapter 5 utilises validated basis function models with a time-varying elastance model
to separate patient effort and patient respiratory mechanics, providing a potentially
better estimate of this clinical parameter.
Chapter 6 presents protocol for CURE RCT. This clinical protocol explains the trial design
for model-based MV in the adult intensive care unit, and includes all trial details and
design. This work has previously been published in Kim et al. (2020).
Chapter 7 identifies patient-specific and breath-specific lung elastance using the vali-
dated single compartment model in neonatal cohort. Known physiological factors af-
fecting elastance, such as surfactant and weight are used to further validate the results
obtained. It is first-ever analysis of model-based and patient-specific lung mechanics in
this cohort. This work has previously been published in Kim et al. (2019a).
Chapter 8 explores sex difference in lung mechanics, specifically the mass normalised
in elastance, in neonates. The specific elastance accounts for weight and allows direct
comparison between patients. Sex differences are sometimes explored in this neonatal
cohort, but none have examined breathing mechanics in comparing male and female
cohorts. This outcome differences found are validated against clinical reports and ex-
pectations and represent novel results in the field with potential clinical impact. This
work has previously been published in Kim et al. (2019b).
Chapter 9 quantifies spontaneous breathing effort in neonatal cohort with similar ap-
proach as taken in Chapter 5. Neonates are not sedated during their ventilation period
and thus quantifying patient-specific and breath-specific breathing effort in this cohort
can provide further insight and clinical value.
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Chapter 10 summarises the work performed and concludes this thesis, delineating main
outcomes.
Chapter 11 provides plans and suggestions for potential future work.
CHAPTER 2
Equations and Models
2.1 Model-Based Mechanical Ventilation
The diversity of lung condition in patients with respiratory failure shows significant
inter- and intra- patient variability. Thus, a patient specific and time specific or evolving
treatment approach is desired. The ability to track and view patient’s current lung con-
dition will allow patient-specific care and thus, able to achieve more optimal ventilation
therapy. Using model-based methods allow prediction of lung condition. Calculating for
every breath allows further understanding of patients condition over time.
Model-based methods allow greater insight to patient condition by identifying patient-
specific respiratory mechanics, which in turn can provide further insight into underly-
ing patient condition (Chiew et al., 2015a; Greenspan et al., 1988; Schranz et al., 2013;
Kim et al., 2019a; Morton et al., 2019b; Sundaresan et al., 2011; Sundaresan and Chase,
2012; Ben-Tal, 2006). A wide range of models have been successfully used in adult ICU
patients to calculate patient-specific lung mechanics (Chiew et al., 2011, 2015a, 2018;
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Schranz et al., 2013; Morton et al., 2019b,a; Howe et al., 2020). In particular, the single
compartment model is the most basic model which represents as a single homogeneous
volume with associated elastance (1/compliance) and airway resistance (Bates, 2009;
Chiew et al., 2011; Kim et al., 2019a). A real-time implementation of this model allows
real-time identification of lung mechanics at the patient bedside (Szlavecz et al., 2014;
Chiew et al., 2011).
2.2 Single Compartment Model
The linear single compartment model also known as lumped parameter model has been
commonly been utilised to estimate lung stiffness, also known as elastance (1/compli-
ance) (Chiew et al., 2011; Sundaresan et al., 2011). This model treats the respiratory
mechanics as a balloon connected to a pipe. The balloon is a reservoir (lung space) with
elasticity modelled as a spring (elastance) (Bates, 2009). The pipe captures the endo-
tracheal tube (ETT), and thus the flow resistance. Figure 2.1 shows diagram of the single
compartment model.
Figure 2.1: Single compartment model diagram, (Left) Mechanical definition, (Right)Electrical definition.
The tension of the spring or elastance in Figure 2.1, increases linearly as it is stretched.
The pressure inside the lung also linearly increases with the volume. Thus, the pressure
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inside the lung is defined:
Plung (t) = ErsV (t) (2.1)
Flow of air is delivered to the lungs by MV via endotracheal tube (ETT) and thus, a driv-
ing pressure (∆P) is required:
∆P(t) = RrsQ(t) (2.2)
Therefore the airway pressure is the sum of the pressure inside the lung from Eq 2.1
and pressure required to deliver oxygen Eq 2.2 and yields:
Paw = Plung + ∆P
Paw = ErsV + RrsQ + PEEP (2.3)
Where Paw is the airway pressure, Ers is respiratory elastance, V is the volume,Rrs is the
airway resistance, Q is the air flow, and PEEP is the offset pressure (or applied PEEP if
there is no intrinsic PEEP). Ers and Rrs are identified with least mean squared fit using
Paw(t),Q(t), and V (t) as input parameters. The model is fit to inspiration for every breath
(Chiew et al. 2011), where inspiration is positive gas exchange and therefore the period
over which flow is positive. Expiration is the period during which flow is negative.
2.3 Basis Functions
Basis functions have been previously used in adult critical care models (Langdon et al.,
2016, 2017; Morton et al., 2018, 2019b). In particular, Morton et al. (2019b) utilises ba-
sis functions to describe alveoli recruitment and distension (Morton et al., 2019b). The
shape of basis functions for alveoli recruitment and distension are shown in Figure 2.2.
Morton et al. (2019b) showed the model identifies distension at high PEEP (Morton et al.,
2019b).
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Figure 2.2: Recruitment and distension basis function shapes. (Both functions are di-mensionless).
The recruitment basis function φ1 captures the decreasing rate of recruitment alveoli






Where Vm is the upper limit of 1L in adults and φ1 is set to 0 for V > Vm. The 1L limit
should cover all adult tidal volume ranges as they are typically ventilated at 4-8ml/kg
(Brower et al., 2000; Morton et al., 2019a). The distension basis function φ2 captures




Using the basis function Eq 2.4 and Eq 2.5 into the single compartment model Eq 2.3,
yields:
Paw = E1φ1V + E2φ2V + RQ + PEEP (2.6)
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2.4 Time-varying Elastance Model
Many clinically applicable respiratory models assume patients are sedated and so their
breathing is passive and fully controlled by the ventilator (Bates, 2009; Chiew et al.,
2011). Therefore, during lower levels of sedation, patients may additionally show breath-
ing effort, also known as spontaneous breathing (SB) effort, on top of the supported
breathing by MV. Spontaneous breathing effort is the natural breathing performed by
the patient and thus applies a negative pressure to the positive pressure provided by the
ventilator. These spontaneous breathing efforts adds significant variability in respira-
tory mechanics. Therefore, additional methods are required to estimate patient effort to
enable accurate identification of patient lung mechanics (Chiew et al., 2015a; Redmond
et al., 2019). Figure 2.3 shows the negative pressure being added during a breath.

























Figure 2.3: Pressure waveform of spontaneous breathing patient due to low sedation.Inspiration is shown in red, expiration in black and the pressure drop caused by SB isshaded.
Chiew et al. (2015a) proposed time-varying elastance model to utilise dynamic lung elas-
tance to account for patient effort and identify patient-specific elastance (Chiew et al.,
2015a). This model is derived from single compartment model (Eq 2.3) and is clin-
ically applicable. This model lumps underlying lung mechanics as a single dynamic
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lung elastance (Edrs). The Edrs represents the sum of elastic properties of alveoli (Ers),
patient-specific static chest wall elastance (Echest) and elastance generated by patient
effort (Edemand) and defined:
Edrs = Ers + Echest + Edemand (2.7)
Replace Ers from Eq 2.3 with Edrs from Eq 2.7 to account for patient effort:
Paw(t) = Rrs ×Q(t) + Edrs(t) × V (t) + PEEP (2.8)
TheEdrs(t) is time dependent variable and thus cannot be used to compare across breaths
and patients.
2.5 Model-based Ventilation in NICU
NICU ventilation strategies typically utilises lower PEEP settings but remain similar PIP.
The respiratory rate is significantly different as adults receive 20 breaths/min but in-
fants receive 60 breaths/min or higher. Infants are ventilated at low tidal volume set-
tings 4-8ml/kg but due to their extremely small weight, the tidal volume delivered is
small (Clark et al., 2000; Brown and DiBlasi, 2011; Sweet et al., 2010). For this reason,
endo-tracheal tube (ETT) must be considered when modelling for neonates as the the
small diameters of NICU ETT can significantly increase resistance to flow compared to
adults (Kim et al., 2019a).
Jarreau et al. (1999) describes the pressure loss across the ETT. They used an empirical
approach, where the pressure drop (∆PETT) across the ETT is modelled (Jarreau et al.,
1999):
∆PETT = L(0.0203D−4.25Q1.5 + 0.319D−4Q (2.9)
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Where L is the length of the ETT tube in cm, D is the diameter in mm, and Q is the flow
rate in mL/s. Eq 2.9 assumes laminar flow. Turbulence occurs if the Reynolds number is
above the critical value. In this case, the flow is always laminar for small ETT diameters
(under 3.5 mm) (Jarreau et al., 1999), as turbulent,flow requires flow rates greater than
250 ml/s for an ETT diameter of 3.5 mm and typical NICU tidal volumes ranges are 5–20
mL (Sweet et al., 2010).
Thus, accounting for the pressure loss across the ETT, ∆PETT is added to the single com-
partment model from Eq 2.3 is:
Paw = ErsV + RrsQ + PEEP + ∆PETT (2.10)
The basis function described in section 2.3 is used for adult MV data. This model can be
adjusted to apply in the NICU cohort. For NICU infants, the basis functions are defined
over a tidal volume range of 0-14 ml and pressure ranges 0-60 cmH2O, which covers all
likely NICU MV ranges. The 14 ml limit converts the typical adult volumes to the NICU
size (Morton et al., 2019b). The pressure loss across ETT also needs to be considered for
eq 2.6. Thus, yielding:
Paw = E1φ1V + E2φ2V + RQ + PEEP + ∆PETT (2.11)
Neonates are ventilated at constant low PEEP (< 6 cmH2O). Morton et al. (2019b) showed
distension elastance is most significant, and most commonly identified, at higher PEEP
levels. Therefore, it can be assumed infants would have minimal or no distension (E2
=0). The ∆PETT measures the pressure drop across ETT and thus absorbs resistive term
from original single compartment model eq 2.2, yielding:
Paw = E1φ1V + PEEP + ∆PETT (2.12)
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Time-varying elastance or dynamic lung elastance (Edrs) is an elastance term capturing
patient inspiratory effort (Chiew et al., 2015a). The basis function in Eqs 2.4 and 2.5
capture all patient underlying tissue mechanics, but cannot capture patient effort. Edrs
is derived from a time-varying elastance model used in adults (Chiew et al., 2015a), and
is defined:
Paw = Edrs(t) × V (t) + E1φ1V (t) + PEEP + ∆PETT (2.13)
2.6 Summary
This chapter lists models used to identify patient-specific elastance throughout this the-
sis. The single compartment lung model is used to identify elastance (1/compliance) in
sedated patients as MV fully controls patient breathing. The Basis function model is
more complex model, that utilises basis functions, recruitment and distension function
to identify both patient-specific elastance and lung distension in patients. The time-
varying elastance model is a direct function of pressure, while implicitly dependent to
time. The Edrs captures patient effort lumped with patient-specific lung condition.
CHAPTER 3
Clinical Data Cohorts
3.1 NICU CURE Kids Trial
The goal of the CURE Kids sponsored observational clinical trial was to retrospectively
analyse neonatal lung mechanics. Clinical data from 10 invasively mechanically venti-
lated neonates were collected from Christchurch Women’s Hospital Neonatal Intensive
Care Unit (NICU). This trial was an observational trial, and thus no intervention was
performed. Patients were treated using standard practice. Informed parental consent
was obtained before data was collected. This study and the use of this de-identified data
was approved by the New Zealand Northern B Health and Disability Ethics Committee
(study ref:16/NTB/16). Ventilator pressure and flow profiles were collected for up to 24
hours under standard care conditions. Eligibility criteria included:
1. Expectation MV would continue for 24 hours
2. Clinical equipoise
3. General clinically assessed patient medical stability.
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MV modes and settings were clinically determined as part of standard care. Patients
received either conventional ventilation (CV) or high frequency oscillatory ventilation
(HFOV) on a SLE5000 neonatal Ventilator (SLE, UK). Most patients received Patient Trig-
gered Ventilation (PTV), although some were treated with more than one mode. Tar-
geted Tidal Volume (TTV) is an “add on” specific to SLE, where pressure control is adapted
breath-to-breath to improve attempts to meet tidal volume targets under pressure con-
trol.
None of the infants were sedated over the trial period, though some received morphine,
which can have a sedative effect (Chase et al., 2004). In cases where an infant was re-
intubated after weaning from MV, or the infant was later switched to another ventilation
mode, a subsequent 24 hours of data recording was carried out with a second, further
parental consent. Patient characteristics and relevant demographic data are shown in
Table 3.1.
Ventilator data was recorded using MediCollector software (MediCollector, USA) on a
laptop connected to Philips Healthcare MP70 bedside monitor (Philips Healthcare, NZ).
The Philips bedside monitor was connected to the ventilator via a Vuelink M1032A res-
piratory module (Philips Healthcare, NZ). The equipment set-up is shown in Figure 3.1.
Airway pressure (mbar) and flow (L/min) were recorded at a sampling rate of 125 Hz.The
airway pressure and flow are converted into cmH2O and mL/s in model fitting.
Figure 3.1: NICU clinical data recording set up and is a reproduction from Kim et al.(2019a).




































































































































































































































































































































































































































































































































CHAPTER 3. CLINICAL DATA COHORTS 32
NICU ETT diameter size are typically 3-5 mm. The diameter size of ETT is determined
by patient weight as shown in Table 3.2. Clinically ETTs are shortened to an appropriate
patient-specific length by 1-2 cm post-insertion, as clinically determined. The shortened
length was unavailable for this study and thus, it was assumed that all ETTs are short-
ened by 2cm.
Table 3.2: Clinical guidelines for ETT selection
ETT diameter [mm] Un-shortened ETT length [cm] Indication for use
2.0 - Cannot insert a 2.5 mm ETT
2.5 18 Weight < 1.5 kg
3.0 19.5 Weight 1.5 - 2.5 kg
3.5 20 Weight 2.5 - 4.0 kg
4.0 - Weight > 4 kg
3.2 Pressure Support (PS) and Neurally Adjusted
Ventilatory Assist (NAVA)
Spontaneously breathing (SB) patients undergo assisted spontaneous breathing (ASB)
ventilation mode. ASB aims to assist weaning and is used until extubation as a step
from fully controlled ventilation. Weaning is a critical procedure as the patient transi-
tion to spontaneously breathing and the ventilator assists that translation. Spontaneous
breathing with supported MV breaths have been reported to have positive impact. SB
patients have increased pulmonary gas exchange, systemic blood flow, and oxygen sup-
ply to the tissue (Burchardi, 2004; Putensen et al., 2005; Spahija et al., 2010; Brander and
Slutsky, 2006; Freebairn and Hickling, 2005; MacIntyre, 1986). ASB mode is synchro-
nised with patient breathing patterns and supports the breath. The amount of assist is
ideally based on the patient’s demand or triggers, and aims to reduce the overall work of
breathing, thus supporting patient effort but not fully controlling it (Spahija et al., 2010;
Tejeda et al., 1997).
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Pressure support (PS) ventilation is a very common ASB ventilation mode. PS detects
the pneumatic signal generated by the initial patient breathing effort, as measured in
the ventilatory circuit with either pressure or flow. In particular, drop in pressure in
the circuit at the commencement of a patient breath triggers the ventilator to provide
sufficient added pressure, flow and PEEP to reduce the work of breathing and assist pa-
tient breathing. These parameters and settings are determined clinically (Spahija et al.,
2010).
Neurally adjusted ventilatory assist (NAVA) is another, emerging assisted ventilation
mode. NAVA utilises a directly measured Electrical activity of the diaphragm (Eadi) sig-
nal to determine patient demand. This measurement is made by a sensor on the endo-
tracheal tube (ETT). The magnitude of this signal driving the breath determines the level
of breath support it provides in the specific breath (Laghi, 2008; Sinderby et al., 2007,
2015).
Piquilloud et al. (2011) conducted a study comparing PS ventilation with the NAVA ven-
tilation mode. They acquired data from 22 invasively mechanically ventilated patients
from University Hospital of Geneva (Switzerland) and Cliniques Universitaires St-Luc
(Brussels, Belgium). The study protocol involved a 20 minute continuous recording of
patients airway pressure, Eadi and flow profile. Data are first measured in PS mode with
clinically set parameters. PS was then switched to NAVA mode with the same parame-
ters were measured for 20 minutes (Piquilloud et al., 2011). Patients were ventilated
using a Servo-I ventilator (Maquet, Solna, Sweden) and data was sampled at 100 Hz us-
ing Servo-tracker V4.0 (Maquet, Solna, Sweden). Patient demographics and ventilator
settings is seen in Table 3.3.
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Table 3.3: Patient demographics and ventilator settings for PS and NAVA fromPiquilloud et al. (2011)
Patients
Age (years) 66 ± 12
P/F ratio 194.8 ± 58.1 mmHg
Ventilator Settings PS NAVA
FiO2 0.43 ± 0.17 0.43 ± 0.17
PEEP 7 ± 2 7 ± 2
Inspiratory Trigger Flow Trigger: 1.2 l/min (20/22 Patients)Pressure Trigger: -4 and -5 cmH2O (2/22 patients) 0.5 µV
Expiratory Trigger
Sensitivity (ETS) 25-30% -
PS Level 13 ± 3 cmH2O -
Pressurisation Slope 100-150 ms -
NAVA Gain Level - 2.2 ± 1.8 cmH2O/µV
3.3 Summary
This chapter outlines the clinical cohorts and data collected. These cohorts and data
are used throughout this thesis to examine models, methods, and lung mechanics in
critically ill. The NICU cohort is especially unique as no similar data set currently exists
for this cohort. The PS/NAVA adult cohort offers a unique opportunity to investigate the
dynamics and characteristics of patient-specific breathing effort.
CHAPTER 4
Quantifying Patient effort in
an Adult Cohort
4.1 Introduction
The estimation of patient-specific respiratory mechanics during mechanical ventilation
(MV) can potentially help personalize and optimize therapy (Sundaresan et al., 2011;
Amato et al., 2015; Major et al., 2018). In particular, the ability to estimate and monitor
patient-specific respiratory mechanics enhances the understanding of patient-specific
condition and leads to individualised care (Chiew et al., 2015a; Sundaresan et al., 2011).
There are several methods to estimate the respiratory mechanics of a fully sedated MV
patient, as the ventilator has full control of the patient’s work of breathing (Sundaresan
et al., 2011; Bates, 2009).
Compared to fully sedated patients, the respiratory mechanics of spontaneously breath-
ing (SB) or patients whose work of breathing is only partially assisted by MV are much
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more difficult to estimate. This difficulty is due to un-modelled and variable patient ef-
fort introduced into the system, obscuring the patient-specific response to the ventilator
(Brochard et al., 2012). Model-based approaches for treating SB patients is not common
because SB severely affects estimation of respiratory mechanics, which is also seen dur-
ing asynchrony in MV patients (Major et al., 2016a; Damanhuri et al., 2016; Kannangara
et al., 2016a; Chiew et al., 2018). However, as studies (Grinnan and Truwit, 2005; Chiew
et al., 2015a) increasingly found partial ventilation or SB ventilation modes may be ben-
eficial for patient recovery, there is a need for model-based approach for estimating
patient-specific respiratory mechanics during SB.
Respiratory system mechanics can be modelled in different ways, ranging from simple
models to complex multi-compartment models (Möller et al., 2011; Bates, 2009; Ben-Tal,
2006). Complex models can provide a more physiological representation of lung be-
haviour, but can be difficult to identify in the clinical environment without additional
invasive measurements (Schranz et al., 2012a; Docherty et al., 2011). Therefore, the ap-
plication of complex models are limited in the clinical environment (Chase et al., 2018;
Morton et al., 2019a). Conversely, simpler models are easier to implement, but lack the
ability to accurately represent all observed dynamics and physiology. Hence, models
used in clinical settings should be a balance between both aspects.
This study utilises the time varying elastance model described in Chapter 2 (Eq (2.8)).
This model can capture respiratory mechanics in SB patients. The time-varying trajec-
tory of Edrs changes during a breath as a direct function of pressure and, implicitly,
time, and has a negative component where measured airway pressure is decreasing,
yet air is still flowing into the lungs due to un-modelled patient effort opening lung vol-
ume (Redmond et al., 2019). The dynamics of this time-varying model allows the capture
of respiratory mechanics for both spontaneous breathing and sedated, fully controlled
breathing to be captured (Chiew et al., 2015a,c).
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In this study, the ability of the time-varying elastance model to capture SB respiratory
mechanics is further investigated. Specifically, this study focuses on the negative elas-
tance component of the model in SB patients and whether it can be used as a metric of
patient effort. Two methods of quantifying negative elastance are presented to quan-
tify negative elastance. Both methods utilise the time-varying elastance model as a basis.
The ability to quantify negative elastance, and thus the patient input effort, as separate
from the ventilator supported work of breathing, can lead to better understanding of
patient breathing effort and lung condition, and thus be used to enhance MV therapy.
4.2 Methods
The Time-varying elastance model described in Chapter 2 section 2.4, Eq (4.1) is used to
compare patient effort with Eadi. This equation is repeated in this chapter for clarity
and ease as Eq (4.1), where the model is defined:
Paw(t) = Rrs ×Q(t) + Edrs(t) × V (t) + PEEP (4.1)
Figure 4.2, repeated for clarity, from Figure 2.3 Chapter 2, shows during spontaneous
breathing effort, patients apply negative pressure to the positive pressure provided.
During this period, the Edrs(t) would be negative, as shown by Chiew et al. (2015a). It is
important to note, there is no physical ’negative elastance’. The negative elastance value
in the identified model means there is a positive inspired volume response to an applied
negative pressure created by the un-modelled patient effort opening the diaphragm to
expand the lung, and thus creating the airflow. It is modelled and identified here as a
negative elastance capturing patient effort.
Patient data is separated into individual inspiratory breaths and elastance is identified
over inspiration. Inspiratory volume is calculated by integrating inspiratory flow with
respect to time. The pressure (P), flow (Q), volume (V ), and electrical activity of di-
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aphragm (Eadi) (Piquilloud et al., 2011) signals are interpolated to 200 data points over
this inspiratory data to allow direct comparison between breaths and patients.
Edrs(t) is calculated from rearranging Eq (4.1), which yields:
Edrs(t) = Paw(t) − RQ(t) − PEEPV (t) (4.2)
Taking the integral of Edrs(t) yields in area under the curve (AUC) of Edrs and is nor-






The normalised AUCEdrs from Eq 4.3 is similar to a two point static elastance and can
be used to describe patient-specific disease state (Chiew et al., 2015a):
AUCEdrs = Average Ers (4.4)
In this study, two methods are used to estimate the negative elastance component of
Edrs and AUCEdrs. The Zero Crossing method and the Trapezoidal method.
4.2.1 Zero-Crossing Method
The zero-crossing method is a straight forward approach in quantifying the negative
Edrs. Zero-crossing points for when Edrs changes from positive to negative and flow is
greater than 50 ml/s. At the start of inspiration, flow and volume are very small, thus,
any decrease in Paw below PEEP results in very large negative values of Edrs, but is
likely due to small measurement and computational errors. Therefore, flow less than
50 ml/s is discarded.
Once the negative Edrs is calculated, the AUC of negative Edrs region is used to find
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patient effort. As shown in Figure 4.1, the two vertical red lines represents point where
flow is greater than 50 ml/s and the zero-crossing of the Edrs and the respective pres-
sure, flow, Eadi, and Edrs shown. This region between zero crossing and flow greater
than 50 ml/s can be considered where patient demand elastance is greater than the elas-
tance from the chest wall and lung, and eliminates only a very few data points likely
influenced by ventilator dynamics and not the patient.
















































Figure 4.1: Inspiratory Pressure, Flow, Eadi, and Edrs with respect to normalised timewith zero-crossing method region
4.2.2 Trapezoidal Method
The small drop in pressure before recovering due to patient effort is seen in Figure 4.2,
which is a repeat of Figure 2.3. This drop is clearly visible as the blue line is measured
inspiratory pressure, the black line is expiratory pressure and the area shaded in grey
shows potential patient effort as this region results in negative elastance using the model
defined. This is used to quantify the AUC of the shaded region in Figure 2.3. The elas-
tance value is identified from the time-varying elastance model of Eq (4.2). This method
CHAPTER 4. QUANTIFYING PATIENT EFFORT IN AN ADULT COHORT 40
utilises AUC of pressure, volume and flow, rather than the AUCEdrs is calculated from
it.

























Figure 4.2: Repeat of Figure 2.3, Pressure waveform with small drop caused by patient’sspontaneous breathing effort (shaded). Red is inspiration and black is expiration.
Integrating each of the components of the single compartment model yields the follow-
ing equation:
∫
Paw(t) dt = Ers
∫
V (t) dt + Rrs
∫
Q(t) dt + PEEP
∫
dt (4.5)
From Eq (4.5), the normalised AUCEdrs can be substituted for Ers to yield:
∫
Paw(t) dt = AUCEdrs
∫
V (t) dt + Rrs
∫
Q(t) dt + PEEP
∫
dt (4.6)
From this model, the area where pressure drops in Figure 4.2, and is then restored to




Paw dt WhereEdrs ≤ 0 (4.7)
Thus:
Areanegative pressure = AUCEneg × Areavolume + R × Areaflow (4.8)
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Rearranging Eq (4.8) results in:
Enegative =
Areanegative pressure − R × Areaflow
Areavolume
(4.9)





Paw(t) dt − R
∫
Q(t) dt − PEEP
∫
dt∫
V (t) dt (4.10)
4.2.3 Clinical Patient Data
The PS and NAVA patient cohort detailed in Chapter 3 Section 3.2 is used in this study.
22 invasively mechanically ventilated patients were recorded using PS and NAVA ven-
tilation modes. Patients were recorded initially with PS mode for 20 minutes and sub-
sequently switched to NAVA mode for another 20 minutes. Patients had their electrical
activity of diaphragm measured during the data recording (Piquilloud et al., 2011). This
chapter only utilises NAVA patient data.
4.2.4 Analysis of Negative Elastance Metric
AUCEdrs values calculated using both methods are compared. Negative AUCEdrs val-
ues are normalised by the median values and the absolute values are recorded. The
Bland-Altman plot is used to check for bias between these two methods (Altman and
Bland, 1983). The two methods are compared with the measured peak EAdi signal using
Pearson’s correlation coefficient to compare to a physiological measure of diaphragm
muscle activation. Eadi is thus taken as a measure of patient inspiratory effort, where
peak Eadi and AUC Eadi are effectively the same (Moorhead et al., 2013). Note, because
EAdi can vary between patients due to sensor placement and other factors, comparing
between patients is not possible.
The coefficient of variation (CV) for eachAUCEdrs estimation method is also calculated.
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The CV values will allow better understanding of variability of the negative elastance
component analysed. Comparing the two variability metrics will show how much vari-
ations could exist in negative elastance results.
4.2.5 Positive Elastance
The zero-crossing method and trapezoidal methods are metric to quantify patient effort
which, occurs at the start of inspiration while SB is present. The positive patient elas-
tance is calculated by taking AUC of Edrs from the positive portion of Edrs trajectory.
This positive trajectory of Edrs is the passive lung dynamics as ventilator takes over
patient breathing and thus, positive AUCEdrs is a measurement of patient-specific lung
elastance in response to MV.
4.3 Results
Table 4.1 summaries results for both methods, includes negative and positive AUCEdrs
using two methods and normalised AUCEdrs. This table also includes the CV of negative
AUCEdrs values. The median [Interquartile Range (IQR)] of zero-crossing point across
all patient is 32.5 [26-39] and median [IQR] of flow> 50 ml/s was 5 [4 - 9]. The normalised
negative AUCEdrs values of -3.29 [-4.80 - -2.50] cmH2Os/l for the zero-crossing method
and –1.90 [-2.36 - -1.66] cmH2Os/l for the trapezoidal method. The absolute valued CV of
negative AUCEdrs across all patients is: 0.18 [0.15 - 0.26] cmH2Os/l for the zero-crossing
method and 0.15 [0.13 - 0.23] cmH2Os/l for the trapezoidal method.
Figure 4.3 shows scatter plots of positive AUCEdrs normalised values using both meth-
ods for Patients BRU2, BRU10 and GE07. The minimum correlation coefficient value
over all patients is R = 0.84, median is R = 0.98, and maximum correlation coefficient is
R = 0.99. These results show the two methods can capture positive elastance correctly
and similarly. Therefore, they both should be able to quantify the negative elastance
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Table 4.1: Summary of zero-crossing method and trapezoidal method (25th, 50th, 75th)
Zero-Crossing method Trapezoidal method
25th 50th 75th 25th 50th 75th
Negative AUCEdrs [cmH2O/l] -61.58 -48.09 -42.76 -133.99 -116.26 -94.33
Negative AUCEdrs normalised -4.80 -3.29 -2.50 -2.36 -1.90 -1.66
Positive AUCEdrs [cmH2O/l] 19.29 24.21 27.46 21.09 26.84 31.17
Costive AUCEdrs normalised 0.11 0.14 0.17 0.12 0.16 0.19
CV of Negative AUCEdrs 0.15 0.18 0.26 0.13 0.15 0.23
component.
Figure 4.4 shows the Bland-Altman plot for individualised patients who have no bias
between the two methods, a small bias, and a clear bias. Most patients have the AUCE-
drs calculated using two methods lie within 95% confidence interval, the example of
can be seen in Figure 4.4, for Patients BRU10, BRU6, BRU11, and BRU12. Some of the
patients, such as Patients GE08 and BRU14 shows a clear bias as either the difference
would increase or decrease as mean increases as the value increases.
Figures 4.5 and 4.6 shows scatter plots of Eadi signal and negative AUCEdrs calculated
using the two methods. The median [IQR] of R values calculated across patients are -0.01
[-0.27 - -0.14] for zero-crossing method and -0.04 [-0.29 - 0.07] for trapezoidal method. It
is clear, the correlations are not strong, but the plots are patient-specific.
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BRU10, Max R value = 0.98







































BRU2, Min R value = 0.84







































GE07, Max R value = 0.99
Figure 4.3: Comparison of positive AUCEdrs values from each method. left). Showslowest correlation coefficient, Middle). Shows median correlation, and right). showshighest correlation.

























BRU10, Mean: 0.11; SD: 0.46

























BRU11, Mean: 0.53; SD: 0.23
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BRU14, Mean: 8.16; SD: 8.28

























BRU6, Mean: 0.79; SD: 0.50

























BRU8, Mean: 1.35; SD: 0.43
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GE08, Mean: 2.34; SD: 0.56
Figure 4.4: Bland-Altman plot of negative AUCEdrs using zero-crossing and trapezoidalmethod for cases where no bias exists to where clear bias exists (Altman and Bland,1983).
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BRU10, R = -0.00

























BRU14, R = -0.81

























BRU2, R = -0.63
Figure 4.5: Samples of peak Eadi signal vs Negative AUCEdrs using zero-crossing methodwith different Pearson’s correlation. Left). High Middle). Medium, Right). Low.

















































BRU2, R = -0.68
























BRU6, R = -0.04
Figure 4.6: Samples of peak Eadi signal vs Negative AUCEdrs using trapezoidal methodwith different Pearson’s correlation. Left). High Middle). Medium, Right). Low.
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4.4 Discussion
The estimated normalised negative AUCEdrs values for the trapezoidal method is lower
than zero-crossing method (42.26%). As shown in Table 4.1, the median of median AUCE-
drs value and IQR of median is shown to be lower. Similar behaviour was also found in
positive AUCEdrs where the AUCEdrs of the trapezoidal method have higher value.
The median [IQR] of zero-crossing index for all patients is: 32.5 [26-39] or 16.25% [13-
19.5%] of the data. This result shows that the first 16.25% of inspiratory data repre-
sents negative elastance contributions primarily and 83.75% of the data makes up for
positive AUCEdrs. This result holds considering the primary driver of overall observed
behaviour.






































































Figure 4.7: Scatter plot of Negative AUCEdrs with corresponding positive AUCEdrs forall patients. Left). Zero-crossing method, Right). Trapezoidal method.
Negative elastance values are compared with positive value to see if there are any re-
lationship between the two. From Figure 4.7, it is clear that the negative AUCEdrs does
not correlate with positive AUCEdrs as the median IQR of R = 0.18 [-0.43 - 0.40] for the
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zero-crossing method and R = 0.19 [-0.16 - 0.29] for the trapezoidal method. This result is
somewhat expected where negative AUCEdrs is a metric and a measurement of patient-
specific SB effort, whereas positive AUCEdrs is a measure of patients-specific lung con-
dition in response to MV. The amount of patient effort has little influence on the lung
condition, but is more a function of patient’s sedation state and how they respond to MV
treatment.
Flow less than 50ml/s is not removed for the trapezoidal method because the initial as-
sumption was that the small drop in pressure is the negative elastance component. The
drop in pressure is very small and thus removing small amount of data at the start of
already small section of the breath would result in removing large portion of negative
elastance.
The Eadi is unreliable due to the fact, the placement of these sensors vary from patient-
to-patient as it would be placed on general approximate location and that it is also signal
processed voltage measurement. Therefore can lead to amplifying even noise signal.
Eadi is an electrical input to a biochemical to physical response of the muscle. This
response is at least a second order system (coupled 1st order equation), which implies a
phase shift of 180◦ and thus a measurable time lag as the outcome muscle motion leading
to breathing will be the convolution solution of this second order (or more) system in
response to Eadi input
Finally, every muscle may respond differently, for example due to level of sedation, to
a given electrical Eadi input. There is thus a sensitivity to this response that is patient
specific and sedation specific (At minimum). Plus, humans are horribly variable!
All these factors reduce the viability of Eadi as a metric correlating well to breathing
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activity or action. We measure output action of breathing and Eadi is the electrical
input, they are not proportional or directly comparable for the reasons above, outside
of very broad comparison
One of the main limitations of this study is that the only measurable metric available to
validate the negative Edrs values is through using Eadi. Eadi is the electrical signal to
trigger a diaphragm movement. However, as the Eadi signal is a processed signal, these
data in some cases, may not be representative of the patient’s actual demand (Piquil-
loud et al., 2011). Further variation in Eadi can arise due to exact sensor location and
placement. Further, Eadi may also reflect a saturated signal, where any value over a
level trigger activity. Thus, much of its value may not capture patient-specific demand.
Hence, may not be a gold standard to assess patient-specific effort.
It is important to further verify the patient-specific demand elastance (negative Edrs)
using other approaches, such as an oesophageal pressure measurement to investigate
the pleural pressure changes in response to negative elastance, which would be a more
true signal of patient-specific demand. Equally, since rising demand could indicate the
potential to reduce support or wean the patient, an outcome assessment or successful
reduction or weaning could better validate the clinical utility of these metrics.
4.5 Summary
Negative elastance is a conceptual component in time-varying elastance during MV breath-
ing. It can be used to quantify patient’s direct involvement/demand during breathing.
However in this study, when attempting to quantify this it was shown to be clinically
inapplicable as negative AUCEdrs captures more than only patient effort. Further re-
search is needed to better validate any use of this metric against a true gold standard
measure of patient effort to observe patient effort.
CHAPTER 5
Quantifying patient effort in
an adult cohort using basis
functions
5.1 Introduction
In Chapter 4, patient effort was quantified using two methods, the zero-crossing and
trapezoidal methods. These methods were applied to a time-varying elastance model
Chiew et al. (2015a) to capture spontaneous breathing effort (Kim et al., 2017), where a
negative elastance in assumed to largely represent patient effort (Chiew et al., 2015a).
However, results in Chapter 4 showed the use of Edrs did not align fully with electric
activity of the diaphragm (Eadi) as it was not able to fully differentiate between patient-
specific lung condition and patient effort. Chapter 4 concluded a different method would
be needed.
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Morton et al. (2019b) utilised basis function models to identify patient-specific alveoli
recruitment and distension, as well as providing accurate prediction of lung mechan-
ics after MV changes (Morton et al., 2018, 2019b,a). The basis functions use defined
shapes to identify desired lung mechanics parameters over volume and pressure, en-
abling prediction. In particular, the alveolar recruitment basis function used in Morton
et al. (2019b) identifies patient-specific alveoli recruitment in comparison to the single
compartment model (Bates, 2009), which identifies lung elastance and can not differen-
tiate heterogeneity of the lung or active patient effort (Bates, 2009).
More specifically, these models capture passive lung mechanics well in response to ven-
tilator inputs. However, currently they cannot capture (un-modelled) patient-specific
breathing effort, as seen in prior studies using these models to identify and manage
asynchrony (Newberry et al., 2016; Kannangara et al., 2016a; Chiew et al., 2015b, 2018).
Thus, there is a need to combine existing models with different approaches in order to
assess both lung condition and patient breathing effort.
In this chapter, the recruitment basis function model of Morton et al. (2019b) is com-
bined with time-varying elastance to separate lung condition and mechanics from spon-
taneous breathing effort. This approach is applied to data from patients under neu-
rally adjusted ventilatory assist (NAVA) ventilation, as described in Chapter 3 (Piquilloud
et al., 2011; Moorhead et al., 2013; Chiew et al., 2013). The aim is for the recruitment ba-
sis function model to capture lung mechanics, while the time-varying elastance model
reflects the negative pressure dynamics of patient effort in addition to these mechanics
(Chiew et al., 2015a; Morton et al., 2019b).
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5.2 Methods
5.2.1 Patient Cohort and Acquisition
Mechanically ventilated data from 22 patients on NAVA as, described in Section 3.2, is
analysed in this chapter. In this cohort, patients were initially ventilated using pressure
support (PS) mode for 20 minutes and than switched to subsequent 20 minutes on NAVA.
The electrical activity of diaphragm (Eadi), pressure, flow data were recorded (Piquil-
loud et al., 2011). Only the NAVA cohort is analysed in this analysis as NAVA mode adjusts
input and thus resulting tidal volume in proportion to breathing effort (Morton et al.,
2019b; Chiew et al., 2015a) whereas the pressure support mode delivers a set pressure
in response to patient breath triggering. Hence, these patients and this mode provide
data where tidal volume and effort are in proportion, which can be used to evaluate the
resulting modelling approach to estimate patient-effort.
5.2.2 Model Fitting
A linear single compartment model described in Section 2.2 Eq (2.3) is modified for use
with recruitment and distension basis functions in this analysis. The single compart-
ment model is repeated here for clarity and reading ease, and is defined:
Paw = ErsV + RrsQ + PEEP (5.1)
Where, Paw is the airway pressure, Ers is the elastance of the lung, V is the volume, Rrs
is the airway resistance, Q is the flow, and PEEP is the pressure offset.
The single compartment model from Eq (5.1) is modified using basis functions described
in Section 2.3 to identify alveoli recruitment and distension basis functions (Morton
et al., 2019b). The shape of these basis functions is also repeated from Figure 2.2 as
Figure 5.1 for ease. The recruitment basis functions is repeated from Chapter 2, Eq (2.4)
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Where Vm is the upper limit of 1L in adults and φ1 is set to 0 for V > Vm. The 1L limit
should cover all adult tidal volume ranges, as they are typically ventilated at 4-8ml/kg
(Brower et al., 2000; Morton et al., 2019b). And the distension basis function is repeated




The two basis functions are added to single compartment model, repeated from Eq (2.6):
Paw = E1φ1V + E2φ2V + RQ + PEEP (5.4)
Figure 5.1: Recruitment and distension basis function shapes. (Both functions are di-mensionless) repeated from Chapter 2 Figure 2.2.
The NAVA patient cohort were on a partial ventilation mode where the ventilator sup-
ports patient breathing based on their Eadi. Therefore, it is assumed, there was no dis-
tension, and the distension basis function is ignored in this analysis to improve identi-
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fiability. This assumption leaves:
Paw = E1φ1V + RQ + PEEP (5.5)
Figure 5.2 shows an example of inspiration of pressure, flow and Eadi. In this figure, the
pressure drop caused by spontaneous breathing effort is clearly visible at the beginning
of the supported breath. The model identified in Eq (5.5) is defined to capture only pas-
sive breathing mechanics, and does not account for spontaneous breathing effort. This
means the early spontaneous breathing efforts would hinder model fitting, as no spe-
cific ”shape” in pressure for spontaneous breathing effort. As a result, the 30% to 70%
range of inspiration data (shown in red dashes) is used to identify patient-specific elas-
tance, E1 from Eq (5.5), as this range is expected to better reflect the pressure-volume
lung recruitment dynamics, without the significant non-linear inspiratory drive seen at
the start of the breath.
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Figure 5.2: Example of pressure and flow with basis function model fit region (Patient22)
Spontaneous breathing effort is quantified using the time-varying elastance model de-
fined in Chapter 2. The time-varying elastance model utilises dynamic lung elastance,
Edrs, which, is a sum of lung elastance and patient demand elastance. For this reason,
Edrs is identified from the error after the initial model fit from Eq (5.5). This two-step
approach results in final equation defined:
Paw = E1φ1V + RQ + PEEP + Edrs(t) × V (5.6)
where Edrs(t) is defined:
Edrs(t) = Paw(t) − PModelfit(t)V (t) (5.7)
ThisEdrs term essentially absorbs all model-fit error of the ’expected’ passive breathing
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dynamics defined by the recruitment basis function. Thus, the Edrs component is able
to capture patient effort where it is defined as (Edrs(t) < 0), after identifying the under-
lying ’passive’ lung mechanics. Edrs is expected to approach 0 as inspiration comes to
an end, where E1 becomes the dominant factor in determining airway pressure. Tak-
ing the area under the curve (AUC) of Edrs is denoted AUCEdrs, which quantifies this
time-dependent term and allows direct comparison between breaths and patients. Since
patient effort is defined as negative Edrs (Edrs < 0), taking the AUCEdrs of negative
component is assumed to capture patient effort.
5.2.3 Edrs Analysis
Preliminary analysis and data plotting showed many breaths start with fluctuations
in pressure before the NAVA modes support becomes dominant where spontaneous
breathing effort may also vary. Figure 5.3 shows small fluctuations in pressure at the
start with low flow, which mathematically, causes Edrs to be positive in a very short
portion (≤ 0.05 secs) during very early portion of inspiration. In Figure 5.3, the blue
Edrs curve is the original Edrs curve calculated through fitting from Eq (5.7). However,
due to these fluctuations, which may be caused by sensor sensitivity or other factors
because the lung does not respond that quickly, Edrs is positive. Thus, there is rea-
son to believe these Edrs values should be zero or negative and is only positive due to
quantised data points, where physiologically, the patient is trying to breath in. Thus, the
early section of Edrs is adjusted using all subsequent points within first 10% of inspira-
tion data is interpolated. This approximation allows estimation of a model-based ’true’
patient demand.
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Figure 5.3: Example of Edrs adjusted
5.2.4 Analyses
Model fit and patient effort are presented and analysed as median and interquartile
range (IQR). Scatter plots comparing AUCEdrs with resulting tidal volume is used to
compare the relationship between tidal volume and patient effort. Prior work by Moor-
head et al. (2013) showed good correlation between Eadi and tidal volume despite the
muscle dynamics betweenEadi input and tidal volume response (Moorhead et al., 2013).
Thus, comparing tidal volume and AUCEdrs < 0 compares these input to the clinically
relevant output. Tidal volume and patient demand for oxygen should be correlated as
the higher the patient demand, larger tidal volume is delivered to the patient by the
ventilator.
5.2.5 Asynchrony
Preliminary results showed some patients exhibit asynchronous breaths. An example
of one such breath is shown in Figure 5.4. The pressure waveform of these breaths
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typically rises then falls as patient demand becomes greater than ventilator driven me-
chanic. In this figure, pressure rises but flow is low and Eadi is also very small, and
thus indicates patient-ventilator asynchrony. In this chapter, asynchronous breaths are
noted and will be presented as percentage of the total number of breaths per patient.
Figure 5.4: Example of Asynchronous breath from Patient 22
5.3 Results
5.3.1 Model Fit
Model fit using basis functions on NAVA data was good and the use of Edrs captured ex-
pected spontaneous breathing effort. Figure 5.5 shows how the model with basis func-
tion and Edrs is able to capture a typical example breath. In this figure, it is also clear,
how the shape of the NAVA pressure waveform is close to being linear rather than a
ramp or square waveforms generally seen in fully controlled ventilation modes (Bates,
2009; Chiew et al., 2011; Kim et al., 2019a; Chiew et al., 2015a). Figure 5.6 shows zoomed
Edrs plot from Figure 5.5. This figure shows the negative AUCEdrs range, shaded in
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orange and positive AUCEdrs region shaded in purple.













































































Figure 5.5: Example breath with model fit



























Figure 5.6: Zoomed Edrs plot from Figure 5.5. Negative Edrs is shaded in Orange andpositive is shaded in purple.
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5.3.2 Patient breathing Effort
Table 5.1 shows E1, negative AUCEdrs, Median AUCEdrs, and tidal volume. Overall, the
median [IQR] of recruitment basis function fit, E1, across this cohort was 46.14 [27.38 -
71.85] cmH2O/l which is within typical ranges seen for MV patients (Morton et al., 2018,
2019b,a). The quantified negative AUCEdrs was -33.49 [-52.15 - -20.09] cmH2O/l. The
median [IQR] of settling positive AUCEdrs is 14.78 [8.97 - 19.77] cmH2O/l. The median
IQR of tidal volume was 0.43 [0.35 - 0.5]l across this cohort.
Patient 16 had the lowest median [IQR] basis function model fit with 11.99 [7.38 - 18.25]
cmH2O/l, while Patient 19 was highest with 99.27 [87.69 - 109.5] cmH2O/l. Patient 22
had the highest negative AUCEdrs value with -102.21 [-406.36 - -44.91] cmH2O/l, whereas
Patient 12 had lowest negative AUCEdrs with -10.00 [-31.36 - -3.95]cmH2O/l.
Table 5.1: Model Fitting Results
Patient E1 [cmH2O/l] Negative AUCEdrs [cmH2O/l] MedianAUCEdrs [cmH2O/l] Vt [l]
1 31.14 [25.61 - 36.29] -48.88 [-58.29 - -41.67] 12.84 [11.20 - 15.00] 0.63 [0.59 - 0.67]
2 33.10 [25.79 - 40.41] -52.38 [-59.96 - -45.11] 20.26 [17.37 - 23.32] 0.46 [0.43 - 0.50]
3 41.68 [34.06 - 50.98] -34.52 [-45.29 - -28.85] 16.97 [14.14 - 20.11] 0.39 [0.36 - 0.43]
4 17.39 [10.86 - 28.12] -32.17 [-55.70 - -21.58] 2.28 [0.90 - 4.67] 0.31 [0.29 - 0.34]
5 61.88 [42.77 - 75.33] -59.63 [-68.28 - -52.06] 24.90 [20.60 - 29.61] 0.38 [0.35 - 0.41]
6 17.74 [10.02 - 28.21] -14.28 [-22.40 - -10.97] 7.52 [6.15 - 9.39] 0.46 [0.42 - 0.49]
7 60.42 [47.51 - 75.81] -21.29 [-36.78 - -10.07] 7.59 [0.89 - 20.22] 0.28 [0.18 - 0.48]
8 25.63 [8.58 - 56.79] -88.28 [-130.54 - -61.25] 7.53 [2.39 - 11.80] 0.56 [0.37 - 0.94]
9 80.57 [66.89 - 97.55] -43.64 [-50.07 - -35.44] 20.06 [13.39 - 25.26] 0.47 [0.34 - 0.52]
10 26.10 [16.18 - 36.22] -30.18 [-38.55 - -24.68] 17.73 [15.40 - 20.26] 0.42 [0.39 - 0.44]
11 35.47 [29.09 - 42.63] -27.64 [-33.01 - -24.03] 16.87 [14.51 - 19.46] 0.42 [0.38 - 0.48]
12 67.39 [58.23 - 79.43] -10.00 [-31.36 - -3.95] 3.26 [-1.15 - 6.99] 0.29 [0.26 - 0.33]
13 12.67 [5.97 - 24.56] -32.20 [-38.26 - -27.60] 15.77 [12.33 - 18.10] 0.50 [0.47 - 0.53]
14 43.02 [32.37 - 60.51] -40.69 [-50.52 - -33.30] 16.66 [10.94 - 22.40] 0.43 [0.14 - 0.57]
15 90.37 [77.30 - 107.92] -28.73 [-36.89 - -23.10] 17.09 [13.96 - 22.16] 0.54 [0.47 - 0.61]
16 11.99 [7.38 - 18.25] -23.33 [-33.62 - -9.20] 14.66 [12.95 - 17.15] 0.62 [0.59 - 0.65]
17 28.04 [16.88 - 41.04] -29.33 [-40.63 - -21.90] 12.98 [10.62 - 16.01] 0.48 [0.37 - 0.58]
18 71.00 [59.50 - 83.95] -18.82 [-30.24 - -10.53] 9.84 [5.59 - 14.22] 0.44 [0.34 - 0.52]
19 99.27 [87.69 - 109.50] -3.55 [-10.35 - -1.80] 2.84 [-1.97 - 8.54] 0.29 [0.24 - 0.34]
20 54.75 [48.62 - 60.66] -14.84 [-25.37 - -10.49] 9.46 [6.61 - 11.94] 0.43 [0.38 - 0.49]
21 12.48 [3.54 - 55.49] -43.05 [-54.17 - -31.99] 13.30 [9.91 - 17.30] 0.77 [0.66 - 0.87]
22 71.03 [54.81 - 86.99] -102.21 [-406.36 - -44.91] 19.56 [15.11 - 24.07] 0.44 [0.40 - 0.48]
All 46.14 [27.38 - 71.85] -33.49 [-52.15 - -20.09] 14.78 [8.97 - 19.77] 0.43 [0.35 - 0.50]
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Figures 5.7, 5.8, and 5.9 shows a scatter plot of range90 of AUCEdrs and tidal volume
Vt with an example model fit for a breath and its corresponding Edrs curve. Patient 15
had the best correlation, Patient 11 had moderate correlation and Patient 22 had poor
correlation. The example model fit curves within these figures show how Edrs is able to
capture the rest of the observed breathing mechanics. Scatter plots for all patients can
be seen in Appendix A.






















































































Figure 5.7: Scatter plot with good correlation of AUCEdrs and Vt from Patient 15. Thespecific breath is red dot.
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Figure 5.8: Scatter plot with moderate correlation of AUCEdrs and Vt from Patient 11.The specific breath is red dot.






















































































Figure 5.9: Scatter plot with bad correlation of AUCEdrs and Vt from Patient 22. Thespecific breath is red dot.
5.3.3 Asynchrony
Table 5.2 shows asynchrony detected for each patient. From this table, Patients 4, 8, 16,
and 22 have high asynchrony rates. Patient 22 was mostly asynchronous with 70.69%
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of breaths displaying asynchrony. Patients 1, 5, 12, and 21 had zero incidence of asyn-
chrony.
Table 5.2: Model Fitting Results





1 249 0 0.00
2 615 3 0.49
3 452 3 0.66
4 173 126 72.83
5 749 0 0.00
6 553 105 18.99
7 340 3 0.88
8 300 22 7.33
9 470 49 10.43
10 683 19 2.78
11 616 2 0.32
12 497 0 0.00
13 732 16 2.19
14 334 4 1.20
15 237 5 2.11
16 385 79 20.52
17 706 82 11.61
18 459 5 1.09
19 576 4 0.69
20 434 1 0.23
21 221 0 0.00
22 928 656 70.69
5.4 Discussion
The recruitment basis function used in this chapter, has previously been used and vali-
dated in sedated adults on conventional fully supported mechanical ventilation modes.
E1 has been utilised to identify patient alveoli recruitment (Morton et al., 2018, 2019b,a).
The time-varying elastance model also used in this chapter, captures patient effort through
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the use of dynamic elastance, Edrs (Chiew et al., 2015a). These two models were utilised
in a two-step approach to capture patient lung condition in partial ventilation cohort,
in attempt to further quantify patient effort. Overall, E1 was able to capture patient-
specific lung condition and Edrs was able to capture patient effort through AUCEdrs.
The overall identified E1 in this cohort was 46.14 [27.38 - 71.85] cmH2O/l and the quanti-
fied spontaneous breathing effort, AUCEdrs was -33.49 [-52.15 - -20.09] cmH2O/l. There
was large variation in both E1 and AUCEdrs across the patients as seen in Table 5.1.
These results match value and inter-patient variability seen in Morton et al. (2019b,a).
Patient 19 had the largest E1 median [IQR] range with 99.27 [87.69 - 109.50]cmH2O/l,
and low tidal volumes of 0.29 [0.24 - 0.34]l. Similarly Patient 15 had E1 of 90.37 [77.30
- 107.92]cmH2O/l with median tidal volume ranges of 0.54 [0.47 - 0.61]. These higher
elastance values suggest, these two patients have much stiffer lungs compared to other
patients.
The E1 value cannot be fully fit to inspiration of NAVA cohort clearly showing there are
un-modelled, non-passive patient dynamics in the data. This is largely due to the fact
the basis function best reflects fully controlled ventilation in sedated patients, where
patient breathing is driven by the ventilator and pressure outcomes are a function of
recruitment and airway resistance only. In addition, many ventilator supported breaths
are either ramped or square in shape, whereas NAVA breaths are more linear, as a result
of the NAVA mode and these dynamics.
Figure 5.10 shows example breath with inspiratory pressure, model fits, Edrs and Eadi
for Patient 21. In this figure, the basis function model fit towards the end of the breath
appears to have poor fit. However, given the maximum volume reached, only small
positive Edrs is required to compensate for this apparent error and therefore the model
fitting using basis function is acceptable. Physiologically, this difference occurs as pa-
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tient effort is ending, the air is forced in by the ventilator and thus, positive Edrs is seen,
which is much like the always positive Edrs seen in fully sedated passive ventilation.


































































Figure 5.10: Example Pressure with model fit, Edrs and Eadi.
Figures 5.7, 5.8, and 5.9 showed good, typical and poor correlation between patient effort
and tidal volume delivered. Patient 15 and 11 shows good and moderate correlations,
clearly showing a linear trend. This trend shows the lower the tidal volume delivered,
lower the spontaneous breathing effort. This outcome matches the method used by the
NAVA mode, as tidal volume is adjusted based on the diaphragm activity of the patient
meaning higher the activity (higher demand), more volume is delivered and Figures 5.7
and 5.8 definitely shows this trend. Patient 22 from Figure 5.9 does not show same linear
trend as other patients. Notably, poor correlation was only seen in 4 patients of the 22
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analysed. Most were good (see Appendix A).
Figures 5.11, 5.12, and 5.13 shows scatter plots comparing AUCEdrs with Eadi for the
same three Patients 11,15, and 22. The AUCEdrs trend with Eadi is similar to Vt as ex-
pected. Moorhead et al. (2013) showed the Eadi and Vt have linear correlation and thus
the when both are compared with AUCEdrs is expected to show similar trends (Moor-
head et al., 2013). Intuitively, the Eadi measures electrical activity of diaphragm to con-
trol patient breathing and therefore should be correlated with tidal volume as higher
diaphragm movement indicates larger breath is needed and thus larger tidal volume is
supplied. The figures comparing AUCEdrs with Vt and Eadi showed same trends, which
implies the AUCEdrs is a metric that can be used to measure spontaneous breathing
effort without the use of external and/or invasive sensors as required with NAVA.















































































Figure 5.11: Scatter plot with good correlation of AUCEdrs and Vt from Patient 15.
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Figure 5.12: Scatter plot with moderate correlation of AUCEdrs and Vt from Patient 15.















































































Figure 5.13: Scatter plot with bad correlation of AUCEdrs and Vt from Patient 15.
The poor correlation betweenAUCEdrs andVt is an indication of large patient-ventilator
asynchrony present. Table 5.2 shows asynchrony rates of each patient and high inci-
dence of asynchrony matched Patients with poor corellations between AUCEdrs and
Vt. Edrs used in this analyses captures patient effort from very early portion of inspi-
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ration. In this analyses, the early positive Edrs is also adjusted due to fluctuations that
occur in normal NAVA breathing. However, doing so on asynchronous breath, results
in altering of ’correct’ Edrs behaviour.
Top Figure 5.14 shows boxplot of AUCEdrs values for all patients and bottom shows
AUCEdrs values after asynchronous breaths has been removed. Patients who had more
asynchronous breaths such as Patients 6 and 22, the AUCEdrs is less variable and their
interquartile range is much narrower. This indicates some of the patients were highly
asynchronous during their recording period and thus, can not truly represent their
spontaneous breathing effort in which results in poorer correlation between patient
effort and tidal volume seen in Appendix 1.











































Figure 5.14: Boxplot of AUCEdrs per patient. Top) All patient breaths. Bottom) Asyn-chronous breaths removed.
Further study will be required to apply this method to capture patient-spontaneous
breathing effort in clinical environment. Although this model was able to capture both
patient-specific lung mechanics, condition and patient effort, further validation will be
required.
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5.5 Summary
Overall, the basis function with time-varying elastance model was able to capture both
patient-specific elastance and spontaneous breathing efforts. The E1 was fit to the data
from 30% to 70% inspiration due to large spontaneous breathing effort occurring early
in the inspiration. AUCEdrs was able to accurately quantify patient effort in compar-






It is well known and established to use lower tidal volumes in MV therapies (Brower
et al., 2004). However, there is relatively no consensus for PEEP selection (Briel et al.,
2010; Oba et al., 2009; Mercat et al., 2008b; Meade et al., 2008; Villar et al., 2006; Amato
et al., 1998; Brower et al., 2004; Major et al., 2018). Traditionally, lower PEEP have been
used to minimise risk (Gattinoni et al., 2003; Hickling et al., 1990), but low PEEP can
lead to increased cases of oxygen desaturation and hypoxaemia (Guerin, 2011; Brower
et al., 2004) and worsened lung injury indicated by a greater number of rescue therapies
and death after rescue therapy (Briel et al., 2010). High PEEP is able to increase alveoli
recruitment, but can decrease cardiac output and lead to further lung injury by baro-
trauma and/or volutrauma or overdistension (Hillman and Albin, 1986; Petersen and
Baier, 1983; Gammon et al., 1992; Cullen and Caldera, 1979; Thammanomai et al., 2013;
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Dreyfuss and Saumon, 1992; Briel et al., 2010; Brower et al., 2004; Albaiceta and Blanch,
2011; Tremblay and Slutsky, 2006; Slutsky and Ranieri, 2013b).
PEEP can be optimised to reduce hypoxemia (Meade et al., 2008) and intrapulmonary
shunting (Mercat et al., 2008b), improve gas exchange (Oba et al., 2009) and oxygenation
(Brower et al., 2004; Borges et al., 2006; de Matos et al., 2012), by maintaining recruitment
of injured or collapsed alveoli (Thammanomai et al., 2013). In patients with ARDS, lower
PEEP reduces ventilator-induced lung injury (VILI) (Briel et al., 2010; Brower et al., 2004;
Albaiceta and Blanch, 2011; Tremblay and Slutsky, 2006; Slutsky and Ranieri, 2013b),
increases recruitment (Malbouisson et al., 2001; de Matos et al., 2012; Borges et al., 2006),
and reduces inflammatory mediators in plasma and bronchoalveolar lavage fluid (Oba
et al., 2009). It has been hypothesized MV strategies combining low tidal volumes with
recruitment manoeuvres (RMs) and higher PEEP to prevent VILI would be ideal for lung
protection (Rose et al., 2009; Meade et al., 2008). However, currently, there is still no
standardisation of how this potentially higher optimal PEEP should be selected, nor how
often it should be adjusted or recalculated.
Experimental animal trials by Lambermont et al. (2008); Suarez-Sipmann et al. (2007);
Carvalho et al. (2007) (Lambermont et al., 2008; Suarez-Sipmann et al., 2007; Carvalho
et al., 2007) reported ARDS induced pigs experienced a minimal respiratory elastance at
a specific PEEP associated with higher oxygenation, maximum recruitment, and higher
functional residual capacity, all without signs of lung overdistension. Equally, it has
been proposed to set PEEP where the lung has minimal respiratory elastance (or max-
imum compliance), which could be clinically beneficial by balancing the risks of PEEP
set too low or too high (Suter et al., 1975; Chiew et al., 2015c; Pintado et al., 2013). Aside
from the work by Suter et al. (1975) (Suter et al., 1975), Pintado et al. (2013) (Pintado
et al., 2013) also showed PEEP selection at minimal elastance is beneficial to patients.
Despite some consistent findings, the application of minimal elastance PEEP selection
CHAPTER 6. CLINICAL UTILISATION OF RESPIRATORY ELASTANCE 71
remains limited and hindered by the lack of an objective, reliable, and easy to use this
method to determine elastance at the bedside in real time.
In a pilot study, Chiew et al. showed the potential benefit of minimal-elastance PEEP
selection (Chiew et al., 2011, 2015c). Following the study, a phase 2 randomised con-
trolled trial (RCT) was designed to assess mechanical ventilation of ARDS patients at
minimal elastance PEEP versus standard practice of care in a single centre hospital.
In particular, patient-specific respiratory system elastance and corresponding minimal
elastance PEEP is determined using a validated model-based method and computer soft-
ware (Szlavecz et al., 2014). This trial uses real-time identified patient-specific respi-
ratory system elastance, and thus the trial is named Clinical Utilisation of Respiratory
Elastance (CURE) RCT. This manuscript presents the detailed clinical protocol for this
phase 2 CURE RCT. This trial is registered with the Australian New Zealand Clinical Trial
Registry (ANZCTR): ACTRN12613001006730
The CURE trial was initially proposed in 2014. Since then, the protocol for this trial has
gone through extensive and significant changes. These changes were applied to make
this trial more pragmatic, and safe. The Acute Respiratory Distress Trial (ART) (Caval-
canti and ART Investigators, 2017) raised concerns with the use of recruitment manoeu-
vre as this study resulted in higher mortality and length of stay. Therefore significant
changes have been made to the trial design. In this chapter, the protocol for CURE trial is
presented in full, outlining and presenting all the details required for any such clinical
trial (Kim et al., 2020).
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6.2 Methods
6.2.1 Methods and Trial Design
The CURE RCT is a two-arm randomised controlled trial comparing model-based me-
chanical ventilation (MBV) with current standard practice mechanical ventilation (SPV)
in patients with a partial pressure of arterial blood oxygen (PaO2) / fraction of inspired
oxygen, (FiO2), P/F ratio ≤ 200. It is to be conducted in a single centre hospital intensive
care unit (ICU), Christchurch Hospital, in Christchurch, New Zealand.
The primary objective is to assess the impact of model-based ventilation in PEEP selec-
tion (MBV) therapy on clinically significant patient outcomes and patient centred quality
of care metrics. The other objectives of this study include: 1) to provide the knowledge
and methods to make care more patient-specific and timely to optimise treatment and
improve outcomes for a large cohort critically ill patients; and 2) to improve the under-
standing of the patho-physiological basis of critical illness via what we will learn about
the hourly and daily evolution of lung injury in terms of patient-specific elastance and
response to care through this study.
The primary outcome of this study is the area under the curve (AUC) of PaO2/FiO2 over
the period of mechanical ventilation. Secondary outcomes include: length of MV (LoMV),
ventilator free days (VFD) up to 28 days, ICU and hospital length of stay (LoS), AUC of
SpO2 / FiO2 during MV, number of desaturation events (frequency and fraction of time
SpO2 < 88%), changes in respiratory mechanics and chest X-ray Index scores, rescue
therapies (prone positioning, nitric oxide use, ECMO) and hospital and 90-day mortal-
ity. These outcomes and their corresponding four levels of specification based on Zarin
et al. (2011) are shown in Table 6.1. The secondary analysis includes comparison of the
means of: length of MV, VFD, length of stay of hospital and ICU, 90 day mortality, chest
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Table 6.1: Four levels of specification in primary and secondary outcomes
Level 1: Domain Level 2: Specific Domain Level 3: Specific Metric Level 4: Method of Aggregation
Oxygenation AUC P\F ratio Difference in AUC Comparison of the means of AUCAUC SpO2/FiO2
MV Length of MV Number of Days Comparison of the means of number of daysVentilator Free Days (VFD) up to 28 days 28 days - days of MV Comparisons of the means of VFD
Length of Stay
Hospital Number of days Comparisons of the means of length of stayICU
90-day mortality Time to event Comparison of number of 90 day mortality
Other Chest X-ray index scores Index scores over period of MV Comparison of index scores over timeRescue therapies Comparisons of index scores over time Comparisons of rescue therapies used
x-ray index scores, and rescue therapies used.
A difference in primary and secondary outcomes will show the impact of MBV compared
to SPV. No difference would show that enhanced, model-based metrics of patient-specific
condition have no effect on patient-centred or clinical outcomes. Either outcome will
yield clinical guidance.
Two Arm Randomised Controlled Trial
Eligible patients are randomised to either the model-based intervention group (MBV) or
the control group (SPV). Both groups will have designated computer software to monitor
their breathing (Szlavecz et al., 2014). The software uses real-time measurements of
pressure and flow from the ventilator to objectively calculate the patient- and breath-
specific respiratory system elastance for every breath (Szlavecz et al., 2014).
Participants on MBV will undergo recruitment manoeuvres (RM), an initial maximum
recruitment manoeuvre (RMMax) or subsequent PEEP adjUstment and Monitoring Pro-
cedure (PUMP) mini recruitment manoeuvres. The respiratory elastance at each PEEP
step during these protocolised RMs is calculated and recorded. The software will rec-
ommend a patient-specific minimal-elastance PEEP to the clinicians in setting ventilator
PEEP. Patients on SPV will have PEEP selected using current clinical practice without the
aid of the software, but all breaths will be analysed and elastance recorded blind to clin-
ical staff
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Adherence to intervention
Patients recruited into this study will be under constant supervision in the ICU. However
their outcomes are measured by intent to treat, taking into account protocol variations,
which naturally occur. These variations will be reported to primary investigator at the
earliest opportunity and followed up. There will be detailed training on the use of CURE
equipment and protocol to allow adherence to trial.
Protocol amendments
This trial is based on intention to treat. Thus, protocol amendments may be required to
ensure patient safety and outcomes, and the primary investigators will instigate proto-
col amendments if necessary. The amendments will be reviewed by the data monitor-
ing committee (DMC) to warrant patient safety and outcomes. The DMC may also refer
protocol amendments based on outcomes of the interim analysis reports. Finally, if par-
ticipant enrolment is slow, amendments may also be made to allow faster recruitment.
Concomitant care and intervention
The trial results critically ill participants who are mechanically ventilated. Thus, it is
likely and acceptable for participants to be receiving medication related to any other
concomitant co-morbid conditions while participating in CURE RCT.
Participants of this study will not be concomitant to another study that would affect
the results of this study. Participants will not be co-enrolled to another study that have
different oxygenation settings, recruitment manoeuvre procedures and anything that
may affect the outcomes of this study.
6.2.2 Eligibility Criteria
The following are the CURE RCT inclusion, exclusion and P/F ratio criteria:
CHAPTER 6. CLINICAL UTILISATION OF RESPIRATORY ELASTANCE 75
Inclusion Criteria
1. P/F ratio ≤ 200
i on any level of PEEP or FiO2, OR
ii P/F ratio ≤ 200 on FiO2 = 50% and PEEP = 5
Exclusion Criteria
1. P/F ratio > 300 on any level of PEEP or FiO2
2. P/F ratio > 200 on FiO2 = 50% and PEEP = 5
3. Ventilated > 48 hours (including time spent in another hospital)
4. Not expected to be ventilated for another 48 hours
5. Patients with age < 16.
6. Any medical condition associated with a clinical suspicion of raised intracranial
pressure and/or a measured intracranial pressure ≥ 20 mmHg.
7. Patients who have a high spinal cord injury with loss of motor function and/or
have significant weakness from any neurological disease.
8. Patients who have a barotrauma (pneumothorax, pneumomediastinum, subcuta-
neous emphysema or any intercostal catheter for the treatment of air leak).
9. Patients who have asthma as the primary presenting condition or a history of sig-
nificant chronic obstructive pulmonary disease.
10. Patients who are moribund and/or not expected to survive for > 72 hours.
11. Agreed limitations of care due to co-morbidities, or not expected to survive 90 days
12. Lack of clinical equipoise by intensive care unit (ICU) medical staff managing the
patient. (For example, patients with unremarkable CXR findings with possibility
of thrombotic or fat pulmonary emboli).
13. Patients previously been enrolled in CURE RCT
P/F ratio Criteria
1. P/F ratio ≤ 200; Patient is eligible for enrolment
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2. If 200 < P/F ratio ≤ 300; Set FiO2 = 50% and PEEP = 5 cmH2O and repeat the ABG
within 10 minutes of the change to measure the new P/F ratio:
(a) If the new P/F ratio ≤ 200; Patient is eligible for enrolment.
(b) If the new P/F ratio > 200; Patient is not eligible for enrolment and, if appro-
priate, will be re-screened at later time.
This trial will recruit patients who have P/F ratio ≤ 200, a criterion in the definition of
severe to moderate ARDS defined by The ARDS Definition Task Force- The Berlin Defini-
tion (Definition et al., 2012). They will be eligible if their P/F ratio is ≤ 200 on any level
of PEEP and FiO2. Those patients with a 200 < P/F ratio ≤ 300 will be placed on PEEP =
5 cmH2O, and an FiO2 = 50%. If a subsequent P/F ratio is ≤ 200 they will also become
eligible. The P/F ratio measured at FiO2 of 50% and PEEP of 5 cmH2O is based on Villar
et al. 2013 (Villar et al., 2013).
6.2.3 Consent,compliance, and withdrawal
Consent Procedure
First, it is important to note standard ventilation practice may include recruitment ma-
noeuvres to increase lung recruitment and oxygenation. However, these clinical prac-
tices are widely variable and often not standardised. The recruitment techniques used
to improve oxygenation and mechanics of ventilation in the intervention and control
arms of this study are within the scope of standard ICU clinical practice. The proto-
cols used will standardise these existing interventions to recruit lung volume and titrate
PEEP.
Study participants will be unable to consent to participation in this study prior to enrol-
ment as they will be sedated and mechanically ventilated. It is also equally important
participants be randomised into either arm of the RCT at the commencement of MV to
ensure a fair comparison. Patients who have been ventilated ≤ 48 hours are eligible for
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the CURE RCT. Given this time frame, CURE RCT will recruit patients once family consent
is obtained. However, if the treating clinician firmly believes a recruitment manoeuvre
is in the best interests of the patient, and no family is available for consent, the par-
ticipant will be enrolled and randomised and the appropriate protocolised recruitment
manoeuvre will follow. In this case, delayed consent is obtained as early as possible.
Once the participant recovers from their condition and is discharged from the ICU, we
will seek their informed consent.
In cases where the family cannot attend the hospital to sign a statement of assent, their
opinion will be obtained by telephone in the first instance. Information about the study
will either be made available by emailing them the information sheet and contacting
them later by telephone, or the information sheet will be read to them over the tele-
phone. The telephone conversation(s) and their opinions will be documented in the
patient’s medical record. As soon as the family is able to attend the hospital, they will
be asked to sign the statement. If the family are not able to sign a statement during the
patient’s time in the ICU, they have the option of printing out the statement, signing it,
and mailing/emailing/faxing it back.
Withdrawal of consent
If the participant’s family / relative/ friend do not agree to their continued participation,
they will be withdrawn from the study and we will seek agreement from them to use
information related to mechanical ventilation collected up until that point.
If a participant chooses to withdraw from the trial, we also will seek agreement to use
information related to mechanical ventilation collected up until that point. If they do
not agree, then all study information obtained will be destroyed.
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Randomisation and Blinding
Randomisation will be performed in blocks, where the block sizes are generated using
a randomisation program. The program will randomly assign patients into either a con-
trol group or intervention group through a random block size (block size is either 4, 6, 8
or 10 patients). Eligible and consented patients will be block randomised with a ratio of
1:1. No effort will be given to stratifying the subgroups considered in the secondary anal-
yses. By the nature of the intervention, CURE cannot be double-blinded. Un-blinding is
not applicable due to the nature and setting of the intervention.
6.2.4 Ventilation settings, Oxygenation, and Patient Positioning
Tidal volume and driving pressures during MV
Tidal volume (VT) is adjusted to 6-8 ml/kg per ideal body weight (IBW), and the maximum
minute ventilation (VEmax) ≤ 0.2 L/kg/minute. The ideal body weight (IBW) is measured
by the patient’s height and look-up table at the bedside or calculated using the formulae:
Men : 50 + 0.91 × (height[cm] − 152.4)kg (6.1)
Women : 45.5 + 0.91 × (height[cm] − 152.4)kg (6.2)
The driving pressure (DP) is the plateau pressure (PPlat) minus the PEEP. In patients with
very severe ARDS 6-8 ml/kg may be injurious if the DP is higher than 15 cmH2O. A DP ≤
15 cmH2O was associated with better patient survival when assessed using a multilevel
mediation analysis of 3562 patients in 9 RCTs of ARDS (Brochard et al., 2015). There-
fore, the DP will be limited to ≤ 15 cmH2O at all times. In addition, during spontaneous
ventilation, pressure support will be limited to ≤ 15 cmH2O.
Ventilation rate is set between 12 and 20 breaths per minute. The aim is to keep the
plateau pressure Pplat ≤ 30 cmH2O. If necessary, VT may be reduced as low as 4 ml/kg
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and the respiratory rate (RR) kept ≤ 30 breaths per minute. CO2 will frequently rise in
severe lung injury (permissive hypercapnia) when patients are mechanically ventilated
within these guidelines. However, if CO2 ≥ 80 mmHg or increased ≥ 50% in the previous
4 hours, the intensive care specialist on duty will be notified, and they may choose to
deviate from these guidelines.
Ventilation Mode
All patients enrolled are to be ventilated using a pressure-controlled mode. For exam-
ple, the Bi-Level ventilation mode on the Puritan Bennett PB840 ventilator (Covidien,
Boulder, CO, USA), or PC-SIMV+ on the Drager Evita Infinity V500. Patients will be venti-
lated using Bi-Level/PC-SIMV+ mode, which allows unrestricted spontaneous breathing
efforts to lessen ventilator dyssynchrony. However, during any recruitment manoeuvre
procedures, synchronized intermittent mandatory ventilation (SIMV) with pressure-
controlled (PC) ventilation is used and returned to original mode afterwards. Should
patients already be ventilated using a ventilator incompatible with the CURE computer
system, they will have their ventilator changed to a compatible ventilator for the trial.
Patients will be transitioned to Assisted Spontaneous Breathing (ASB) if they meet the
weaning criteria.
In severe ventilator dyssynchrony, a very a high respiratory drive may result in sub
atmospheric circuit pressures and risk of aspiration of gastric contents around the en-
dotracheal cuff. If a participant has a high respiratory drive on Bi-Level/PC-SIMV+ ven-
tilation, producing a fall in airway pressure during inspiration, muscle relaxants will be
considered to facilitate controlled breathing. However, if the clinician feels the partici-
pant may benefit from breathing spontaneously, transition to ASB may be made if they
substantially meet the weaning criteria.
However, spontaneous breathing efforts may mask high trans-pleural pressures and
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produce high levels of regional lung strain. Oesophageal pressures will not be measured
during this trail. If the treating clinician is concerned about patient self-inflicted lung
injury (P-SILI) (Brochard et al., 2017; Brochard, 2017), they will consider using muscle
relaxants to control ventilation.
Patients will not undergo any procedures using a cough assist machine prior to weaning
and transitioning to spontaneous breathing. However, the treating clinician may use a
cough assist machine to aid secretion removal (during spontaneous breathing) if they
believe it is in the patient’s best interests.
Finally, in any circumstances where the patient is planned to be temporarily discon-
nected from the ventilator, their endotracheal tube will be clamped to prevent de-recruitment
SpO2 Targets
To ensure a fair comparison, all CURE study participants will have inspired oxygen lev-
els titrated to achieve the following pulse oximetry saturations, SpO2:
i) SpO2 = 93-95% if FiO2 is less than 60%.
ii) SpO2 = 90-92% if FiO2 is greater than or equal to 60%.
The aim is to spend greater than or equal to 90% of time in the target range. The FiO2
should only be increased above 21% if these targets are not met, using 5% increments
starting with a FiO2 = 25%. There is natural variability in SpO2 levels. To avoid toggling
between two FiO2 levels, 10 minutes of settling time will be allowed before changing
the FiO2. The best FiO2 is chosen to keep the saturation over 90% of the time within the
specified targets ranges.
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Patient Position, Turning, and Prone Positioning
Patients are kept at 30° head up whenever possible. This position maximises recruitment
of the lung and may reduce the risk of aspiration. Wherever possible, patients should
be rolled from supine to right-side down, back to supine, then to left-side down. This
turning of patients is ideally performed every 3 hours.
Transient hypoxaemia frequently occurs after a patient has been turned and may be
worse if there is inadequate PEEP. Hypoxaemia may also become more severe if partic-
ipants are rolled from left-side down to right-side down due to cyclical de-recruitment
of the non-dependent lung and re-recruitment of the dependent lung. This cyclical de-
recruitment of the lung has the potential to contribute to VILI. Thus, patients with severe
lung injury may be very intolerant of being turned. In some instances, the lungs may
need to be re-recruited. If desaturation does occur, this will be recorded as a serious
adverse event (SAE).
Prone positioning of patients may be considered if the P/F ratio is ≤ 100 and FiO2 ≥ 60%.
Patients randomised to the intervention arm (MBV) may still undergo a protocolised
recruitment manoeuvre. For patients in the standard practice ventilation arm (SPV) a
staircase recruitment manoeuvre is left to clinical judgement.
6.2.5 Arterial blood gas (ABG) recordings
The primary outcome of this trial is the AUC of the P/F ratio. For this reason, manda-
tory daily ABGs are performed daily for up to 10 days from enrolment. ABGs are taken
around 0600 hours and 1800 hours. The ABGs are also acquired within 60 minutes of any
recruitment manoeuvre procedure and 30-60 minutes after the recruitment manoeuvre
procedure. The added ABGs from RM procedures will be used in secondary analysis, but
will be omitted during primary analysis to ensure the same number of data points per
day for all patients.
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6.2.6 Duration of intervention
Patients randomised to the model-based ventilation (MBV) cohort will remain in the pro-
tocol up to 10 days. Thereafter, they will receive the same care as participants assigned
to standard practice ventilation (SPV). However, if participants have been extubated,
but then require intubation and re-ventilation at any time within 10 days of enrolment,
they will return to the original assigned protocol (MBV or SPV). All patients will receive
standard care beyond 10 days of enrolment, and their data recording including ABG
recordings will continue to be collected for up to 28 days.
6.2.7 General Procedures
Procedures for Control group, SPV
1. PEEP is selected as per standard practice.
2. The decision to carry out a staircase recruitment manoeuvre will be based on clin-
ical judgement. The protocol for performing staircase recruitment manoeuvre is
explained in the recruitment manoeuvre section.
3. ABGs will be taken twice daily.
4. Ventilator data collected continuously until disconnected.
Procedures for Intervention group, MBV
1. For patients included for MBV (intervention), the PEEP and MV will be guided by
clinicians using bedside computers while maintaining VT and FiO2.
2. Patients randomised to MBV will undergo protocolised recruitment manoeuvres
(RM)
(i) Before the RM, the patient should be sedated and paralysed, if required, with
muscle relaxants to prevent spontaneous breathing efforts.
(ii) The first RM used is a Maximum Recruitment Manoeuvre (RMMax). This is
done at the beginning of the trial by clinicians and only repeated if clinically
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indicated.
(iii) The PEEP adjUstment and Monitoring Procedure is referred to as a ‘PUMP’,
where the PEEP is adjusted -4 cmH2O to +4 cmH2O of the current PEEP setting.
The PUMP may be performed by ICU staff trained in this technique.
3. The participant will no longer undergo a PUMP when:
a FiO2 ≤ 35%,
i And they have fully transitioned to spontaneous breathing
ii And the, PaO2 ≥ 60 mmHg for the last 24 hours, OR
b After 10 days from study enrolment.
c At the discretion of the clinician, for example:
i New neurological condition
ii They are awake and breathing normally without evidence of respiratory
distress, and where sedation (with or without paralysis) is not considered
to be in their best interests.
4. ABGs will be taken twice daily, and before and after any recruitment procedure.
5. Data will be collected continuously until the patient is disconnected from the ven-
tilator.
6.3 Recruitment Manoeuvres (RM)
Patients enrolled in this study will undergo recruitment manoeuvres. RMs are only car-
ried out by senior medical staff or senior trainees familiar with this technique. Maxi-
mum Recruitment (RMMax) and PEEP adjUstment and Monitoring Procedures (PUMPs)
are for participants randomised to the MBV protocol arm only. Patients assigned to the
SPV arm may undergo a staircase recruitment manoeuvre (SRM) at the discretion of the
treating clinician according to standard practice.
All RMs will be performed in SIMV Pressure Controlled (PC) ventilation mode. The peak
inspiratory pressure (Pi) is set to achieve a tidal volume (VT) 6-8 ml/kg IBW. Preferably,
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VT should result in a driving pressure (DP) ≤ 15 cmH2O above PEEP.
Before and after each RM, arterial blood gases (pH, PaCO2, PaO2, HCO3), SpO2, end tidal
carbon dioxide partial pressure (ETCO2), FiO2, PEEP, respiratory rate (RR), and VT will
be recorded. In addition, during the RMMax (Model Based Ventilation arm) or SRM (Stan-
dard Practice Ventilation Arm), at each PEEP increment, Heart Rate, Rhythm, mean ar-
terial pressure (MAP), SpO2, FiO2, VT, RR, ETCO2, and rates of vasoactive drugs will be
recorded. This data will be valuable in assessing the safety of the RMMax, PUMP, and
SRM.
In many cases, where the lung stiffness, or respiratory elastance (E) is high, it will not be
possible to deliver a VT of 6 ml/kg. Furthermore, during the recruitment manoeuvre, the
delivered VT may fall further as the elastance increases. As a result, it may be necessary
to increase the respiratory rate to accommodate the reduction in minute ventilation.
For example, if E is > 40 cmH2O /L (or compliance < 25 ml/cmH2O) in a 58 kg (IBW)
patient, (normal range 15-20 cmH2O/L), the VT will be < 6 ml /kg (<350 ml) when the
driving pressure is 15 cmH2O.
It is important that oxygenation targets for both arms are carefully followed to ensure
a fair comparison between them. The SpO2 will be kept in the target range prior to
any RM. This approach allows small decreases in oxygenation to be detected during the
decremental PEEP phase of the recruitment manoeuvre, while also providing a suffi-
cient buffer in the event of significant de-saturation due to ventilation perfusion (V/Q)
mismatch. V/Q mismatch increases with higher airway pressures when pulmonary ar-
terial blood is shunted away from the pulmonary capillaries by-passing aerated regions
of the lung.
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6.3.1 Recruitment Manoeuvre checklist
Before performing any RM, following criteria are considered. Any RM must be delayed
until these conditions are corrected:
1. Consider at-risk patient conditions:
a Haemodynamic instability (e.g. ongoing haemorrhage).
b Not optimally resuscitated with fluids? (e.g. stable blood pressure, but pulse
pressure variation ≤ 12% because of inadequate left ventricular preload). (Only
applicable in absence of spontaneous breathing)
c Evidence of barotrauma since enrolment? If there is new barotrauma, RMs
must not be attempted and the participant will be withdrawn from trial. They
will continue to be observed and followed up. A serious adverse event (SAE)
will be reported.
6.3.2 Recruitment Manoeuvre preparation steps
Once the RM checklist conditions are met, the patient can be prepared for a RM by en-
suring:
1. There is a reliable arterial line.
2. The patient is supine; 15-30° head up
3. The endotracheal tube (ETT) cuff is inflated to 45 cmH2O (RMMax or SRM) or 35-40
cmH2O (PUMP) to ensure there is no leak at maximum airway pressures. The ETT
cuff is deflated to less than 30 cmH2O at the end of the RM procedures.
4. The peak pressure alarm is set to 45 cmH2O (RMMax, PUMP, SRM)
5. SpO2 is in the target range (FiO2 < 60%: 93-95% or FiO2 ≥ 60%: 90-92%), and an
ABG has been taken within the last 60 mins
6. If patient is not on vasoactive drugs, i.v. adrenaline (or other suitable vasoactive
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drug) is available in the event of hypotension.
6.3.3 Recruitment Manoeuvre termination
RMs should be terminated if, at any time during the RM, if any of the following changes
persist for more than 3 minutes:
1. Desaturation with SpO2 < 88%
2. New bradycardia (heart rate < 60 beats per minute) or,
3. New tachycardia (heart > 140 beats per minute) or,
4. New arrhythmia leading to (2) or (3) above or,
5. New hypotension (reduction in MAP by 40% or MAP < 60 mmHg).
This RM termination criteria applies to all recruitment manoeuvre procedures in both
arm.
6.3.4 Maximum Recruitment Manoeuvre (RMMax; MBV)
The RMMax is a computer-guided staircase recruitment manoeuvre procedure in the
MBV intervention arm. This method is designed to safely increase the inspiratory pres-
sure to a maximum airway pressure of 40 to 43 cmH2O, with driving pressure (DP) lim-
ited to 15 cmH2O, and maximum PEEP limited to 25-28 cmH2O. The RMMax is guided by
the CURE software using a validated model-based method, which estimates elastance to
determine the optimal PEEP (Redmond et al., 2014; Chiew et al., 2015c).
The RMMax is carried out by Intensive Care specialists or senior trainees familiar with
this technique. This procedure is only carried out during working hours (0800-1800h),
but preferably within 4-6 hours of enrolment. However, for patients enrolled overnight,
unless there are compelling reasons to carry out an RMMax, this procedure may be de-
layed till the following morning (0800 hours).
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Contra-indicated preconditions to an RMMax are excluded using the RM checklist. If it is
safe to proceed, the patient is prepared for the RMMax.
The following instructions are given to the clinician:
1. Adjust oxygenation to meet the target range.
2. Titrate sedation so the patient is not verbally responsive and has loss of their eye-
lash reflex. Use fentanyl or morphine increments with propofol to provide a ‘bal-
anced’ deeper sedation level. Give Rocuronium 1.0 -1.5 mg/kg through a reliable
i.v.; ensure the line is flushed.
3. Set the ventilator to SIMV-PC (pressure control) mode.
4. Set peak inspiratory pressure (Pi) to 15 cmH2O above PEEP.
5. Ensure the initial PEEP is ≤ 15 cmH2O.
6. Start Maximum Recruitment on the CURE soft program.
7. Follow the steps of the CURE Soft protocol: During the RMMax, increase PEEP in
steps of 4 cmH2O above the baseline PEEP level until peak airway pressure reaches
(Pi) 40-43 cmH2O or PEEP 25 to 28 cmH2O. Then reduce PEEP in 4 cmH2O decre-
ments until the original starting PEEP is reached. Adjust FiO2 throughout the pro-
cedure to keep SpO2 ≥ 90
8. Once PEEP has been returned to the initial setting, perform a second RMMax using
the same method in 7. The RMMax is carried out twice. During the first RMMax the
elastance changes in PEEP level are more variable and therefore less predictable.
The non-recruited lung is highly heterogeneous with regions of collapse and con-
solidation. The first maximal recruitment manoeuvre is used to recruit these de-
recruited regions. The second manoeuvre is used to estimate optimal PEEP from
repeated estimates of elastance changes during decremental PEEP titration.
9. The CURE soft program will recommend an optimal PEEP at the end of the sec-
ond RMMax. You may either accept this computerised recommendation, or reject it
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(with a reason) if you feel the new PEEP level is inappropriate. If rejected, record
your reason(s) on the program.
10. Return the patient to the previous ventilation mode.
11. Adjust VT ≤ 6-8 ml/kg IBW. If the plateau pressure is > 30 cmH2O, adjust the VT
down to 4-6 ml/kg IBW and tolerate permissive hypercapnia. Also ensure that the
DP remains ≤ 15 cmH2O. You may increase the respiratory rate up to 30 breath-
s/min provided there is no significant auto-PEEP causing breath stacking.
12. Reduce the ETT cuff pressure to the previous level and re-set ventilator alarms to
previous settings.
13. Take an ABG 30 to 60 mins following the conclusion of the procedure
6.3.5 Repeating Maximum Recruitment Manoeuvre (RMMax)
The RMMax may be repeated only when the following conditions are met:
1. If there is a significant change in the participant’s condition, e.g. new severe hy-
poxaemia (SpO2 < 90% and FiO2 ≥ 60%; P/F 100)
2. AND patient conditions for which lung recruitment is contraindicated are excluded
(e.g. endobronchial intubation, mucous plugging, pneumothorax etc).
3. AND analgesia and sedation, and patient position have been optimised (Consider
small changes to respiratory rate, tidal volume and pressure support, or a rocuro-
nium infusion).
4. AND the PEEP adjUstment and Monitoring Procedure (PUMP) fails to improve oxy-
genation.
6.3.6 PUMP: PEEP adjUstment and Monitoring Procedure
PEEP adjUstment and Monitoring Procedures (PUMPs) are regular mini-recruitment
manoeuvres procedure designed to adjust PEEP level based on patient-specific changes
in condition. This mini-RM is also guided by CURE software and moves between ± 4
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cmH2O from current PEEP level. PUMPs should be performed twice daily during normal
working hours (0800-1800h) or at any other time if lung de-recruitment is considered
to be the likely cause of new desaturation. The inspiratory pressure (Pi) will be left as
same as current ventilator settings.
To ensure a PUMP, can be safely carried out, the RM checklist and preparation steps are
to be followed. If the checklist preconditions are met, the PUMP may be carried out.
The following instructions are given to the clinician:
1. Titrate sedation so the patient is not verbally responsive and has loss of their eye-
lash reflex. Use fentanyl or morphine increments with propofol to provide a ‘bal-
anced’ deeper sedation level. Give Rocuronium 0.5 -1.0 mg / kg through a reliable
i.v.; ensure the line is flushed.
2. Set the ventilator to SIMV-PC mode with appropriate settings mentioned above.
3. Reduce the PEEP to 4 cmH2O less than the current PEEP setting. The CURE software
cannot estimate an optimal PEEP that is lower than the current PEEP setting.
4. Start PUMP on the CURE soft program.
5. Follow the steps of the CURE soft PUMP protocol. During PUMP procedure, increase
PEEP in two steps of 4 cmH2O. Then decrease PEEP in two steps of 4 cmH2O. (You
may need to adjust the FiO2 to keep the SpO2 ≥ 90
6. Once you have returned PEEP to starting PEEP level (initial PEEP -4 cmH2O), per-
form a second PUMP using the same method in 5.
7. The CURE soft program will recommend a new PEEP at the end of the second PUMP.
You may either accept this computerised recommendation, or reject it (with a rea-
son) if you feel the new PEEP level is inappropriate. If rejected, record your rea-
son(s) on the program.
8. Return the patient to the previous ventilation mode.
CHAPTER 6. CLINICAL UTILISATION OF RESPIRATORY ELASTANCE 90
9. Adjust to VT ≤ 6-8 ml/kg IBW. If the plateau pressure is > 30 cmH2O, adjust the VT
down to 4-6 ml/kg IBW and tolerate permissive hypercapnia. Also ensure that the
DP remains ≤ 15 cmH2O. You may increase the respiratory rate up to 30 breath-
s/min provided there is no significant auto-PEEP causing breath stacking.
10. Reduce the ETT cuff pressure to the previous level and re-set ventilator alarms to
previous settings.
11. Take an ABG 30 to 60 mins following the conclusion of the procedure
6.3.7 Standard practice Staircase Recruitment manoeuvre (SRM)
Participants assigned to standard practice ventilation (SPV) have PEEP determined using
clinical judgement, as per local unit standard care. However, if oxygen requirements are
high or have recently increased e.g. an FiO2 ≥ 50% to keep SpO2 in the target range of
93-95%, the following should be considered if the treating clinician is intending to carry
out an SRM:
1. Patient conditions for which lung recruitment are contraindicated are excluded
(e.g. endobronchial intubation, mucous plugging, pneumothorax etc).
2. Analgesia and sedation, and patient position have been optimised.
3. Small changes to respiratory rate, tidal volume, pressure support, or neuromuscu-
lar blockade to optimise mechanical ventilation
If the oxygenation does not improve with the above interventions, then PEEP may be
increased in increments of 2 cmH2O. If the PEEP is ≥ 15 cmH2O and FiO2 ≥ 60%, (P/F
100) in spite of addressing the above points, a staircase recruitment manoeuvre (SRM)
may be considered if the clinician feels this is in the best interests of the patient.
SRM procedure does not utilise CURE software to perform recruitment and therefore
the software will not guide the user, nor make any PEEP suggestions. The software will
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still record airway pressure and flow through this procedure.
To ensure a SRM, can be safely carried out, the RM checklist and preparation steps are to
be followed. If the checklist preconditions are met, the SRM may be carried out: (Note,
the SRM procedure does not utilise CURE software to perform recruitment).
The following instructions are given to the clinician:
1. Titrate sedation so the patient is not verbally responsive and has loss of their eye-
lash reflex. Use fentanyl or morphine increments with propofol to provide a ‘bal-
anced’ deeper sedation level. Give Rocuronium 1.0 -1.5 mg/kg through a reliable
i.v.; ensure the line is flushed.
2. Set the ventilator to SIMV-PC mode.
3. Set peak inspiratory pressure (Pi) to 15 cmH2O above PEEP.
4. Ensure the initial PEEP is ≤ 15 cmH2O. If PEEP is set ≤ 15 cmH2O, the corresponding
plateau pressure will not exceed 30 cmH2O
5. Increase PEEP in a stepwise manner every minute in steps of 4 cmH2O to a achieve
Pi of 40-43 cmH2O.
6. Reduce PEEP to 24, and then by decrements of 2 cmH2O, every two minutes, until
the SpO2 begins to fall by no less than 2% of the maximum observed. Hold PEEP
at this level and then increase PEEP to maximum that was previously used for
one minute before returning to a PEEP level 2 cmH2O above the level when the
SpO2 was first noted to have fallen. (The decrements of 2 cmH2O will allow a PEEP
selection between 16 and 24 cmH2O, which is within the high PEEP protocol from
the ARDS Clinical Network study of high vs. low PEEP [4].
7. If there is no desaturation during the decremental phase of the SRM, reduce PEEP
to 16 cmH2O; no further changes in PEEP are required.
8. Return the patient to the previous ventilation mode.
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9. Adjust the DP ≤ 15 cmH2O to give a VT of ≤ 6-8 ml/kg IBW. If the plateau pressure
is > 30 cmH2O, adjust the DP so that VT is to 4-6 ml/kg IBW and tolerate permissive
hypercapnia. You may increase the respiratory rate up to 30 breaths/min provided
there is no significant auto-PEEP causing breath stacking.
10. Reduce the ETT cuff pressure to the previous level and re-set ventilator alarms
to previous settings. Take an ABG 30 to 60 mins following the conclusion of the
procedure
6.4 Ventilator Dyssynchrony
Ventilator dyssynchrony occurs when a patient’s spontaneous respiratory efforts are
not synchronised with the ventilator. This commonly causes agitation and respiratory
distress; often described as “fighting the ventilator”. Dyssynchrony should be consid-
ered in patients with increased respiratory efforts, unexplained agitation, tachycardia,
or sweating. Ventilator wave forms can be used to identify dyssynchrony.
In participants assigned to Model-Based Ventilation (MBV), dyssynchrony will often cause
large spikes in the elastance recordings. The CUREsoft algorithm does not account for
patient breathing efforts and “sees” inspiratory effort as a rapid reduction in lung elas-
tance (Thille et al., 2006; Carlucci et al., 2013; Chiew et al., 2015a; Redmond et al., 2019;
Newberry et al., 2016; Kannangara et al., 2016a; Damanhuri et al., 2016). In contrast,
coughing, breath-holding, and other dyssynchronous efforts may cause an apparent
increase in elastance (de Wit et al., 2009). Figure 6.1 shows an example of ventilator
dyssynchrony in a pressure controlled mode. Dyssynchrony may be seen as negative
deflections (“M” waves) in the flow-time waveform, as shown in Figure 6.1. In contrast
the airway pressure is may only be changed minimally by patient effort.
It is important to exclude reversible mechanical causes that might lead to patient dis-
tress and ventilator dyssynchrony. Endobronchial intubation, obstruction of a major
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bronchus, or a pneumothorax should be excluded.
Usually ventilator dyssynchrony can be managed by increasing sedation. However, in
many cases it may be preferable to use intermittent muscle relaxants to fully control
ventilation. It also may be helpful to trial the patient on assisted spontaneous breath-
ing (ASB) to improve ventilation synchrony, if PEEP ≤ 10 cmH2O and the FiO2 ≤ 40%.
However, caution should be exercised, lest the patient become exhausted.
Figure 6.1: An “M” wave is seen in the flow time waveform (flow starvation), followedby a spontaneous (pressure-supported) breath.
6.5 Weaning assessment
These guidelines are a pragmatic and consistent way to transition patients to assisted
spontaneous breathing (ASB). Weaning is challenging and difficult to protocolise be-
cause there are many different factors to consider. For this reason, the weaning process
is typically determined by clinical judgement. However, the guidelines presented here
are set to ensure consistency of care.
ASB is considered when the participant’s condition is improving. They should prefer-
ably be afebrile, have resolution of the underlying processes that led to their ICU ad-
mission and improving gas exchange. They should have improving muscle strength,
decreasing sedation requirements with an improving Glasgow Coma Score (GCS) and
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Richmond Agitation Sedation Score (RASS) between -3 and +1. Generally, the FiO2 should
be ≤ 40%and PEEP ≤10 cmH2O.
If the following are substantially present, then participants may be transitioned to ASB:
1. Improving condition
2. Minute ventilation acceptable (VE) ≤0.2 L/kg
3. FiO2 ≤ 40
4. SpO2 93-95
5. pH ≥ 7.3
6. Heart rate ≤ 120/minute
7. Low vasoactive drug requirements (Noradrenaline + adrenaline ≤ 10 mcg/minute)
The following instructions or recommendations are used to guide transition to ASB:
1. Set mandatory respiratory rate (RR) ≤ 10 cmH2O
2. Set pressure support (PS) 10-15 cm cmH2O
3. Consider PEEP level
a Generally keep PEEP ≤ 10 cmH2O.
b PEEP maybe up to 15 cmH2O in obese participants or when the chest wall or
abdominal elastance is increased.
4. Monitor RR, HR and SpO2 over the next 30 mins. If there is significant increase
in distress, desaturation, or an increased oxygen requirement, the participant is
reverted back to the previous controlled ventilation mode.
5. If there is no significant deterioration, change the ventilation mode to ASB.
6. If the participant is comfortable, you may reduce PEEP and PS after 12 hours.
Titrate PEEP and PS as clinically indicated by ≤ 2 cmH2O. PEEP; PS should remain
≥ 5 cmH2O. Reductions in PEEP and PS should be generally made between 0800-
CHAPTER 6. CLINICAL UTILISATION OF RESPIRATORY ELASTANCE 95
1800h.
Observations during ASB:
1. Check RR, HR and SpO2 every two hours
a If there are increases in heart rate, agitation, delirium, respiratory distress,
minor desaturations, or an increasing oxygen requirements, (∆FiO2 ≥ 10% or
FiO2 ≥ 50%) check the patient and the ventilator:
i Exclude patient conditions, e.g. endobronchial intubation, mucous plug-
ging, pneumothorax etc.
ii Optimise analgesia / sedation and patient position
iii Consider increasing:
A. Pressure Support up to 15 cm.
B. Expiratory time for triggering ( e.g. adjusting E sens up to 50% on the
PB840 ventilator)
C. Triggering sensitivity.
b If the FiO2 ≥ 50% or the FiO2 has increased by ≥ 10% in the previous two hours,
consider adjusting PEEP by ≤ 2 cmH2O up (or down). Consider repositioning
the patient and optimising sedation.
c If secretions are obstructing large airways, or there are significant regions of
consolidation, these conditions are unlikely to respond to increases in PEEP
and increases in PEEP may impair oxygenation. Thus, if the PEEP is greater
than 10 cmH2O consideration should be given to reducing it.
d If the above measures do not im prove oxygenation, re-sedate and revert back
to the previous controlled ventilation mode (Bi-Level or PC-SIMV+ or equiva-
lent)
e If the oxygenation has not improved after 12 hours on controlled ventilation,
or there is an unanticipated new problem causing deterioration, the partici-
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pant should return to their previously assigned ventilation arm (MBV or SPV)
e.g.
i. New lung injury / de-recruitment / aspiration/sepsis.
ii. Haemodynamic instability.
iii. Need to return to the operating room or to undergo invasive procedure.
2. If there is continual improvement, proceed towards separation from mechanical
ventilation (extubation, or CPAP via a tracheostomy).
6.6 Patient Enrolment and Data Management
6.6.1 Patient Data
Data on patient airway pressure and flow generated from the mechanical ventilator will
be recorded using the CURE Software (CURE Soft.) provided with the RCT. The patient
data is backed up on regular basis to external storage with encryption applied using
VeraCrypt encryption software (VeraCrypt, USA).
Other clinical data also gathered are patient demographics, waveforms, arterial blood
gases, routine biochemistry, patient radiology, patient positioning during MV, rescue
therapies, loMV and VFD, amount of sedation, duration of ICU stay, frequency and du-
ration of renal support therapies and all causes of ICU, hospital and 90 day mortality.
6.6.2 Blood samples
No person or authority will have access to participant’s blood. The blood samples are
not stored. They are discarded and incinerated as soon as practicable, in accordance
with NZS 4304:2002 ’Healthcare Waste Management.
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6.6.3 Data Management
All CURE RCT data will be stored at the University of Canterbury (UC). All paper forms
(patient sheets, consents, etc) will be scanned and stored at UC. All electronic data will
be stored in double encrypted repository and only the participating researchers have
access to it. Currently there is no plans on sharing the data but if requested data may be
shared. Participants to the study can request their copy of data.
The data will be backed up weekly and again, once participant is finished with the trial
and left the hospital. This task will only be performed by the participating researchers.
Any protocol variations will be followed-up and noted. The CURE RCT will store data for
20 years.
6.6.4 Study Outcome
The trial will utilise a primary composite end point incorporating area under the curve
(AUC) of the P/F ratio over the period of mechanical ventilation. Every participant in
the Intervention (MBV) group is compared with every participant in the control (SPV)
group. Test statistics will be performed using one-sided Wilcoxon ranksum test at alpha
with 0.05. No significance in intervention will also result in the rejection of intervention
treatment as a standard of care and thus, the secondary clinical outcome assessments
will include the number of desaturation events measured as peripheral capillary oxygen
saturation less than 88%, length of mechanical ventilation (LoMV), ventilation free days
(VFD) for 28 days, the quality of mechanical ventilation care measured as AUC of SpO2
/FiO2 and Chest X-ray Index scores over time. Test statistic will be performed using one-
sided Wilcoxon ranksum test at alpha of 0.05.
A difference in primary outcome will show the impact of MBV compared to SPV. No
difference would show that enhanced, model-based metrics of patient-specific condition
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have no effect on patient-centred or clinical outcomes. Either outcome will yield clinical
guidance.
6.6.5 Sample Size Study
A Monte-Carlo simulation was performed to determine the sample size and found a
minimum effective sample size of approximately 160 per arm is required to identify a
25% reduction in median LoMV with a 0.8 power at double sided significance level of
5% (Morton et al., 2017).
6.6.6 Stopping Rule
A linear alpha spending approach will be used for early termination of the trial for
safety. Linear alpha spending falls between a Pocok and O’Brien-Fleming boundary
(Todd et al., 2001). With analysis points of 50, 75, 100, 125 and 160 patients per arm, and
an assumed control group mortality of 0.2, the mortality difference required to stop the
trial (MortalityIntervention – Mortalitycontrol) at each analysis point respectively are: 0.20,
0.16, 0.14, 0.12, 0.10. This approach has cumulative α=0.025.
6.6.7 Safety, Ethics and Dissemination
Ethics Approval has been filed with the New Zealand National Health and Disability
Ethics Committee. The CURE RCT clinical protocol and data usage has been filed with
the New Zealand South Regional Ethics Committee (Reference number: 14/STH/132).
The CURE trial is also registered in the Australian New Zealand Clinical Trial Registry
(ACTRN12614001069640).
All results and any subsequent analysis will be published and only the participating
investigators will be authors. Currently there is no plan to share data with other organ-
isations. The data collected in this study will also be used for future research.
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6.6.8 Adverse Event (AE) and Serious Adverse Event (SAE)
Reporting
Adverse events (AEs) are defined as any unexpected change in physiology in a study
participant associated with either the maximum recruitment manoeuvre (RMMax) or
PEEP adjustment and monitoring procedure (PUMP). This does not necessarily have to
have a causal relationship with the above procedures. Typically this would be an un-
expected, non-life threatening event, which rapidly resolves following simple correc-
tive measures. For example, hypotension will occur in most participants under-going
an RMMax, or PUMP. However if the procedure had to be shortened or abandoned, but
the participant recovered with simple corrective measures (e.g. temporarily increas-
ing noradrenaline ≥ 5 mcg / min) or giving more than a 500 ml fluid bolus) this would
be recorded as an Adverse Event (AE). It is very important these events are accurately
recorded as risk factors for AEs need to be defined when carrying out RMs.
Serious adverse events (SAEs) are defined as any untoward medical occurrence that:
1) results in death; or 2) is life-threatening; or 3) prolongs hospitalisation; or 4) results
in disability or incapability. However, the baseline mortality of intensive care patients
enrolled in the trial will likely be high due to the critical illness necessitating admission
to the ICU. Despite attempts at prevention, trial participants will frequently develop life-
threatening organ failure(s) unrelated to study interventions. Events that are a part of
the natural history of the primary disease process or expected complications of critical
illness will not be reported as SAEs in this trial. Additionally, events already defined and
reported as study outcomes, such as mortality, re-admission to ICU, will not be labelled
and reported separately as SAEs unless they are considered to be causally related to the
study intervention or are otherwise of concern in the investigator’s judgement.
SAEs will be reported to the principal investigator within 24 hours of any investigator
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becoming aware of the event. The minimum information to report includes:
• Patient trial identifier.
• The nature of the event.
• The time the event commenced and ceased.
• An investigator’s opinion of the relationship between study involvement and the
event (not related, unlikely, possibly, probably or definitely related).
• Whether treatment was required for the event and what treatment was adminis-
tered.
SAEs could include: pneumothorax; hypotension leading to cardiac arrest; transient
desaturation leading to severe or prolonged desaturation; tachycardia, bradycardia, ar-
rhythmia, anaphylaxis and unintended protocol deviations.
In the unlikely event of a physical injury to the participant as a result of their participa-
tion in this study, they will be eligible to apply for Accident Compensation Corporation
(ACC) NZ within its limitations. If the participant’s family/friend have any questions
about ACC, they will be able to ask the researchers for more information before they
agree to take part in this trial.
ACC cover is not automatic and their case will need to be assessed by ACC according to
the provisions of the 2001 Injury Prevention Rehabilitation and Compensation Act. If
the claim is accepted by ACC, they still might not get any compensation. This depends
on a number of factors such as whether they are an earner or non-earner. ACC usually
provides only partial reimbursement of costs and expenses and there may be no lump
sum compensation payable. There is no cover for mental injury unless it is a result of
physical injury. If your relative or friend has ACC cover, generally this will affect their
right to sue the investigators.
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6.6.9 Data Monitoring Committee
An independent DMC comprising experts in clinical trials, biostatistics and intensive
care medicine is established before patient enrolment to review all trial protocols, and
oversee and advise this trial. The DMC will be forwarded a copy of all SAE reports as soon
as they become available to the trial investigators. The DMC will review all SAE reports
that they receive and report back to investigators if any further action is required.
6.6.10 CURE RCT Composition
The steering committee of CURE RCT are the primary investigators Geoff Shaw, Geoff
Chase, Chris Pretty and Yeong Shiong Chiew. The clinical data are collected by research
nurses in the ICU and mechanical ventilation data and oxygenation (bedside monitor)
data will be collected by researchers from UC. All study data will be stored in double
encrypted repository at UC. The interpretation of data will be done by participating re-
searchers. The open and close case interim reports will be performed by Paul Docherty
and will be performed every 6 months and at 50, and 100 patients. The DMC will have
authority on continuation and stopping of the trial based on interim reports.
6.7 Discussion
Mechanical ventilation using PEEP set at minimum elastance has long been investigated
in both experimental and clinical trials. These studies ranged from healthy general
anaesthesia patients to those with acute respiratory distress syndrome. However, only a
few studies have investigated its clinical potential. Recent studies by Pintado et al. (2013)
and Chiew et al. (2015c) have shown the potential and feasibility patients ventilated us-
ing minimum elastance PEEP. However, setting PEEP based on elastance is problematic
due to the increased need of muscle relaxants, protocol burden and potential contra-
dicting findings (Pintado et al., 2013; Chiew et al., 2015c). The pilot trial was also un-
derpowered and thus, a larger clinical trial such as CURE RCT is required to provide
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further insight and validate the potential benefit of optimising mechanical ventilation
PEEP with model-based methods.
The CURE RCT implements a protocolised staircase PEEP recruitment manoeuvre to-
gether with novel computer software to calculate respiratory system elastance in real-
time. The computer software, CURE Soft (Szlavecz et al., 2014), uses a single compart-
ment lung model (Brochard et al., 2017) together with other model-based approach (Chiew
et al., 2011, 2015a) to aid clinicians during PEEP selection. This process potentially re-
duces selected PEEP variability and provides more consistent clinical guidance.
There are several limitations of the CURE RCT design that should be noted. In particu-
lar, the recruitment manoeuvre is a double staircase and design specific. Studies have
reported not all patients benefit from recruitment manoeuvres (Pelosi et al., 2010; Fan
et al., 2008), and the benefit of an RM is dependent on the patient-specific disease state,
as well as the design of the RM. The double stair-case RM in this trial was designed to
assess lung recruitment and provide consistent PEEP titration. It is noted not all patients
included in this study will necessarily be recruitable.
Another limitation worth noting is the control group clinical protocol. Clinically, there is
relatively little consensus an ‘optimal’ mechanical ventilation mode. Thus, the standard
practice ventilation in the participating hospital relied on general approaches (Brower
et al., 2004) and is highly variable between clinicians. There may be no equal compara-
tor for a mechanical ventilation study resulting from this variability. Patients recruited
to the CURE RCT will have both intervention and control group MV mode set to Bi-level
ventilation. It is debatable that Bi-level may lack certain ventilation advantages. How-
ever, this procedure will reduce variability and provides the opportunity for fair com-
parison between groups.
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In the participating ICU, there were more than > 700 patients per year requiring inva-
sive MV. However, only an average of< 5 patients were diagnosed with ARDS as the pri-
mary diagnosis per year. ARDS is nearly always regarded as a complication of an acute
process. One concern is that the desired sample size cannot be achieved. However,
this number is also too low compared to reports (Bersten et al., 2002; Rubenfeld et al.,
2005). The low number may be due to the changes of ARDS definition (Villar et al., 2013;
Bernard et al., 1994) and misdiagnosis (Estenssoro et al., 2003). Estenssoro et al. (2003)
found misdiagnosis could occur due to delayed screening (Estenssoro et al., 2003). Thus,
in the CURE RCT, any patient requiring invasive mechanical ventilation is screened im-
mediately, as per Villar et al. (2013), where the P/F ratio is measured at PEEP = 5 cmH2O,
and FiO2 = 50% (Villar et al., 2013). Equally, a retrospective screening was also per-
formed and found > 200 patients eligible for the trial per year. Hence, a 3-year study is
planned for to achieve the target sample size at an estimated recruitment rate of 50%.
6.8 Summary
Optimising patient-specific mechanical ventilator settings remains a huge clinical chal-
lenge due to patient disease variability, as well as clinical practice variability. Thus, there
is a need of a method to provide consistent patient-specific treatment. The CURE RCT is
the first single centre large clinical RCT using model-based minimum elastance PEEP se-
lection in mechanical ventilation. It provides a means to select patient-specific PEEP in
a consistent fashion and patient outcomes are compared to current practice. The CURE
RCT investigation group hope results from this trial will support the use of model-based
methods to estimate optimal PEEP, and will serve as platform to assess other patient-
centred outcomes in future mechanical ventilation studies in ARDS /ALI.
The CURE RCT was proposed to start in 2014, it has gone through significant changes
and the protocol has only been recently finalised (Kim et al., 2020). This trial will ideally
start in 2020 but due to delays in ICU movement at Christchurch Hospital and COVID-19,
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Due to pre-maturity and under-development of their lungs, pre-term neonates are sus-
ceptible to respiratory distress syndrome (RDS). They thus require mechanical venti-
lation (MV) to assist breathing (Sweet et al., 2010; Lauterbach et al., 2001; Brown and
DiBlasi, 2011). Under-development of the lungs results in reduced alveoli growth and
surfactant production (Torday and Nielsen, 1987; Rettwitz-Volk et al., 1998; Polin et al.,
2014), resulting in poor gas exchange and non-compliant (stiff) lungs. Invasive MV is
utilised to enable gas exchange.
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However, Prolonged duration or sub-optimal ventilator settings on preterm infants with
invasive MV can result in bronchopulmonary dysplasia (BPD) and ventilator-induced
lung injury (VILI), varying from 30-75% among newborns with birth weight less than
1 kg (Kair et al., 2012; Carvalho et al., 2013b; Jobe and Bancalari, 2001). VILI can also
result from asynchrony, where the neonate is breathing against the ventilator (Brown
and DiBlasi, 2011; Carvalho et al., 2013b; Keszler, 2009; O’Donnell et al., 2004). Thus, MV
strategies in this cohort are also focused on reducing MV duration (Brown and DiBlasi,
2011).
MV is common in the neonatal intensive care unit (NICU). While infants exhibit differ-
ent pulmonary mechanics compared to adults, it still is not widely studied. The use of
low tidal volume in adults is a well-accepted approach (Brower et al., 2000) but not in
neonates (Chow et al., 2002; Donn and Boon, 2009). In contrast, Brown and DiBlasi (2011)
states using tidal volume of 5ml/kg is more beneficial than 3ml/kg in neonates, where
both these values are lower than 6-8ml/kg accepted for adults. The gap in these values
of 3-5ml/kg is also very large with no consensus on which is better due to primarily to a
lack of study (Brown and DiBlasi, 2011). There is thus a need for in-depth understanding
of neonatal pulmonary mechanics to better understand and inform MV practice in this
cohort.
A study by Bhutani et al. (1988) has used neonatal data and a single compartment model
similar to (Bates, 2009; Chiew et al., 2011) to describe neonatal respiratory mechanics.
However, this study was limited in both the hardware used (external pneumotachome-
ter and pressure transducer) and the size of the data (20-40 breaths per patient) (Bhutani
et al., 1988). It is a near lone study of deterministic modelling of neonatal lung mechan-
ics in the last three decades.
This study is a first in-depth attempt to quantify the underlying lung mechanics for MV
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in the NICU (Kim et al., 2019a). It will apply model-based methods, specifically a sin-
gle compartment model to a clinical data cohort to assess and quantify the underlying
elastance and resistance, with a secondary aim to identify the incidence of asynchrony
and spontaneous breathing attempts, which can interfere with MV (Chiew et al., 2018;
Gutierrez et al., 2011; Thille et al., 2008). If the model translates and successfully captures
respiratory mechanics in this cohort, it could be possible to apply a similar model-based
MV approach (Morton et al., 2019a; Szlavecz et al., 2014; Chiew et al., 2011) clinically in
this cohort. This outcome would offer potential improved, patient-specific care to this
cohort in a core area of NICU care significantly impacting outcomes, length of care and
stay, and cost.
7.2 Methods
7.2.1 Patient Data and Processing
The NICU ventilation cohort detailed in Section 3.1 is used in this chapter. Airway pres-
sure and flow data from 10 invasively ventilated infants from Christchurch Women’s
Hospital Neonatal Intensive care unit (NICU) is used. All patients were under stan-
dard care and no intervention was performed during data recording. Parental consent
was obtained prior to data recording. Ethics for the implementation of this trial and
anonymised use of this data was approved by the New Zealand Northern B Health and
Disability Ethics Committee (study ref:16/NTB/16).
Waveform data was nominally collected for 24 hours under standard care conditions.
Eligibility criteria included the expectation MV would continue for 24 h, clinical equipoise,
and general clinically assessed patient medical stability. Informed consent from parents
or legal guardians was obtained in all cases.
Patients received either conventional ventilation (CV) or high frequency oscillatory ven-
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tilation (HFOV) on a SLE5000 neonatal ventilator (SLE, UK) [30] as determined by stan-
dard clinical practice. None of the infants were sedated over the trial period, though
some received morphine, which can have a sedative effect (Chase et al., 2004). The clin-
ical characteristics and demographics of patients are shown in Chapter 3 Table 3.1 This
table is repeated in this chapter for both clarity and ease of read as Table 7.1.
In cases where an infant was re-intubated after being weaned from MV, or the infant
was later switched to another ventilation mode, a subsequent 24 h of data recording
was carried out with further parental consent. This second stage allows comparison of
lung mechanics over different modes, or changes over time. Infants thus had 1 or more
recording periods.
Data was recorded from the ventilator, with no additional re-sampling, smoothing or
filtering. Patient data was separated into individual breaths characterised by inspira-
tion (positive flow) and expiration (negative flow). As tiny fluctuations in pressure and
flow are observed prior to expiration and/or inspiration onset, additional criteria for
inspiration/expiration onset are defined:
• Inspiration start: the first major positive airflow associated with an overall in-
crease in flow (inspiratory flow rate> 16.67 ml/s) and pressure (Pressure increased
to P > (PEEP + 2 cmH20)).
• Expiration start: the first major negative airflow associated with an overall de-
crease in flow (expiration flow rate > 16.67 ml/s).
Both inspiration and expiration start is checked over 20 data points to ensure there is a
consistent increase/decrease in flow and PEEP. Expiration is defined as a major negative
airflow decaying towards zero followed by inspiratory postive flow at the next breath.
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As pressure-flow profiles can be interrupted, or modified by clinical care or patient asyn-
chrony, additional criteria were applied to identify ‘true’ breaths from the raw signal
data:
• Total inspiratory volume was > 0.5 ml
• PIP was > (PEEP + 1 cmH20)
• Expiration was identified within 1.1 s of the calculated onset of inspiration defined
above, where standard CV respiratory rates(RR) are 60/min or 1 s for both inspira-
tion and expiration.
These criteria eliminate asynchronous and small partial breaths.
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7.2.2 Model and Identification
The single compartment model described in Section 2.2, Eq (2.3) is used to identify NICU
pulmonary mechanics. However, the pressure loss across the endotracheal tube (ETT)
may be significant in NICU, as their small ETT diameters (3-5mm) can significantly in-
crease resistance to flow and must be considered. Thus, Jarreau’s equation described in
Chapter 2 Section 2.5, Eq (2.9) is incorporated into the single compartment model. The
single compartment model using this term to account for ETT pressure loss is presented
in Chapter 2, Eq (2.10) and is repeated in this chapter for clarity and ease, where the
model is defined:
Paw = ErsV + RrsQ + PEEP + ∆PETT (7.1)
Where, Paw is the airway pressure, Ers is the elastance, V is the volume,Rrs is the airway
resistance, Q is the flow, PEEP is the pressure offset, and ∆PETT is the pressure loss
across the ETT, specifically defined in Eq (2.9).
The ETT diameter is a function of patient weight. The typical size of ETT diameter are
3-5 mm. ETTs are clinically shortened patient-specifically by 1-2 cm post-insertion. The
shortened length was unavailable for this NICU cohort and therefore was assumed all
ETTs are shortened by 2 cm providing a minimum estimation of ∆PETT , where Rrs may
capture additional resistance due to longer lengths. Table 3.2 from Chapter 3 is repeated
in this chapter for ease of read as Table 7.2
Table 7.2: Clinical guidelines for ETT selection repeated from Chapter 2 Table 3.2
ETT diameter [mm] Un-shortened ETT length [cm] Indication for use
2.0 - Cannot insert a 2.5 mm ETT
2.5 18 Weight < 1.5 kg
3.0 19.5 Weight 1.5 - 2.5 kg
3.5 20 Weight 2.5 - 4.0 kg
4.0 - Weight > 4 kg
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7.2.3 Analysis
This study only examines model fit to conventional ventilation data. Data from Patient
1 was excluded because they were recorded in only HFOV mode, where preliminary
analysis suggests pressure characteristics are more a function of the ventilator, rather
than patient specific lung mechanics, due to the rapid Respiratory Rate (RR = 300+/min).
An analysis of HFOV was thus deemed out of scope in this study, leaving N = 9 patients
(Patients 2–10 in Table 7.1).
Elastance (Ers) is fit breath-to-breath, and resistance (Rrs) is fit using a moving window
of 30 breaths to avoid mild parameter trade-off between Ers and Rrs. in identifying Eq
(7.1) (Docherty et al., 2011; Chiew et al., 2011). This moving window reduces variability,
and improves both identifiability and breath-to-breath consistency in identified values.
In particular, the model used in this study is focused on non-spontaneous breathing
(Chiew et al., 2011). Non-sedated infants cry, try to breath spontaneously, and have
clinical interactions, causing asynchronous breaths, all of which can be detected by
the model (Kannangara et al., 2016a, 2018; Redmond et al., 2019; Major et al., 2016b;
Damanhuri et al., 2016, 2019; Chiew et al., 2011, 2018; Newberry et al., 2016; Kannan-
gara et al., 2016b). These asynchronous breaths do not yield the patient’s true under-
lying pulmonary mechanics or condition as these events distort the pressure and flow
waveforms, and spontaneous breathing provides a negative pressure, which trades off
with the positive pressure supplied by ventilator.
This study aims to capture these underlying lung mechanics in neonates and thus, some
breaths are eliminated for this analysis. Further filtering criteria used to remove outlier
breaths and/or poor model fits include:
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• Model-fit error > 15%
• Model-based Ers ≤ 0 (un-physiological, occurs with spontaneous effort (Chiew
et al., 2015a))
• Model-basedErs outside 5th and 95th percentiles as the focus is on central behaviour
and mechanics.
Model fit is assessed using the percent mean absolute relative difference (MARD). Data
is presented as median and [IQR] (interquartile range), unless specified otherwise.
Model fitting error > 15% are discarded for this analysis because fitting error > 15% in-
dicates that model does not accurately represent patient’s physiological condition (Chiew
et al., 2011). Considering this analysis is a proof of concept study attempting to quantify
NICU pulmonary mechanics, including breaths with error > 15% is not included.
Different subgroup comparisons were carried out to validate the identified model-based
elastance against clinically and physiologically expected trends. Elastance and resis-
tance are compared in infants who received surfactant treatment to untreated infants,
where surfactant is expected to reduce elastance. However, it is difficult to directly com-
pare patients treated with surfactant and not treated with surfactant due to the large
range of weight, as larger infants would have more developed lungs (Brown and DiBlasi,
2011). Thus, specific compliance is used to normalise to weight and adjust for this factor.
Specific compliance is often used metric in neonatal MV as it is a measure of intrin-
sic elasticity of the lung tissue while being independent of lung volume (Phelan and
Williams, 1969). Compliance is an inverse of elastance, and specific compliance can be
calculated by dividing compliance by the weight (Kannangara et al., 2018). Thus, specific
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Therefore Especific is defined:
Especific = Ers ∗m (7.3)
Where, C is the compliance and m is the mass of the infant.
Because infant size is a factor affecting respiratory mechanics, increased birth weight
is expected to result in decreased elastance due to more developed lung structures and
larger volumes (Kannangara et al., 2018). Therefore, different birth weight groups are
compared based on the hypothesis larger infants would have lower elastance. As they
are compared by weight, elastance, Ers, is used directly.
7.2.4 Statistics
All statistical comparisons are made using non-parametric statistics due to non-Gaussian
distributions. Statistically as noted, to get the main or broad central tendency of be-
haviour the 90% range of results for each infant is analysed. Due to very large data
sets and smaller number of patients, bootstrapping was used to examine the difference
in median values, in each comparison (Motulsky, 1995). Data was bootstrapped 10,000
times with replacement. A 99% Confidence Interval (CI) for difference in median specific
elastance values are created. If the CI does not cross zero, differences in medians are
statistically significant with p ≤ 0.01, which is more conservative than p ≤ 0.05 because
of multiple comparisons and very large data vectors (Motulsky, 2015).
This bootstrapping statistical comparison is chosen between surfactant and non-surfactant
cohort. Patients are not individually compared, but compared as whole group instead.
10,000 data are randomly chosen from each surfactant and non-surfactant cohorts with
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replacement. Then the difference in medians and mean of medians are calculated. This
is repeated another 10,000 times and 99% CI is calculated.
7.3 Results
7.3.1 Breaths and Asynchrony
Airway pressure and flow data were recorded for 10 patients, comprising 205.9 hours of
conventional ventilation (CV; N= 9; Patients 2-9), and 53 hours of HFOV (N = 3; Patients
1,2,5). Measured ventilator outcomes are given in Table 7.3 for the conventionally ven-
tilated patients analysed here. Patient 2 had three different recording sessions (2 CV,
1 HFOV). However, due to technical difficulties resulting in a loss of laptop power, the
CV recordings were cut to 2 and 3 hours. Patient 5 has <24 hours of data in CV as they
started with HFOV, but switched to CV. In many cases, total hours per patient was slightly
<24 hours due to these issues, extubation, or other clinical factors. Patient 2 episode 2
(2-2 in Table 7.3) had the minimum number of breaths with 4110, and Patient 10 had the
maximum of 93185. Table 7.3 also shows number of filtered breaths per patient. From
this table it can be seen the PSV and SIMV mode creates a higher occurrence of fitting
error and extremities in elastance, as they have more filtered breaths in comparison to
those on PTV.
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Figure 7.1: Consort diagram showing tabulated post filtering process. Percentages re-flect percentage of total breaths detected.
Figure 7.1 shows filtering criteria used to remove further outlier breaths and/or poor
model fits with total number still left. Most breaths removed using this filtering crite-
ria were unusual breaths with significant spontaneous breathing effort, or effects in
the pressure-flow profiles caused by clinical interactions with the infant. Examples of
filtered breaths due to significant spontaneous breathing and/or clinical interaction are
shown in Figure 7.2, where it is clear these breaths were not representative of the under-
lying lung mechanics in the infants typical breathing pattern, and were thus excluded.
Between initial filtering and post-fitting filtering, a total of 112,953 of 535,428 (21%)
breaths were excluded as asynchronous or otherwise altered, leaving 422,475 breaths
over the n=9 infants.




















































































































































































































































































































































































































































































































































































































































































Figure 7.2: Four examples of excluded breaths showing poor model fit (red) along withthe corresponding pressure-flow and volume profiles (blue).
Table 7.4 shows mean and standard deviation of PEEP, driving pressure (∆P), and vol-
ume/target volume per patient of normal and filtered breath. It can be seen that the
standard deviation for filtered breaths are higher. Filtered breaths have higher stan-
dard deviation, as they are mostly asynchronous and/or spontaneous breathing.
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Table 7.4: Mean and standard deviation of PEEP, driving pressure (∆P) andvolume/target volume for normal and filtered breaths.
PEEP ∆P V/targetV
Normal breath filtered breath Normal breath filtered breath Normal breath filtered breath
Patient mean std mean std mean std mean std mean std mean std
2* 5.38 0.28 5.59 0.57 11.44 2.96 11.55 3.44 0.98 0.23 0.95 0.39
3 5.59 0.17 5.63 0.46 10.23 1.66 7.84 2.39 5.43 1.62 6.68 6.53
4 4.62 0.13 4.7 0.41 10.98 3.03 10.78 3.55 3.12 0.74 4.03 2.49
5 5.36 0.19 5.31 0.7 9.78 0.93 9.93 2.65 1.71 0.29 1.73 0.87
6 5.61 0.32 5.68 0.88 16.85 2.58 16.7 3.61 1.17 0.15 1.23 0.47
7 6.18 0.22 6.23 0.45 13.45 2.71 13.94 3.76 1.6 0.32 1.95 0.87
8 5.14 0.76 5.24 0.84 11.33 2.63 11.2 2.65 0.86 0.23 0.96 0.5
9 4.97 0.45 5.04 0.79 17.34 3.69 15.52 5.22 1.14 0.26 1.35 0.71
10 4.8 0.17 4.85 0.45 11.85 1.87 11.85 2.6 0.76 0.12 0.84 0.32
ALL 5.24 0.61 5.37 0.74 13.36 3.81 11.3 4.45 1.55 1.26 3.26 4.57
* Patient 2-2 and 2-3 are merged under 2 due to smaller number of breaths
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7.3.2 Cohort Elastance and Resistance
The single compartment model with ETT compensation in Eq (7.1) was fit to every breath.
Overall, model fit was very good with median [IQR] percentage MARD of 5.7 [5.2-6.3]%
across all conventionally ventilated patients. Elastance across all patients was median
1.622 [0.854 - 2.253] cmH2O/ml and resistance was median of 5.223 [0.000 - 33.851] cmH2O.s/ml.
The median [IQR] of elastance, resistance and MARD across 6 hourly time intervals
( 21600 breaths per patient) are given in Table 7.5. Figure 7.3 shows a range of fitting
outcomes, demonstrating extremely good fit (MARD, 2.27%), good fit with spontaneous
breathing effort causing a dip in pressure at inspiration onset (MARD, 6.93%), and rela-
tively poor fit (MARD, 11.50%).
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Table 7.5: Mechanical Ventilation characteristics of recruited patients on conventionalventilation (CV). Elastance (Ers) is in cmH2O/ml, and Resistance (Rrs) is in cmH2O.s/mL.
Median [IQR]
Patient Hours: 1-6 Hours: 7-12 Hours: 13-18 Hours: 19-24 Overall
Ers 1.24 [0.76 - 2.08] 1.20 [0.76 – 2.08]
Rrs 0.00 [0.00 - 0.00] 0.00 [0.00 – 0.00]2-2
%Mard 5.39 [4.13 - 7.80] 5.39 [4.13 – 7.80]
Ers 0.78 [0.57 - 1.62] 0.78 [0.57 – 1.62]
Rrs 0.00 [0.00 - 0.00] 0.00 [0.00 – 0.00]2-3
%Mard 8.58 [7.09 - 0.29] 8.58 [7.09 – 0.29]
Ers 0.16 [0.11 - 0.23] 0.14 [0.09 - 0.20] 0.14 [0.10 - 0.19] 0.14 [0.10 - 0.21]
Rrs 0.00 [0.00 - 0.00] 0.00 [0.00 - 0.00] 0.00 [0.00 - 0.00] 0.00 [0.00 - 0.00]3
%Mard 8.05 [6.78 - 9.87] 8.33 [6.78 - 0.28] 8.23 [6.38 - 10.84] 8.20 [6.66 - 10.32]
Ers 0.49 [0.29 - 0.74] 0.46 [0.24 - 0.75] 0.27 [0.18 - 0.47] 0.39 [0.23 - 0.67]
Rrs 0.02 [0.01 - 0.03] 0.03 [0.02 - 0.04] 0.01 [0.00 - 0.02] 0.02 [0.01 - 0.03]4
%Mard 6.27 [5.20 - 8.09] 6.33 [5.26 - 7.99] 6.65 [5.52 - 8.26] 6.43 [5.32 - 8.11]
Ers 1.67 [1.31 – 1.92] 1.67 [1.31 – 1.92]
Rrs 0.00 [0.00 – 0.00] 0.00 [0.00 – 0.00]5
%Mard 6.05 [4.80 – 7.73] 6.05 [4.80 – 7.73]
Ers 2.79 [2.55 - 2.98] 2.12 [1.90 - 2.29] 1.87 [1.69 - 2.06] 2.18 [1.87 - 2.60]
Rrs 0.00 [0.00 - 0.00] 0.00 [0.00 - 0.01] 0.00 [0.00 - 0.00] 0.00 [0.00 - 0.00]6
%Mard 3.83 [3.22 - 4.58] 3.12 [2.65 - 3.88] 2.91 [2.33 - 3.83] 3.31 [2.68 - 4.22]
Ers 1.21 [0.92 - 1.49] 1.12 [0.91 - 1.30] 0.90 [0.65 - 1.21] 0.65 [0.49 - 0.92] 1.01 [0.68 - 1.28]
Rrs 0.08 [0.06 - 0.12] 0.05 [0.04 - 0.06] 0.06 [0.04 - 0.08] 0.05 [0.04 - 0.07] 0.06 [0.04 - 0.08]7
%Mard 6.29 [4.98 - 8.20] 5.03 [4.21 - 6.33] 5.64 [4.67 - 7.32] 5.54 [4.54 - 7.18] 5.58 [4.55 - 7.28]
Ers 1.39 [1.11 - 1.78] 1.46 [1.16 - 1.84] 2.13 [1.49 - 3.21] 1.58 [1.23 - 2.16]
Rrs 0.03 [0.01 - 0.06] 0.00 [0.00 - 0.01] 0.04 [0.01 - 0.07] 0.02 [0.00 - 0.05]8
%Mard 5.82 [4.11 - 8.26] 4.45 [3.39 - 6.11] 5.42 [3.99 - 7.33] 5.13 [3.73 - 7.23]
Ers 2.99 [2.73 - 3.21] 2.73 [2.03 - 3.23] 2.70 [2.02 - 3.09] 2.36 [1.70 - 2.78] 2.73 [2.11 - 3.11]
Rrs 0.03 [0.02 - 0.04] 0.04 [0.02 - 0.07] 0.03 [0.02 - 0.04] 0.01 [0.00 - 0.02] 0.03 [0.01 - 0.04]9
%Mard 4.59 [3.88 - 5.68] 6.46 [4.69 - 8.85] 5.72 [4.32 - 8.01] 6.51 [5.14 - 8.34] 5.70 [4.34 - 7.81]
Ers 1.64 [1.26 - 2.20] 1.67 [1.31 - 1.92] 1.73 [1.45 - 1.95] 1.88 [1.59 - 2.11] 1.74 [1.38 - 2.02]
Rrs 0.00 [0.00 - 0.02] 0.00 [0.00 - 0.00] 0.00 [0.00 - 0.00] 0.00 [0.00 - 0.01] 0.00 [0.00 - 0.00]10
%Mard 6.66 [5.51 - 8.19] 6.02 [4.79 - 7.67] 5.49 [4.43 - 7.19] 5.48 [4.44 - 7.36] 5.95 [4.71 - 7.66]
* Patients 2-2 and 2-3 did not have enough recording time for 6 hourly time frame therefore median IQR represents 3 hours.















































































Figure 7.3: Three examples of model fit (red) showing low MARD (2.27%), mediumMARD (6.93%) and high MARD (11.5%)
7.3.3 Subgroup analyses: Surfactant
Patients treated with surfactant, shown in Table 7.6, had significantly lower specific
elastance than those without the treatment, as seen in Figure 7.4 showing the expected
response to treatment (Baraldi and Filippone, 2007; Yuksel et al., 1993; Wood and Jobe,
1993). The difference of the median of specific elastance with 99% CI is -0.48 [-0.49 -0.48]
cmH2O.kg/ml, showing a p ≤ 0.01 statistically significant difference in specific elastance.
Resistance is similar across both cohorts as the difference of the median of resistance
with 99% CI is 0.21 [-0.12 0.53] cmH2O.s/ml.
As surfactant lowers surface tension, lowering the pressure required to keep alveoli
and airways open. Thus, a reduction or lower value of respiratory elastance in patients
treated with surfactant is expected. This result thus shows the model’s ability to capture
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a known response to typical care Baraldi and Filippone (2007); Yuksel et al. (1993); Wood
and Jobe (1993); Brown and DiBlasi (2011); Carvalho et al. (2013b).
Table 7.6: Patient characteristics of selected patients who were and were not treatedwith surfactant
Subject Study Weight [g] Day of MV Morphine Target Vt[ml] ETT diameter [mm]
Treated with Surfactant 5 1580 1 Y 7.9 3.08 770 2 N 3 2.5
Not Treated with Surfactant
2 890 27 Y 4 2.5
3 3400 3 Y 13 2.5
4 2750 2 Y 11 3.5
6 1170 1 Y 5 3.5
7 1990 5 Y 6.6 3.0
9 820 5 Y 4 2.5





























































Figure 7.4: Specific elastance and resistance in subgroups of patients (5, 8; N = 81,435breaths) with surfactant therapy, and patients (2, 3, 4, 6, 7, 9, 10; N = 341,040 breaths)without surfactant therapy.
7.3.4 Subgroup analyses: Weight based trends
Elastance decreased with increasing weight, as seen in Figure 7.5 and Table 7.7 (p ≤ 0.01
in all comparisons). This result is expected, as PEEP and the plateau pressure remain
largely the same over all these the patients, and thus effective elastance drops due to
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increasing in tidal volume. This result may also reflect greater lung maturity with in-
creasing infant weight (and maturity) resulting in lower, less stiff lungs (Hislop et al.,
1986). Resistance was similar, as expected.
Table 7.7: Patient characteristics of selected patients who were and were not treatedwith surfactant
Subject Study Weight [g] Day of MV Surfactant Morphine Target Vt [ml] ETT diameter [mm]
<1000g
2 890 27 N Y 4 2.5
8 770 2 Y N 3 2.5
9 820 5 N Y 4 2.5
10 810 1 N N 4 2.5
1000g-2000g
5 1580 1 Y Y 7.9 3.0
6 1170 1 N Y 5 3.5
7 1990 5 N Y 6.6 3.0


















































Figure 7.5: Model-based elastance and resistance in selected patients grouped by weightwith <1000g (Patients 2, 8, 9, 10; N = 219,029 breaths); 1000-2000g (Patients 5, 6, 7; N =137,239 breaths); >2000g (Patients 3, 4; N = 66,207 breaths).
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7.4 Discussion
7.4.1 Breaths and Asynchrony
A total of 422,475 (79%) of identified breaths from raw data were used in the model-
based analyses, and 112,953 (21%) breaths were removed. The breaths filtered out
primarily represent significant spontaneous breathing and/or clinical interactions af-
fecting the pressure-flow waveforms. These breaths are thus asynchronous for one or
more of these reasons, and per Figure 7.2, and do not represent typical MV supported
breaths determined primarily or solely by the underlying fundamental pulmonary me-
chanics. The authors could find no prior studies of this scale to compare this incidence
rate, which is clinically large and potentially unexpected.
Table 7.4 shows mean and standard deviation of PEEP, driving pressure and volume/-
targeted volume for normal and filtered breaths. The filtered breaths shown to have
higher standard deviation, these breaths are much more variable. High variability in
standard deviation implies either asynchrony or spontaneous breathing effort.
Many of the breaths that were filtered are ‘odd’ breaths like those shown in Figure 7.2,
and the standard deviation is higher in filtered breaths in comparison to normal breaths
shown in Table 7.4. For these reasons, the 21% filtered breaths are considered asyn-
chronous or highly spontaneous breathing efforts. It should also be noted that Chiew
et al. (2011), states that fitting error >15% does not represent patient physiological con-
dition (Chiew et al., 2011).
Table 7.5 shows number of filtered breaths. It can be seen PSV and SIMV modes have
higher number of breaths removed. Patient 3 who was ventilated using SIMV mode
has significantly high number of breaths removed compared to other patient and ven-
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tilation modes. However, Patient 3 was most developed infant with weight of 3400g,
gestation age of 41.5 weeks and severe hypoxic ischemic encephalopathy and seizures.
However, given the lack of patient numbers and data on other SIMV ventilation modes,
it is hard to determine whether the ventilation mode itself is the cause for such large
number of breaths removed. Patient 2 was on both PTV and PSV modes. When compar-
ing PTV to PSV modes for this patient, PSV mode can be considered to give results with
a higher incidence of filtered breaths.
7.4.2 Cohort Elastance and Resistance
A single compartment lung model is used with clinical data to capture respiratory me-
chanics in the NICU patients. Model fit error (MARD) was 5.7 [5.2 – 6.3]%. Overall results
were consistent across weight and a known therapy directly affecting elastance for a
smaller number of infants in these subgroups. Thus, based on this first analysis, the
model can be used without further alteration to Eq (7.1) to estimate clinical breath-to-
breath lung mechanics, specifically, elastance and resistance, in this cohort.
Elastance and resistance values across all conventionally ventilated patients are given
in Table 7.5. Elastance differed significantly within and between patients. Elastance
also differed significantly across periods as short as 30 seconds ( 30 breaths) due to com-
monly occurring increases in PIP, as shown in Figure 7.6 and Figure 7.7. Elastance can
be approximated by change in pressure over change in volume. Thus, a doubling in PIP,
with no change in tidal volume, will result in a doubling of elastance for that breath.
This outcome is clearly seen in Figure 7.8, where elastance changes with increases in
PIP, while inspired tidal volume remains roughly the same. These increases in elastance
may reflect periods of patient relaxation/weakness with no spontaneous breathing, or
clinical interactions compressing the thorax, muscle tension, or crying. Unfortunately,
all these potential observations were not directly recorded at the bedside, and thus re-
main to be confirmed.
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Figure 7.6: Raw data from 20minutes of ventilation in Patient 4 showing significant andperiodic increases in PIP.
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Figure 7.7: Raw data from 20minutes of ventilation in Patient 9 showing significant andperiodic increases in PIP.
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Figure 7.8: PIP increase and decrease over period of 60 seconds for Patient 4 in hour 8of recording
Underlying intra-patient variability is large. As shown in Table 7.5, both intra- and inter-
patient elastance (Ers) differs largely over a 24 hour period. Large inter-patient vari-
ability is expected, as patients have different birth weights, degrees of prematurity, and
clinical diagnoses and co-morbidities. However, the observed intra-patient elastance
(Ers) is unexpectedly variable in comparison to adult MV (Kim et al., 2017).
Some patients were observed (Table 7.5) to have zero model-fit resistance (Rrs = 0) be-
cause the ∆PETT term captures the main contribution to resistance without any addi-
tional requirement for an additional resistance term This result matches these seen in
adults where much of the resistance is due to the ETT which also ses the highest flow
rates (Damanhuri et al., 2014). For this reason, resistance values shown in Table 7.5
are all relatively small or effectively zero. This Rrs = 0, result may also be due, in part,
to the assumed ETT length. A shorter length than assumed, if used, would have lower
∆PETT and thus it would capture lower resistance pressure drops. Equally, the Jarreau
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equation approximation used in ∆PETT could be too large in some cases (Docherty et al.,
2011). However, as Rrs is constrained to change more slowly than elastance, it does not
significantly affect trends in Ers.
7.4.3 Subgroup Analyses
Patients who received surfactant treatment had lower specific elastance (99% CI differ-
ence in medians: -0.49 [-0.48 -0.48] cmH2O.kg/ml) compared to those that did not (Pa-
tients 5 & 8 vs Patients 2, 3, 4, 6, 7, 9, & 10) with p ≤ 0.01. This result matches expected
behaviour. In particular, surfactant lowers the surface tension, thus lowering the pres-
sure required to keep alveoli and airways open (Wood and Jobe, 1993; Yuksel et al., 1993;
JM et al., 1988).
Elastance decreased with increasing patient weight. This result reflects the fact all pa-
tients are receiving similar PEEP levels with similar driving pressure. Therefore, in-
creases in tidal volume with increasing in weight, would decrease elastance and thus,
this result is expected (Kannangara et al., 2018). Equally, the more premature the in-
fant, the less developed the lung (Greenspan et al., 1988; Liggins et al., 1972), with lack
of surfactant production and fewer underdeveloped alveoli (Hislop et al., 1986), and an
overall lower weight. Thus, the model effectively captures this expected physiological
difference, as desired, demonstrating its ability to assess underlying pulmonary me-
chanics in this cohort.
7.4.4 Elastance and Resistance Comparison to Literature
Bhutani et al. (1988) used the single compartment model to fit specific compliance to
data from 22 neonates (Bhutani et al., 1988). The specific compliance median IQR for
Bhutani et al. (1988) was 0.40 [0.34 - 0.57] ml/cmH2O/kg (Bhutani et al., 1988). The specific
compliance median IQR for this study was 0.61 [0.42 - 0.95] ml/cmH2O/kg. The median
and range of IQR for specific compliance for this study is slightly higher than the results
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from Bhutani et al. (1988), of the same order of magnitude with overlapping ranges.
There are several different factors that may cause the slightly higher results in this study.
Bhutani et al. (1988), performed their analyses in 1988 using external pneumotachome-
ter and pressure transducer, and size of the data was limited to 20-40 breaths per patient
in comparison to this study, where ventilator data was retrieved with 20,000 breaths
per patient in this study. Patient weight is higher in Bhutani et al. (1988), with lowest
weight being 1.51 kg, in comparison to 0.81 kg in this study, so per our results in Figure
7.5, this lower elastance for the Bhutani et al. (1988) cohort is expected. Other factors
such as respiratory rate and ventilator mode also differed.
7.4.5 Limitations
This study has small patient numbers (n=9), but very large numbers of recorded breaths
(535,428 breaths). After removing asynchronies from all potential cases, 422,475 (79%)
breaths were successfully fit using the single compartment model with ETT compensa-
tion term (Equation 1). Overall, the results indicate the model captures fundamental,
underlying patient-specific elastance and resistance within these limitations.
The results from subgroup analysis also provide preliminary indication the model cap-
tures expected physiological and clinical outcomes and trends. This latter point is criti-
cal for any model used in clinical monitoring or care. This is a proof of concept study to
apply model-based method to clinical infant data to assess underlying pulmonary me-
chanics and therefore the small number of patients was deemed less important than the
very large number of breaths (422,475) captured for analysis.
Patients underwent different recording period lengths for clinical and technical rea-
sons, and so varying numbers of breaths were used in the analyses for each patient.
However, given the minimum number of breaths used per patient is 10,000 breaths,
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there is sufficient data for this analyses. Comparing different subgroups with widely
different number of breaths does not change the results either, as a minimum of 60,000
breaths were present per subgroup, and elastance values were not observed to shift
significantly over time (Table 5) when compared to subgroup differences.
7.4.6 Comparison to Adult MV
Compared to elastance values of adult ICU patients (Chiew et al., 2011, 2015c), neonates
have significantly higher elastance. This result confirms neonates cannot be treated like
small adults in managing MV. It also suggests they have differences in lung mechanics
(Chakson et al., 2017). However, the underlying model appears to translate cohorts well,
implying the underlying mechanical behaviours are similar, even if the specific mechan-
ics values vary. In particular, neonates have a high spontaneous breathing or clinical
interaction affecting breaths ( 21%). Infants also have high intra- and inter- patient vari-
ability. Such behaviour is different in comparison to adults as adult ICU patients are
sedated (Chase et al., 2004; Wøien et al., 2012; Patel and Kress, 2012; Luks, 2013; de Wit
et al., 2009).
7.4.7 Future Work
Future work is required to use model-based method to capture patient-specific lung me-
chanics in NICU clinical settings in real time. CURE Soft (Szlavecz et al., 2014) allows
monitoring of patient-specific lung mechanics in adult ICU in real time. CURE Soft can be
modified to be used in NICU settings. 21% of the data were considered as asynchronous
or severe spontaneous breathing effort. In adult patients, methods such as pressure
reconstruction, allows adjusting asynchronous or spontaneous breath and be able to
quantify them (Chiew et al., 2018). Therefore, these methods can be implemented be
able to apply model-based methods using the single compartment model to approach
neonatal MV.
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7.5 Summary
The work performed in this chapter is the first in-depth (535,428 breath) study of NICU
pulmonary mechanic quantifying neonatal elastance. The results shows unique be-
haviours including large inter- and intra- and breath-to-breath patient variability. This
study also shows there is significantly greater than expected asynchrony rate of 21%,
where there are no prior reparts to compare to. This model was further validated by
comparing the sub-cohorts with known differences in elastance, as well as comparison
to adults and another NICU study. Technically, the model fit was good and captured the





Newborn male infants have a higher incidence of RDS, morbidity, and mortality than
females at similar birth weight (Miller and Futrakul, 1968; Torday et al., 1981). In utero,
male foetuses are less developed than females at the same gestational age by 1.5-2 weeks
3 (Torday and Nielsen, 1987). Thus, premature male infants produce less surfactant in
comparison, and are more likely to receive invasive MV (Stevenson et al., 2000). Anec-
dotally, male infants are harder to ventilate, but no studies have yet quantified any dif-
ferences in lung stiffness or mechanics to support this observation.
It is well documented, model-based methods can be used to identify patient-specific lung
mechanics (Chiew et al., 2015c; Bhutani et al., 1988; Chiew et al., 2011; Kim et al., 2019a)
and enable better understanding of patient specific condition using existing bedside
CHAPTER 8. PULMONARY SEX DIFFERENCES IN NEONATES 134
measurements. A simple model comprising of a single compartment has been used to
describe lung mechanics in adults (Bates, 2009; Chiew et al., 2011, 2015c) and is currently
used in a MV trial to guide PEEP selection (Chiew et al., 2015c). In this model, the lungs
are treated as a single volume expanding against a spring-stiffness with pressure losses
in the airways due to flow resistance. This model has also been applied to retrospective
neonatal MV data to describe lung elastance and its differences between infants and
changes over time (Kim et al., 2019a).
This chapter analyses MV data to quantify patient-specific elastance, and inter- and
intra- patient variability between male and female neonates. The model is fit to clinical
data from 9 NICU infants of varying prematurity and condition who were invasively
ventilated. Specific elastance is used to factor out weight and size, thus allowing fairer
comparison between infants of different maturities. Male infants have stiffer lungs
(Carey et al., 2007) and are thus hypothesized to have higher model-based elastance
and lower intra-patient variability. This analysis of specific elastance and its variability
aims to provide further insight on differences in response between sexes in NICU MV,
as well as quantifying the incidence and the level of asynchrony in this cohort for the
first time. Both outcomes will provide significant real clinical insight.
8.2 Methods
8.2.1 Patient Data and Acquisition
Mechanically ventilated infant airway pressure and flow data described in Section 3.1 is
used in this chapter. A total of 10 infants were ventilated using conventional ventilation
mode (CV) or high frequency oscillatory ventilation mode (HFOV), or both. In this cohort,
6 of 10 patients are female infants and other 4 are male infants, where 1 female will be
excluded as they were only ventilated using HFOV. In this chapter, the NICU pulmonary
mechanics of male and female infants are compared to verify and quantify anecdotal
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sex difference characteristics.
8.2.2 Model Fitting
The single compartment model described in Section 2.2, Eq (2.3) and also used in Chapter
7 Eq (7.1) is used in this Chapter. This equation is repeated for ease of reading:
Paw = ErsV + RrsQ + PEEP + ∆PETT (8.1)
Where, Paw is the airway pressure, Ers is the elastance, V is the volume,Rrs is the airway
resistance, Q is the flow, PEEP is the pressure offset, and ∆PETT is the pressure loss
across the ETT, specifically defined in Chapter 2, Eq (2.9).
The NICU patient cohort has varying weight as it was an observational study and preterm
neonate can vary from 500-2000g in weight. This variability range is far larger than seen
in other, older and more commonly studied cohort. Thus, specific elastance is utilised to
compare NICU pulmonary mechanics as it allows direct comparison (Kannangara et al.,
2016b; Kim et al., 2019b). The specific elastance is described in Chapter 7 Eq (7.3) and is
repeated here:
Especific = Ers ∗m (8.2)
Where, Especific is the specific elastance, Ers is lung elastance and m is the mass of the
infant.
8.2.3 Male Infants vs Female Infants
Specific elastance based on infant weight is used to account for patient weight as a
marker for maturity. It is useful when comparing infants with large variations in weight
as larger infants typically have larger (and more developed) lungs. Larger lung volumes
result in different apparent elastances for a given underlying tissue stiffness (Brown and
DiBlasi, 2011; Kim et al., 2019a). Specific elastance (Especific) is the reciprocal of specific
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compliance, which is a metric used to measure the intrinsic elasticity of the lung tis-
sue independent of lung volume, as previously described (Kannangara et al., 2018; Kim
et al., 2019a).
In this study, specific elastance (Especific) and airway resistance (Rrs) are compared in
male and female infants. Females are hypothesised to have lower specific elastance
as male infants are typically sicker and less developed (Stocks et al., 2007; Torday et al.,
1981; Torday and Nielsen, 1987). Resistance is hypothesised to be similar between males
and females.
8.2.4 Variability Analysis and Comparison
Preliminary analysis showed large variability between and within patients. This large
underlying inter- and intra- patient variability is quantified using percentage difference
in breath to breath specific elastance (%∆E). The percentage difference in elastance
is determined by current specific elastance (current breath, Especific(N)) and forward
specific elastance (next breath, Especific(N + 1)), defined:
%∆E = Especific(N) − Especific(N + 1)Especific(N + 1)
× 100 (8.3)
The standard box plot is used to show the overall distribution of specific elastance and
its variability for each patient. This plot clearly compares patients and sexes by overall
distribution.
The variability in the cohorts of male and female infants is quantified. It is hypothesised
male neonates will have much lower intra- and inter- patient variability, as stiffer lungs
are harder to inflate and less responsive to small changes in flow-volume input. Overall
variability is calculated using the interquartile range (IQR; 75th-25th) of specific elas-
tance and its percentage change over the distribution. As an indication of the relative
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size of the variability between patients, the IQR is also divided by the median.
8.2.5 Asynchrony
Ventilator asynchrony occurs when the particular ventilator mode and settings do not
match patient breathing efforts. High incidence of ventilator asynchrony can lead pro-
longed MV duration (Thille et al., 2006, 2008; Chao et al., 1997; Epstein, 2011). There is
thus significant value in quantifying the incidence of asynchrony in this cohort.
The level of incidence of patient ventilator asynchrony was quantified, and the percent
asynchronous breaths calculated per patient. Asynchrony incidence is compared be-
tween male and female infants. The purpose of this comparison is to show the level
of patient-ventilator interaction obtained, while comparing the differences due to sex.
This result also gives more context to how a patient is responding to MV.
8.2.6 Statistical Comparisons
Statistical comparisons for specific elastance and resistance are made using non-parametric
statistics due to non-Gaussian distributions and large data sets (422,475 breaths) (Motul-
sky, 1995). To assess the overall central tendency of behaviour we analyse the 90% range
of results for each infant. Bootstrapping medians was used as the most robust and fun-
damental means of evaluating statistical comparisons 27, Avoiding the problem of un-
realistically low p-values can arise when data sets used in more traditional comparison
tests are very large (N > 10,000) (Motulsky, 2015).
Bootstrapping compared medians from 10,000 breaths with replacement, repeated 10,000
times. A 99% Confidence Interval (CI) for difference in median specific elastance values
are created. If the CI does not cross zero, differences in medians are statistically signifi-
cant with p ≤ 0.01. This choice of p value significance was made to be more conservative
than p ≤ 0.05, because of multiple comparisons (Motulsky, 2015).
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8.3 Results
8.3.1 Male Infants vs Female Infants
Patient clinical data are shown in Chapter 3 Table 3.1. Male infants had higher specific
elastance compared to females, as seen in Figure 8.1 and Table 8.1. The median [IQR] of
specific elastance for male infants was 1.91[1.33-2.48] cmH2O.kg/ml and higher than fe-
male infants at 1.31[0.86-2.02] cmH2O.kg/ml (p<0.01). The median [IQR] resistance was
0.00[0.00-0.02] and 0.02[0-0.05] cmH2Os/ml for males and females, respectively (p<0.01).
The higher elastance in males matches the hypothesis as male infants are anecdotally
harder to ventilate (Stocks et al., 2007). The difference in resistance, while statistically
significant, is not likely clinically significant. Equally, it could reflect increased resis-
tance in more developed lung structures with a greater number of branches and alveoli,





























































Figure 8.1: Box plot of specific elastance (Especific) and resistance (Rrs) of sex cohorts.Males have higher Especific (P < 0.01) and Rrs.
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8.3.2 Variability
Variability within and between patients is large. The median [IQR] for specific elastance
and breath-to-breath %∆E of each patient and sex is shown in Table 8.1. The median
[IQR] of breath-to-breath %∆E across all patients is -0.20[-9.40 - 9.63]%, with absolute
IQR range of 19.03% indicating a progression towards lower elastance over time. The
minimum per-patient IQR range is 10.96% and the maximum is 67.97%, showing large
intra-patient variability, as well as large inter-patient variability in this metric.
Figure 8.2 shows box plots of specific elastance for all patients. Figure 8.2 and Table 8.1
show Patient 3 has the lowest median specific elastance while Patient 5 has the narrow-
est IQR range for specific elastance as seen in Figure 8.2 but Patient 6 has the lowest IQR
range/Median(Especific). The per-patient IQR range as a percentage of the median value
(IQR Range/Median(Especific)) also varies considerably.
Figure 8.1 and Table 8.1 also show males have consistently higher specific elastance
than females, barring male Patient 3 who was near term and relatively large. They also
show the hypothesized lower intra- patient variability for males versus females, seen in
narrower IQR boxes in Figure 8.2 and values in Table 8.1. Excepting again Patient 3, the
same outcome holds for the IQR range of %∆E, breath-to-breath.
Figure 8.3 plots median specific elastance against the IQR range of %∆E) per patient, as-
sessing breath-to-breath variability as a function of specific elastance. This plot shows
a hyperbolic relationship with R2 = 0.73. Eliminating the outlier at (0.5, 68%; Patient
3 [male]) changes to R2 = 0.71 so the relationship is robust at this level of correlation.
This relationship shows the median specific elastance and IQR range of breath-to-breath
%∆E) per patient are strongly related. It also shows as median specific elastance rises,
breath-to-breath (%∆E) variability falls, as hypothesised. This plot shows variability in
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a function of Especific, not sex. It just happens males have higher Especific per the other
results and hypothesis.





























Figure 8.2: Box plot of specific elastance for all patients. Where males (M) and females(F) are denoted on x-axis.
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Line of Best Fit; R
2
 = 0.73
Figure 8.3: Relationship between median specific elastance and IQR range of %∆E. Ahyperbolic line of best fit is shown in red.
8.3.3 Level of Asynchrony
Asynchronous and outlying breaths were detected. Breaths filtered based on perturba-
tions from a well-accepted model of typical lung dynamics and the relationship between
flow-volume and pressure. These breaths total up to 112953 (21%) of the total 535428
breaths.
The percentage asynchrony per patient is shown in Table 8.2. Patient 3 was highly asyn-
chronous. This high level of asynchrony may be a function of his clinical diagnoses
(seizures) or the fact he was ventilated using SIMV mode, whereas other patients were
on PTV. Male infants (excluding Patient 3) have lower incidence of asynchrony in com-
parison to female infants, although this is not likely to be statistically significant. The
chi-squared test to assess significance is inappropriate here because large data sets re-
sults in p = 0 and the patient cohort is too small to bootstrap test (Motulsky, 2015). Pa-
tient 6 had lowest occurrence of ventilator asynchrony with 11.24% and Patient 4 had
the largest asynchrony with 19.13%.
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Table 8.2: Percentage Asynchrony occurrence per patient.
Males Females
Patient # Asynchrony (%) Patient # Asynchrony (%)
3 60.74 2 23.44
6 11.24 4 19.13
9 17.24 5 18.17






*Percentage asynchrony for male infants not accounting for Patient 3
8.4 Discussion
8.4.1 Specific Elastance
Males have higher specific elastance compared to females (p ≤ 0.01). This behaviour
matches the hypothesis, and is supported by anecdotal and literature evidence male in-
fants are harder to ventilate and tend to have longer ventilation period compared to
females (Deulofeut et al., 2007; Torday et al., 1981). Thus, a single compartment model
is able to quantify established trends, and capture MV behaviour in neonates. Patient 3
was an outlier, in they were male with the lowest overall elastance. However, it was a
full-term infant with weight of 3400g, and is likely more mature in terms of lung struc-
ture and function. This infant was also ventilated for reasons unrelated to lung function
due to severe hypoxic ischemic encephalopathy. Overall, these results match observa-
tions male premature infants are less developed with stiffer lungs (Carey et al., 2007;
Torday and Nielsen, 1987), which may require a different approach to MV for this co-
hort.
The results show an initial finding male infants have stiffer lungs, creating a hypothesis
for a larger, more controlled study and thus, feels the result of this study would still
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hold true for larger and more controlled studies recruiting only pre-term infants with
similar weight and gestational age. In particular, such a study would exclude Patient
3 who was near term and much larger, but also reduced the apparent sex differences
seen. Therefore, based on these results, a larger controlled study would deliver the same
differences with greater statistical power.
8.4.2 Variability
There was large intra- and inter- patient variability observed across the cohort. The low-
est breath-to-breath IQR range of the percentage change in elastance (%∆E) was 11%,
and highest was 68%. The overall elastance distribution of breath-to-breath %∆E varied.
Breath-to-breath variability can differ significantly. Patient-specific elastance changes
hourly, and breath-to-breath changes can be relatively large (Kim et al., 2019b).
The results show male infants have higher specific elastance, but lower variability, as
seen in the IQR range of Especific and breath-to-breath %∆E. Excluding the more mature
Patient 3, males have significantly lower IQR range/median values compared to female
neonates (Table 8.1). This outcome is expected as male infants have higher elastance in
the results, excepting Patient 3. Figure 8.3 indicates variability in elastance in a function
of median elastance, rather than sex. This result makes sense as higher elastance means
stiffer lungs, which are thus less responsive to pressure-flow inputs compared to lungs
with lower elastance, and thus less likely to vary given similar ventilator settings.
In Figure 8.3, the hyperbola shape is chosen because this line does not cross zero, thus
making physical sense. The correlation of determination (R2 = 0.73) value does not
change much if the outlying first data point is removed. It overall suggests variability is
primarily a function of median specific elastance. Such large distributions in variabil-
ity across the patients shows the potential need to change MV modes more frequently.
Equally, it may show a need for better MV modes to account for patient variability in
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the NICU environment.
8.4.3 Asynchrony
A total of 112,953 (21%) of breaths were counted as either asynchronous or significantly
outlying using the method in Figure 7.1 in Chapter 7 and are not representative of typ-
ical MV supported breaths. These 21% of breaths are either asynchronous, or breaths
with relatively very large spontaneous breathing efforts, resulting in extreme elastance
values or poor model fit to a well-accepted model. Infants are not cuffed or sedated
during MV, although morphine is given, which has sedative effects (Chase et al., 2004).
Therefore, neonates are more likely prone to ventilator asynchrony.
Patient-ventilator asynchrony severely interferes with MV and is associated with pro-
longed MV duration and reduced outcomes in adult cohorts (Newberry et al., 2016;
Chiew et al., 2018; Gutierrez et al., 2011; Thille et al., 2006; Chao et al., 1997; Epstein,
2011), but has not been studied in NICU cohorts. For this reason, it can be much harder
to detect and/or reduce ventilator asynchrony in the NICU setting in comparison to adult
ICU (Chiew et al., 2018; Thille et al., 2006). Neonates may thus require much closer and
more frequent attention to ventilator settings and response for this reason, as well to
minimise asynchrony and further enhance patient-ventilator interaction.
Not accounting for Patient 3, who was solely on SIMV mode, male neonates have lower
asynchrony rates. The remaining male and female infants all shared similar ventilator
modes, settings, and approach, as per standard care. However, given females had much
higher ventilator asynchrony incidence, they may require different ventilator settings
than males for this reason, as well as due to differences in lung mechanics and variabil-
ity.
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8.4.4 Overview and Clinical Implications
This analysis used specific elastance, a measure which accounts for patient weight Kan-
nangara et al. (2016b). Other studies indicate lung development and volume are strongly
associated with weight (Brown and DiBlasi, 2011; Kim et al., 2019a). However, the high
variability between patients seen here is also likely a function of infant injury or disease
state and associated complications. Males were seen to have higher elastance and less
variability overall and breath-to-breath.
These results suggest MV management for infant males should be different to infant fe-
males as male neonates have stiffer lungs and are thus less variable in response to MV.
They may also pose a greater risk for over inflation (barotrauma) or under recruitmen-
t/oxygenation. In contrast female neonates showed greater variability associated with
lower specific elastance, and thus may likely need more frequent observation and/or
changes in MV settings.
The identified resistance values for the model are very low due to the ∆PETT term added
to the model and used in this analysis. The ETT is the single largest resistor in patient
breathing. This term thus captures most of the flow resistance behaviour observed in
the data. Calculating it separately, as in this analysis, leaves relatively little further flow
resistance to be identified from the model term. Therefore, the (added) identified airway
resistance, Rrs, is relatively low. Clinically, it implies a need to account specifically for
ETT length, as well as noting there is less need to specifically focus on resistive losses in
this cohort.
8.4.5 Limitations
The major limitation of this study is small patient numbers (n= 9). However, the number
of recorded breaths are large (535,428 breaths). This large number of breaths and the
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robust statistics used help ensure the validity of the results for this initial observational
cohort. Despite the small patient numbers, the male vs female neonates comparisons
showed the hypothesized trends in elastance, which can be further verified in larger
studies.
The model itself is relatively simple (Bates, 2009; Ben-Tal, 2006; Chase et al., 2016, 2018;
Morton et al., 2019a), and analyses lungs as a combined volumetric unit. It is there-
fore unable to independently describe differences in MV properties between the lungs
or lung units (heterogeneity), but presents an overall average description of their com-
bined behaviour. This model has been successfully applied to adults (Chiew et al., 2011),
and has the advantage in it can be easily identified using readily available bedside data
with no additional measurements (Docherty et al., 2011; Schranz et al., 2012c; Docherty
et al., 2014).
Particular, the single compartment model is structurally simple compared to non-linear
models. Non-linear models might be able capture more specific differences and insight
in lung mechanics properties. However, such models are far less identifiable and of-
ten not practically identifiable (Docherty et al., 2011), meaning unique parameter val-
ues may not be able to be found with the clinical data available without invasive and
burdensome added procedures or measurements not typically available for this cohort.
There is thus a trade-off of ease of use and detail (Chase et al., 2018).
8.5 Summary
In this chapter, the difference between mechanically ventilated male and female in-
fants in terms of specific elastance, inter- and intra- patient variability were studied.
Male neonates had higher specific elastance than female neonates. Females had greater
intra-patient and breath-to-breath variability, which increased with declining specific
elastance. These results indicate male and female infants should be ventilated differ-
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ently, where higher variability in females show they may require more frequent ob-
servation and changes during MV. In contrast, males may require different ventilation
modes and/or settings than females.
CHAPTER 9
Quantifying neonatal patient
effort and asynchrony using
basis functions
9.1 Introduction
In previous chapters, neonatal pulmonary mechanics are quantified using single com-
partment mode. Model fit was good, validated by comparing charges to known clinical
and physiological trends (Kim et al., 2019a,b). However, the single compartment model
is limited because it can not uniquely separate heterogeneity of lung in different regions
and can not distinguish asynchrony or spontaneous breathing efforts separate from nor-
mal breathing without significant assumptions (Blanch et al., 2015; Georgopoulos et al.,
2006; Mellott et al., 2014; Vicario et al., 2016; Blanch et al., 2012; Mulqueeny et al., 2007;
Poole et al., 2014; Damanhuri et al., 2016; Chiew et al., 2015b; Major et al., 2016b; Kannan-
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gara et al., 2016a; Chiew et al., 2018). This NICU cohort described in Chapter 2, were not
sedated during their data recording per standard practice, and thus exhibit spontaneous
breathing effort in many to most breaths. These spontaneous breathing efforts cause,
large breath-to-breath variability, which in turn, causes difficulty in separating underly-
ing patient lung elastance and patient effort due to identifiability issues (Docherty et al.,
2011; Schranz et al., 2012b).
In Chapter 5, new method has been developed at separating patient lung mechanics and
patient spontaneous breathing effort in adults on NAVA ventilation. In this chapter, the
same approach is made to segregate patient lung mechanics, patient inspiratory effort
and asynchrony in the NICU cohort. The single compartment model is modified to in-
corporate basis functions and dynamic lung elastance (Morton et al., 2019b; Chiew et al.,
2015a). The two basis functions capture recruitment and distension, and the dynamic
elastance captures both inspiratory effort and asynchrony. Basis functions are a form
of regularisation, defining normal breathing dynamics, where the remainder or error
must be attributable to other courses based on timing and dynamic effect. The aim is
to quantify apparent or estimated inspiratory effort relative to an established model of
lung recruitment.
9.2 Methods
9.2.1 Patient Data and Acquisition
MV data from 10 invasively mechanically ventilated patients described in Section 3.1
is used in this chapter. Only the patients ventilated using conventional ventilation (CV)
mode are examined in this chapter as high frequency oscillatory ventilation (HFOV)
mode does not exhibit normal typical breathing.
In this chapter, the first hour recording for each patient on CV is used to determine basis
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function model fit and validate the method presented to quantify patient effort. Only the
first hour of each patient is used as it allows a more consistent number of breaths per
patient, due to differences in recording periods. At roughly 3600 breath per hour, there
are enough data points to validate this method. See Table 3.1 for patient demographics.
9.2.2 Model Fitting
A linear single compartment model using Jarreau’s equation for pressure loss across
the endotracheal tube (ETT) described in Section 2.2, Eq (2.3) and also used in Chapter 7
Eq (7.1) and Chapter 8 Eq (8.1) is used to estimate patient-specific lung condition (Bates,
2009; Chiew et al., 2011; Jarreau et al., 1999; Kim et al., 2019a,b, 2017). This equation
has been successfully implemented in NICU cohorts (Kim et al., 2019a,b) as described in
Chapters 7 and 8. This equation is repeated in this chapter for clarity:
Paw = ErsV + RrsQ + PEEP + ∆PETT (9.1)
Where, Paw is the airway pressure [cmH2O], Ers is the elastance of the lung [cmH2O/ml],
V is the volume [ml],Rrs is the airway resistance [cmH2Os/ml],Q is the flow [ml/s],PEEP
is the pressure offset [cmH2O], and ∆PETT is the pressure loss across the ETT [cmH2O],
specifically defined in Chapter 2, Eq (2.9).
The single compartment model from Eq (9.1) is modified using basis functions described
in Section 2.3 to describe the alveoli recruitment Φ1 and distension Φ2 (Morton et al.,
2019b,a). These basis functions and similar approaches have previously been used in
adult critical models (Langdon et al., 2017; Morton et al., 2019b,a). For NICU infants,
these functions are defined over a tidal volume range of 0-14ml and pressure ranges 0-
60 cmH2O, which covers all likely NICU MV ranges. Figure 9.1 is repeated from Chapter
2 (Figure 2.2) depicting the basis function shapes.








































Figure 9.1: Recruitment and distension basis function shapes with volume ranges ad-justed for NICU cohort. (Both functions are dimensionless).






Where Vm is the upper limit of 1L in adults and φ1 is set to 0 for V > Vm but the Vm
limit is adjusted to 14ml to fit for NICU volume ranges. The 14ml limit should cover all
NICU tidal volume ranges as they are typically ventilated at 4-8ml/kg (Brown and DiBlasi,




The two basis functions are added to single compartment model, which is also repeated
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from Eq (2.6):
Paw = E1φ11V + E2φ12V + RQ + PEEP (9.4)
As described in Section 2.5, neonates are ventilated at constant low PEEP (< 6 cm2O) and
thus, distension is not identified. In Chapter 8, the resistance term R was near-zero as
the ∆PETT term absorbed most of it. Therefore, these outcomes result in a much simpler
equation, which is repeated from Eq (2.12), leaving:
Paw = E1φ11V + PEEP + ∆PETT (9.5)
Neonates in this cohort are not sedated and thus exhibit spontaneous breathing effort.
Therefore, as described in Section 2.5, time-varying elastance Edrs is utilised to cap-
ture the inspiratory effort (Chiew et al., 2015a). The additional time-varying elastance
equation is shown in Eq (2.13) and is repeated here for ease of reading:
Paw = Edrs(t) × V (t) + E1φ11V (t) + PEEP + ∆PETT (9.6)
Where Edrs(t) is defined:
Edrs(t) = Paw(t) − Pbasismodel(t)V (t) (9.7)
In this formulation, Edrs(t) is the error between expected typical breathing dynamics
defined by the basis functions. It thus captures behaviours like spontaneous breathing
effort (Edrs(t) < 0) and asynchrony (Edrs(t) > 0).
First, E1 using Eq (9.5) is fit and linear least squares regression. Secondly, Edrs is fit
using Eq (9.7). It is thus essentially the error after identifying Eq (9.4), using E1 primarily
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due to spontaneous breathing. Taking the area under the curve (AUC) of Edrs results in
AUCEdrs, an absolute Edrs value can be compared across breaths and patients.
Preliminary study showed there are approximately six common shapes of Edrs(t) as
seen in Figure 9.2. The shapes are commonly occurring across patients, where some
shapes may have significantly higher occurrence than others. As seen in Figure 9.2, the
Edrs values all converge to zero at end inspiration as expected. However, small offset
exists where this convergence does not reach zero. Thus, the median of last 25% of the
inspiratory Edrs is used to determine the effective zero and mitigate small errors.
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It can be hypothesised: Edrs curves for each breath can be used to describe patient-
specific condition and responsiveness to ventilator support. It can be assumed most
of the patient-specific inspiratory effort or asynchrony occurs at the start of inspira-
tion. Thus, Edrs is separated into two sections based on the first two occurrence of zero
crossing points. The first zero crossing section is mostly patient effort and second zero
crossing section is mostly asynchrony. Figure 9.2 shows how each of the common shapes
are divided. Note, inspiratory effort can be positive, rather than negative, if the infant
is asynchronous or coughs and is thus “fighting” the ventilator applied breath, as also
shown in Figure 9.2.
Taking the AUC of the two sections, the patient effort and asynchrony based on the zero
crossing is defined. The first section (start to first zero crossing; AUCEdrs1 in Figure
9.2) would represents spontaneous breathing effort, and is typically a negative area.
The second section (first zero crossing to second; AUCEdrs2 in Figure 9.2) represents
asynchrony, and its typically a positive area.
9.2.3 Analyses
Model fit, patient effort and asynchrony are assessed and presented as median and
[IQR] (interquartile range). The percentage contribution of AUCEdrs1, AUCEdrs2, and
AUCEdrs of rest of the breath are also presented (AUCEdrs1+AUCEdrs2+AUCEdrsrest =
100%). The percentage contribution of each component is also shown, as it could provide
further insight on the magnitude of each component and its contribution on patient-
specific breath.
The patient effort and asynchrony are described by the AUC of Edrs. The cumulative
distributive function (CDF) plots are used to compare the AUCEdrs1, 2 across the co-
hort. The CDF plots on AUCEdrs1 would allow visualisation of distribution of AUCEdrs
across cohort. If majority of AUCEdrs1 are negative, then the AUCEdrs1 are properly
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capturing patient effort. The CDF plots ofAUCEdrs2 will show how much asynchronous
or coughing-like events occur across the cohort. More specifically, asynchrony causes
Edrs > 0, while patient effort causes Edrs < 0 (Chiew et al., 2015a).
A scatter plot comparing AUCEdrs1, 2 is used to compare the relationship between the
two segments. This plot would show both magnitude and frequency of AUCEdrs1, 2
values calculated. It will also show the tradeoff between spontaneous breathing effort
and asynchrony, where it could be hypothesized strong patient effort obviates asyn-
chrony and asynchrony is likely matched to minimal spontaneous breathing effort. If
the model is successful in separating out patient effort and asynchrony, then a large
number of data points would be in negative region of AUCEdrs1 and positive or near
zero for AUCEdrs2, and vice versa for asynchronous breaths from Eq (9.6).
9.3 Results
A total of 25,287 breaths from 9 patients were used to fit basis function model. The num-
ber of breaths detected, used, and the median [IQR] of basis function identified E1 from
Eq (9.5) is shown in Table 9.1. A total of 187 breaths (0.7%) were removed as distorted
breaths, not presentative of typical inspiration and/or expiration using the criteria at
Chapter 7 Figure 7.2. The median IQR identified for E1 is 3.82 [2.09 – 5.80] cmH2O/ml.
Figure 9.3 shows an example of model fit. It can clearly be seen the Edrs term absorbs
the difference between airway pressure and model fit pressure using Eq (9.5), as pro-
posed. Edrs exhibits commonly occurring Edrs shapes, as seen in Figure 9.2, and it
converges to zero, as expected.
Table 9.2 shows the median [IQR] of AUCEdrs1, AUCEdrs2 and the AUCEdrs of the
rest of the inspiration. The overall median [IQR] of AUCEdrs1 is -0.32 [-0.43 - -0.12]
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Table 9.1: Number of breaths detected and used and Median IQR of E1.
Patient Total Breath Breath used Breath removed Median IQR of E1 [cmH2O/ml]
2 2227 2211 16 2.24 [1.72 - 3.83]
3 1770 1741 29 1.04 [0.56 - 2.05]
4 1622 1618 4 3.64 [2.57 - 5.07]
5 3582 3547 35 1.79 [1.37 - 2.35]
6 3595 3595 0 6.57 [6.21 - 6.91]
7 2897 2887 10 4.31 [3.08 - 5.88]
8 2796 2787 9 2.39 [2.01 - 3.09]
9 3279 3198 81 4.66 [3.50 - 5.74]
10 3706 3703 3 5.10 [4.30 - 6.19]
Total 25474 25287 187 3.82 [2.09 - 5.80]






























































Figure 9.3: example of model fit before and afterEdrs is applied Area under curve (AUC)is separated into first, second, and remaining AUC, based on first and second zero cross-ing points.
cmH2O/ml and AUCEdrs2 is 0.00 [0.00 – 0.01] cmH2O/ml. The median IQR percentage of
all AUCEdrs of each of these first two Edrs sections are 79.24 [64.31 – 85.20]% and 1.41
[0.17 – 13.48]%.
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Table 9.2: Median IQR of AUCEdrs and percent contribution of AUCEdrs. AUCEdrs isvisually depicted in Figure 9.3.
MV Median IQR AUCEdrs [cmH2O/ml] Percent [%] Median IQR
AUCEdrs1 AUCEdrs2 AUC remaining AUCEdrs1 AUCEdrs2 AUC remaining
2 -0.35 [-0.41 - -0.18] 0.00 [0.00 - 0.00] 0.09 [0.03 - 0.14] 73.81 [64.63 - 81.66] 0.29 [0.13 - 1.82] 24.94 [16.77 - 32.21]
3 -0.22 [-0.30 - -0.15] 0.01 [0.00 - 0.04] 0.03 [-0.00 - 0.17] 66.04 [51.22 - 84.05] 2.76 [0.23 - 17.48] 16.03 [6.64 - 36.53]
4 -0.47 [-0.64 - -0.35] 0.00 [0.00 - 0.00] 0.43 [0.30 - 0.60] 53.17 [48.09 - 58.70] 0.15 [0.03 - 0.32] 46.06 [40.47 - 51.10]
5 -0.24 [-0.37 - -0.10] 0.00 [0.00 - 0.00] 0.23 [0.17 - 0.29] 46.77 [34.73 - 58.87] 0.28 [0.16 - 0.49] 50.81 [40.41 - 62.12]
6 -0.33 [-0.39 - -0.28] 0.00 [0.00 - 0.00] 0.19 [0.15 - 0.29] 63.69 [52.74 - 68.53] 0.18 [0.05 - 1.12] 35.07 [30.22 - 46.04]
7 -0.32 [-0.45 - -0.06] 0.02 [0.00 - 0.06] 0.09 [0.03 - 0.17] 71.72 [60.71 - 79.02] 4.44 [0.47 - 13.62] 21.57 [12.36 - 29.79]
8 -0.29 [-0.36 - -0.05] 0.00 [0.00 - 0.02] 0.06 [-0.02 - 0.11] 73.10 [59.27 - 80.87] 0.44 [0.10 - 11.47] 23.65 [14.88 - 31.20]
9 -0.11 [-0.35 - -0.03] 0.00 [0.00 - 0.02] 0.07 [-0.02 - 0.20] 57.48 [35.23 - 68.62] 1.17 [0.15 - 17.02] 35.53 [25.10 - 48.06]
10 -0.45 [-0.59 - -0.12] 0.01 [0.00 - 0.05] 0.07 [0.02 - 0.13] 79.24 [64.31 - 85.20] 1.41 [0.17 - 13.48] 16.91 [9.53 - 24.06]
All -0.32 [-0.43 - -0.12] 0.00 [0.00 - 0.01] 0.13 [0.04 - 0.23] 79.24 [64.31 - 85.20] 1.41 [0.17 - 13.48] 16.91 [9.53 - 24.06]
Figures 9.4 shows the CDFs of AUCEdrs1 and AUCEdrs2, a scatter plot of AUCEdrs1
and AUCEdrs2, and example of randomly selected Edrs shapes in range of the 5th, 25th,
50th, 75th and 95th percentiles to show behaviour at each level. Figure 9.4 also shows a
zoomed in scatter plot with corresponding percentile positions for Patient 7. The ran-
domly selected Edrs shapes all retain the ‘common’ shapes shown in Figure 9.2. The
zoomed scatter plot shows a pink box representing the 5th-95th range and a yellow box
representing the 25th – 75th range. Figure 9.4 shows large negative AUCEdrs1 usually
has small or negligible AUCEdrs2, and large positive AUCEdrs1 has small or negligible
negative AUCEdrs2. Thus, breaths usually either have high inspiratory drive, or are
highly asynchronous.
Figures 9.5 show CDF plots of AUCEdrs1, AUCEdrs2 and scatter plot of AUCEdrs1 and
AUCEdrs2 for Patients 5, 9 and 10. The CDFs of AUCEdrs1 show most of AUCEdrs1
are negative, as expected, and show clear signs of spontaneous breathing effort. The
CDFs of AUCEdrs2 show most of the AUCEdrs2 values are positive, which implies, they
are likely asynchronous events, such as a cough during inspiration, even if small in
magnitude. It should be noted 98% (3511/3595 breaths) of AUCEdrs1 values for Patient
6 are negative. Patients 6,7, 9, and, 10, seen in Figures 9.4 and 9.5, show a very small
percentage of AUCEdrs2 are negative, which also indicates asynchrony.
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AUCEdrs1 > 95th (Breath = 934)












AUCEdrs1 < 5th (Breath = 1944)












95th > AUCEdrs1 > 75th (Breath = 1768)












25th > AUCEdrs1 > 5th (Breath = 1406)



























75th > AUCEdrs1 > 25th (Breath = 1976)












75th > AUCEdrs1 > 25th (Breath = 528)
Figure 9.4: CDFs of AUCEdrs1 and AUCEdrs2, scatter plot of AUCEdrs1 and AUCEdrs2and example Edrs curve in range of 5,25,50,75, and 95th percentiles.
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Figure 9.5: CDF plots of AUCEdrs1 and AUCEdrs2 and scatter of AUCEdrs1 and
AUCEdrs2 for Patients 6, 9, and 10.
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9.4 Discussion
The basis functions used here have been previously used to capture patient specific elas-
tance in adult cohorts (Morton et al., 2019a,b) Edrs is intended to quantify spontaneous
breathing effort and asynchrony. Overall, it appears Edrs is able to capture these ef-
fects, as the shape of Edrs decays to zero over time, as would be expected for breathing
effort. The magnitude and shape also match expectations for effort and resistance.
Overall, the recruitment elastance (E1) for this cohort was 3.82 [2.09 - 5.80] cmH2O/ml,
the patient effort (AUCEdrs1) was -0.32 [-0.43 - -0.12] cmH2O/ml and asynchrony (AUCEdrs2)
was 0.00 [0.00 – 0.01] cmH2O/ml. The percentage contribution of spontaneous breathing
and asynchrony on a breath was 79.24 [64.31 - 85.20]% and 1.41 [0.17 - 13.48]% across
the cohort. Generally, these numbers match anecdotal clinical expectations.
Spontaneous breathing is captured as (un-modelled) negative elastance of the beginning
of inspiration with this model (Chiew et al., 2015a). Notably, 91% of AUCEdrs (23070
out of 25287, 91.2%) values were less than zero, implying spontaneous breathing effort.
The CDFs in Figure 9.5 show AUCEdrs1 have negative occurrences of 90th percentile or
higher (Patient 10 was 99th percentile). This outcome is expected in the patient triggered
ventilation (PTV) spontaneous breathing mode used. Thus, this MV model allowed as-
sessment of spontaneous breathing effort in this cohort, where the very high percentage
of AUCEdrs1 < 0 implies it is capturing this effort.
The Edrs parameter is strongly affected during the first 25% of inspiration, where pa-
tient effort is greatest. The negative start and typical rise to zero is expected from dimin-
ishing patient effort as the lung fills. Thus, the shape and nature of Edrs as used here is
capturing a surrogate of physiological, patient-specific and breath-specific inspiratory
effort. Therefore, when Edrs starts negative and rises beyond zero to a noticeable posi-
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tive peak resulting in AUCEdrs1 < 0, it strongly implies spontaneous breathing leading
to patient-ventilator asynchrony represented in the positive portion.
Asynchrony was interpreted as positive Edrs, implying additional resistance to a ven-
tilator delivered breath, not already captured by the basis functions. Patient 7 has the
largest breath asynchrony contribution with 4.44 [0.47 - 13.62]% and had a large IQR
range. This result can also be seen in Figure 9.4 of randomly selected Edrs plots, where
positive Edrs peaks exist after the first zero crossing. Patient 5 has the lowest contri-
bution of asynchrony with 0.28 [0.16 - 0.49]%, which is likely clinically negligible in im-
pact. These results can also be observed in the CDF plots of Figure 9.5 where Patient 5
has mostly a straight vertical line and Patient 7 is not. These findings suggest Patient 7
was ventilated sub-optimally, as this patient was highly asynchronous in comparison to
other patients.
The scatter plots in Figures 9.4 and 9.5, show the relationship between AUCEdrs1 and
AUCEdrs2 for Patients 7, 6, 9, and 10. It shows most of the AUCEdrs1 < 0 and most
of the AUCEdrs2 ≈ 0, implying good synchronisation between patient effort and ven-
tilator delivery. Positive AUCEdrs2 or AUCEdrs1 implies poor synchronisation with
the ventilator, resulting in pressure increases across the airway and lungs. Such pres-
sure increases may be dangerous (Hillman and Albin, 1986; Petersen and Baier, 1983;
Gammon et al., 1992; Cullen and Caldera, 1979).
AUC Edrs could be used for monitoring patient synchrony with the ventilator, for opti-
misation of ventilation modes and settings. For example, the 5th-95th range shown in
pink, and the 25th-75th range shown in yellow in Figure 9.4 for Patient 7. The scatter plot
in Figure 9.4, shows the data points of example Edrs breaths, this plot can be utilised
to provide a real-time means of monitoring asynchrony incidence and magnitude, as
well as monitoring breathing effort. It is thus a real-time diagnostic, easily enabling
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monitoring of patient-ventilator synchrony in real-time, breath-to-breath.
E1 still follows expected trends across all patients. Patient 3 had the lowest elastance
with E1 of 1.79 [1.37 - 2.35] cmH2O/ml and Patient 6 had the highest elastance with 6.57
[6.21 - 6.91] cmH2O/ml. These results are similar to previous work in Chapter 7 Kim
et al. (2019a,b). It should be noted Patient 3, who had the lowest elastance, was a near
full-term infant and likely most developed patient, so this result matches expectations.
Further, this patient was ventilated for reasons unrelated to lung functions implying no
additional stiffness of the lungs due to disease or injury. Patient 6 was a male infant
with gestational age of 27.4 weeks and given the anecdotal expectation boys are harder
to ventilate than girls due to their relative prematurity (Kim et al., 2019b; Peacock et al.,
2012; Torday and Nielsen, 1987) and the results in Chapter 8, it was expected this patient
would have the highest elastance (Kim et al., 2019a,b). This higher elastance implies
one, or a combination, of smaller tidal or recruitment volume, decreased surfactant
production, greater illness or injury, or less developed lung structures.
9.5 Limitations
This analysis has small patient numbers (n=9) and only the first hour from each patient
are used for ease of visualisation and analysis. However, infants have high respira-
tory rate (60 breaths/min) and therefore large number of breaths were analysed (25287
breaths). Thus, this proof of concept analysis shows promises in the application of ba-
sis function models and Edrs(t) to separate patient-specific lung condition (elastance),
spontaneous breathing effort (AUCEdrs1) and asynchrony (AUCEdrs2).
9.6 Summary
The basis function with Edrs was able to separate patient lung condition, E1 with spon-
taneous breathing effort AUCEdrs1, and asynchrony AUCEdrs2. The recruitment basis
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function had overall good fit and captured respiratory mechanics. The Edrs trajectory
was able to estimate spontaneous breathing effort and asynchrony and offers a real-
time method to track these important MV parameters.
CHAPTER 10
Conclusions
This thesis presents patient-specific elastance modelling and quantification of sedated
and spontaneous breathing effort in both adult and neonatal intensive care unit cohorts
receiving invasive mechanical ventilation. In both adults and neonates, new approach
has been developed to quantify patient spontaneous breathing effort usingEdrs, a time-
varying elastance, and physiologically relevant basis functions. The protocol for CURE
RCT is also established and is on-hold for the trial to commence. In neonatal cohorts,
the first in-depth analysis of infant lung mechanics and physiology is presented and the
unique observed sex differences have been quantified.
There has yet to be a study exploring lung physiology in preterm neonates. Chapter 7
presents the first in-depth analysis for identifying lung elastance in neonates. The single
compartment lung model (Bates, 2009) was fit breath-to-breath over 535,428 inspiratory
breath. The breaths were identified well and results were further validated by capturing
known physiological differences. These results provide the first validation of the abil-
ity of this modelling and identification approach extending to very different neonatal
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cohorts.
The existence of sex differences in male and female infants is widely known in the field.
While there are studies which shows male infants have higher incidence of RDS, mor-
tality and morbidity, these differences have not been quantified at a physiological or
lung mechanics level. There are also anecdotal reports male infants are harder to venti-
late than female infants, but again these aspects have never been formally observed or
quantified. In Chapter 8, specific elastance was compared in male and female infants.
Results showed male infants had higher specific elastance, and, as result, lower vari-
ability compared to female infants. These findings support both anecdotal and known
physiological differences in neonates, and quantify them for the first time.
Spontaneous breathing effort is difficult to measure and require invasive techniques,
but would be extremely useful in managing ventilation. It is quantified in this research
using basis functions in combination with Edrs in both adults and neonates. In both co-
horts, Edrs was identified after initial fit using a recruitment basis function. The Edrs
term thus captures the un-modelled spontaneous breathing effort in a unique approach
to the problem. Adult patients on spontaneous breathing NAVA ventilation showed large
spontaneous breathing effort and 18 of 22 patients showed good correlation between
AUCEdrs and tidal volume, and thus good correlation with electrical activity of the di-
aphragm, Eadi. Neonates showed six commonly occurring Edrs profiles, which cap-
tured both spontaneous breathing effort and asynchronous coughs. Overall, the com-
bined, sequential use of basis functions andEdrswere able to separate modelled patient
lung condition and un-modelled spontaneous breathing efforts and asynchrony. This
method allows estimations of patient effort without the need of external and invasive
sensors, and is a unique result in the field.
Overall, this thesis presents new models and methods and validation of existing mod-
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els in identifying physiological pulmonary mechanics in both adults and neonates. The
neonatal research and data are the first in-depth study on neonatal respiratory mechan-
ics, and revealed further insight into neonatal mechanics. The model fitting on neonates
also showed underlying elastance and identified and/or verified known physiologies.
The research on spontaneous breathing effort was able to accurately capture patient ef-
fort and asynchrony without the need of extra invasive sensors or procedures creating
a unique new model-based tool with significant clinical potential.
CHAPTER 11
Future Work
The work performed in this thesis shows good basis for future work. The models devel-
oped could be further validated and be applied in clinical settings with goal assisting
MV care. The identified physiological trends can also be further improved with larger
patient numbers. Several potential works that extends existing research is presented.
11.1 Larger NICU data set for validation
The NICU cohort used in this thesis was small in patient numbers (N=9), but made up
a large data set in breaths(535,428 breaths). However, with larger patient numbers,
more clinical outcomes can be validated. Morphine is administered to some neonates
and it is known to have some sedative effect (Chase et al., 2004), given larger patient
numbers and data with more detailed timings of such administration, morphine and
its impact on MV can also be observed and validated. Further validation on sub-cohort
studies presented in Chapter 7 can be performed. Although work performed in this
thesis showed promising results which validates such physiological observation with
identified elastance, with larger data set again, can be further validated.
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11.2 Sex differences in adults
The sex differences in neonates showed noticeable difference in elastance for male and
female infants. There are studies which looks at sex differences in neonates (Torday
et al., 1981; Miller and Futrakul, 1968; Stevenson et al., 2000; Peacock et al., 2012), but
there are lack of studies for it in adult MV, as adults have fully developed lungs. How-
ever, comparing elastances between male and female adults may provide further in-
sight to lung physiology or show interesting outcomes.
11.3 Spontaneous breathing effort
Spontaneous breathing effort was quantified in both adults and neonates. The NAVA
adult cohort showed good correlation between patient effort and tidal volume, which
also correlate with Eadi (Moorhead et al., 2013). In neonates, the use of Edrs clearly
separated patient lung condition with spontaneous breathing effort and asynchrony.
This method was effective at measuring patient effort in both adult and neonates and
should be verified in clinical setting for further validation. It is important to understand
how much the patient is breathing spontaneously, or if there is patient-ventilator asyn-
chrony. The method defined in this thesis can perhaps be used to measure and allow
clinical adjustment to reduce patient effort or allow faster transition into weaning, pre-
senting significant opportunity for clinical impact. This tool is particularly useful as it
does not require external invasive sensors or other measuring techniques.
11.4 CURE Trial
The CURE RCT should commence as soon as possible. The protocol has been finalised,
ethics has been updated. Future work is required on implementation of Draeger and
Hamiltion ventilation communication on CURE Soft and new mounting for hardware
needs to be developed and manufactured. Once hardware and software is re-established,
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This appendix includes additional results from Chapter 5.
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Figure A.1: Scatter plot of AUCEdrs and Vt from Patient 1.




















































































Figure A.2: Scatter plot of AUCEdrs and Vt from Patient 2.
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Figure A.3: Scatter plot of AUCEdrs and Vt from Patient 3.





















































































Figure A.4: Scatter plot of AUCEdrs and Vt from Patient 4.
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Figure A.5: Scatter plot of AUCEdrs and Vt from Patient 5.





















































































Figure A.6: Scatter plot of AUCEdrs and Vt from Patient 6.
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Figure A.7: Scatter plot of AUCEdrs and Vt from Patient 7.
























































































Figure A.8: Scatter plot of AUCEdrs and Vt from Patient 8N.
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Figure A.9: Scatter plot of AUCEdrs and Vt from Patient 9.


























































































Figure A.10: Scatter plot of AUCEdrs and Vt from Patient 10.
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Figure A.11: Scatter plot of AUCEdrs and Vt from Patient 11.






















































































Figure A.12: Scatter plot of AUCEdrs and Vt from Patient 12.
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Figure A.13: Scatter plot of AUCEdrs and Vt from Patient 13.


















































































Figure A.14: Scatter plot of AUCEdrs and Vt from Patient 14.
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Figure A.15: Scatter plot of AUCEdrs and Vt from Patient 15.





















































































Figure A.16: Scatter plot of AUCEdrs and Vt from Patient 16.
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Figure A.17: Scatter plot of AUCEdrs and Vt from Patient 17.
























































































Figure A.18: Scatter plot of AUCEdrs and Vt from Patient 18.
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Figure A.19: Scatter plot of AUCEdrs and Vt from Patient 19.






















































































Figure A.20: Scatter plot of AUCEdrs and Vt from Patient 20.
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Figure A.21: Scatter plot of AUCEdrs and Vt from Patient 21.






















































































Figure A.22: Scatter plot of AUCEdrs and Vt from Patient 22.
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Settings in Pressure Controlled Ventilation. Biomedical Engineering/Biomedizinische
Technik, c(6):10–11, 2013. doi: 10.1515/bmt-2013-4.
BIBLIOGRAPHY 214
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